var title_f28_59_29616="Clubfoot2";
var content_f28_59_29616=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F59703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F59703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sonogram of fetal clubfoot",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 390px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The plantar surface of the entire fetal right foot can be seen in the same plane as the fibula and tibia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Urania Magriples, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29616=[""].join("\n");
var outline_f28_59_29616=null;
var title_f28_59_29617="Hereditary angioedema";
var content_f28_59_29617=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F71169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F71169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hereditary angioedema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 549px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Top) Severe angioedema of the face during a cutaneous attack of hereditary angioedema. Bottom) The same patient's normal appearance.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fitzpatrick TB, Johnson RA, Wolff K, et al. (Eds). Color Atlas and Synopsis of Clinical Dermatology, 3rd ed, McGraw-Hill, New York, 1997. Copyright &copy; 1997 McGraw Hill.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29617=[""].join("\n");
var outline_f28_59_29617=null;
var title_f28_59_29618="Chigger larva";
var content_f28_59_29618=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F56494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F56494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Larval stage of Trombicula alfreddugesi (450x)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 380px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF8AbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDtYU8++WDzFXKbue9Nc+WzKzZAbbkVn3EkX9pQGcMUiYHKddpqaaOF7a6Fuz4DkhJlJDj0OK+pbaOSyLoYqTuXAHB9qeCOCPSsyz8nUYIPsskouQmG8w5Dkfwn/wCv1qyk7BzBLBIzrw6gYdPfHcfSlzW3DlLc0QkTy3zhh1p6gqiJuZgowCxyfzqpa3MMdrKdSke3lRiEWQY3D2Pepop4Z0VoJo5Aw+UqaSnFuyYOEkua2hMMDkVJ2NM3K6oFXbIB36GlQ5yDwR1FMkeKUHn0FNxjjPNO54B70gHk5FNIyMUv0pc8DvSAEAX86mqLOKcDzyc0AOGdw7D0o5JNKMdc0ueOtIAQPLJJHEFzFEZnyf4QccUq8qMVDLDHM6SOp3pkAg44Pb3FSn6/SkMXHPrSDoMYz35o9KO30oAOccUyTeOVwTnt1xT+aaN2TTAHHT1pjEkHb17fWlbI75OaB35oGQ2f2hLER3rxyTByQ6LjjsDSuAQd6gjuCKe2KrGNhctK0jkMoUJ2HJ5/GhLsG+5OCT0FKDx9KiUngUZ9etMCUcmkPHPH496avXnpTyDikBGsaJjYGwOgJ4X6UHI+tO65zTGPfFMQxj26U09BmoJ1maaIxsixgnzMjJIxwB6c1N9fxoTAbjIpjcCnnnNNbpz0qgITkkZ6U4jIpWX5hSdOvPoKBiDjmlPIoIH9KUDI565oAhwQeakGB3oZDRtycHkkdKYhR1GaMck+lBIQfN1FIrDk44NMlodkAdjR+NMLe9Ird8igViTrz0o4x359Kax44pAcdBSKRIo6H9KUkBck4Ucn2pinj6U5gHVkJ+VhjigTHJHL9mW5ZCsLnCk96Qn0zimxtO0EUE1xvhhGEUCiQkN5Y+aQ/wAI7fWhLuMU5JwOgHT0ppz2/nTtpChnYbT+tNLxqjOSdq8nj9KpBYhaElWRow3OVkB5A9KFtEVy0RMbnnK8VP0PFA6AHoKLiM24tmWfzlbyph/Ht3I31HUVOInvdqThdxz5fluXU4GTtPVT7Vd61JbSG1l81IkY+wGTSa6rcabRg2enReIrySCa6lDW6bl3dSR6g9ae0+kiW2tvsoEcj+UHi/durdiOx5q9eK/2+K6spXQ7vnhaP5seqmq32KK4lZ7u7triKZ+IlGxkOepHY1nLtI2jJayWvkWb2z1HTtvkzreRHrFKPLlX0I7Gks9ctpwguCbefO1lkGOfrV631aaZZM/8fNi3ktbzxFvMTsQ3eqOrzRx28jGIPFN8oi2blRjx07CoXMtyvdlpI1T93jGDzkURtu3A/fQ4Yf1qC18P3llZW8mm3kU+9QZLKd9roe4UnqPSo728FoBNcRvCycOGHGPeqU00ZOHbqXiemKXqKblGQPCweMjcpB6inLyqsucEdaoi1hHJXy1HWRwoqaSN4JDFMuHFV50MibQ2x1YOrDsRUxeaaTzLpg0h4yO9IBysM8ipYVEsqxKyiRvuqTgmq4Hc+tMe2D3UFyruk0JO1l9D1FS03sw6FogqxVxhgcEUHjpRI5klZ2OSxyaBk96BsQnPFAPNLjPekIINMQvQ8GmnOQoGS3QDrS9aQs0cscsUmx4+hxnOeooGNIyeRSAEY9KPOXd7GnDkcUDEYVEVOcipfrSYyTg570AQKgDbiT0xjPFPxkc/nUqR7/lRlLntnmkK7cgimAwDpigkfhQOBmkJ4pADY6bhkUw+9DruAwADnOaXAAIJyaYDMDPvTCMnipQuCcE/SmEHP+FNCImBxz+FMwcZNTEVAdhuHFxI6RLFuTAzub0oGtQYD160w896VWBA2g9O9DZ/D2poQmO2acBzyTUE0qxtErOiebIIw7nCrnuanXjeAQ654Yd6B26gx5/WkJIBOMmkbjrTS3XmmIjgR5XZ5jwOgNOY88dKcewPSmAfN1pgABIJoAGMDk09Rjg07igTI+9KOB9KVjggYJc9FH8z6Cl2lYnkmdEjXlmY7VQe5NK9lcFroCDnnmnbHaURRDdJ3AGdo965u78YWsO6PR7OfU5/urIPkiz7Hqalhg1e6sfN1nUEsbQ/M9rZHDEf7T9TUyk46vRd3/VzRQXV/dr/AMD8TXv7+x0hXN9eRrOeBGg8xx9QOlZdt4r08SmBdOvzGT/r5PlBP941Ppml2505vsHlxs7j5Zh94evqT3qxpWoG6v5rG/jWS0jyrO+I40Qdz3JqHJOPNq1939feNLWyS+f9JfmXbG5tNREkkVvdGNPlQjndjt7Vmanc6jfKLeytxAocAx8ElfUkVVfV9Q1+YWGgrJZ6Dbkq82Nvm89j1rXtLFbaJoonKxt1APX6mrjFrR/iyG1uv6+8mxz1pyjIpg9c9acvfvWhA+lGSeaM+p4oDCkMUZU8k49qZd2NrqHNzEjv2kHDipgOcigqD1ApARi1khje5mmnlMKfKVPLKOxFZFxdxSX9ndWxYbj8g6EMf7w6GtoIAw4xReW1tew+XdW8bgdGUbWH4ip5S1N7NXJL8GOySU+XJsBHqCe49qxtUv1dbY2/nPvXYyOflJP8LZ7VHqlodLhjnsVmktFGJ4N27H+2Kd4ZsYtRuLoJqMa2luyzMhb5mz2A9qzmoqNp7fgaRdlzR3/H8DRk0+wWxF7oV3JYPkKbW6yYw3cBu3NMsdTU3U1leJ9muxhthPDe6nuKddI1xIZbcqlvHlY0B+SRfVvWpI4YLq1dGslxjJjduAfVG6qaSjKKve424vSS1LtOUgrkd/0NZ0cdxY2/mRu97YLw5x+9g9nHce9POpWsDB/OQwyEAkn7p7H/ABqlJNXMnB30NADNOHsaYjhnKrxIvVTT1OVpk2FHfk9aU5pOe3ag845oEKPu9aXHFMz2pVOT1PFAw/Wq85IFWCDyeDzUbpu44oQGQ0sgc45PYZ61qWz7Ig0hxUX2b5+MZzRfRSLbK0S7jG24r6iqeoORMHDEggj60Q+dJt2BgBkNyAMjvjuKpeN9bS78PTSWtsbdo4trHHPPH4fWtA6da3Flp91HEsqSWSnJbdgjisubVJ6XL5Xa5ADLHdwxXxzBMSomVNrQtg4OR2zVxBJLGVn2GUDIlT7sgHqOzVSayjVt0BeJu+w8H6jvRpclzbat5dxGJLOVCDIowVPbiqcbaoV76Ex68dKaQM09snPGajfgHoKoQuOMVGegrI8Uald2OiyvaIzXgdAoQfeUsBke9dFeoFaNthTzYkk2sOhI5H50r62G1oVetIw570vU4pjk7ee1USNYgAimE8cZ61FJJg/MeadGd3FOwCEfN0pCPwqVgB6YqM8cfjQBG6qwKsqsOvzDNH1pTmkB2hi2SAM0wGsSCuVJBPUdqXFPih36aL2SRV3thI880yRiiM23cQOAOpPpQtdgeg1s96bnFQadO89jHLeQyW9y5P7knJI+napiMbmbaigZYscBR6k9qE9LvQdtbIeWAQluABSXMsNnbm4v5khQDKoeWP0A5Nc1f+JWmKx6DAbgq+HupF/dp7gd/wAfyrMutO86/tp7i6upRMShnd8GWT6dl9KluTXu6eZcYLrqdroV9BqSXLQxzbIRvlkfALE9FA7ewri9cbV9U1OL+0dkWmrLj7Kh4Vff1PvXfaHbJY+FxptiiRoGLCQICWf/AG81zXiuJbNIGBJ2t8oKk7z1wcetTQipJqWrJbal2NxJ7TUdGibTI4w9sdjRxxgJjs2fWud1LTpbu6tIVXywZfMuZ8cKoHTPpVjQNZjh0+5Fvp16HnUhbUAYDepY9s0g0/WL+1EWsXXk25HzQWpx8voT3p01NJpr7/61HLli7J/dqMtPEv2DVXGl2y3zo+yCZ13FVxyQvT8TSR6BLdas+p+I73ZFcOZPsyt8kffDY6mtzS7O306AQ2NusSd2Y5Y/U1ZkRZInilVXjYYKkVajGLuv6/yJlJy/r82SWOi39zphvbeRRY43IFPG36dqr2snmxA+tVoLW/tEuLexv2isrjG+MngD0FXIYRFEkcfKjv60JSV+Zp9rfqTfz/4A/g+9KvAqNM5walH3QMVQEbttJqFZQWIFSTfxetUogfMOT0ppBc1Y24BJqXoaitQCAG9an7mpe4IYfXnmlyw5X/Ghu1Ip4yKQCws0eMW6k5JyG21E1tYyX6NNpflvIrK00L4OPcd6sKM9uKkGB3xSC3UjmsTDEkmmhZdi4aAtw3+Bqm82Ua5uIriD5NrQlcgH1zV8kAg56d6ljuGAOHJHoeRUcpamyDS2ZdN+22rlZDkCVTz9CO49qy5b9dRtzGbe0LqzCUCLiQH1Hb8Kf4iEggiuLdWVYtwkWHjIPfHfFP8ABjw6lLe3U8sEcVhF/ul89zUVLJXkaR1V0tf18iDULcWsVofD98GnKh1tbokOnqme4rTe6ktrpINTt3s5pBkBvuk/WqUsMt48jI/leeu1125KAdCD2q9G9wIxDqDnUYT+7KP1VPY+tLllFaO4OSekv6/r5ltSCSD1HXHp60oOW+U8jtWdvaxO6JvtVmuQrZ/eBO6sPUVdkIKCSBtxA3Kezj0qlJMiUOUdkYzSrjimgqypIn3HGRSDOPeqIsSdfWlB+bGOajJx9aQP370DRBql7Hp9v9omSR4wwDeWMkD1q0kkUkUctvL50bDejY2549KF5/8Ar1VvLk2VtLcLGrQQRljH0Jx2HpSa6jWuhg6zqcM18+m3KtHDgtcmHqy8ELz0PvW14d1KHUdJ861WSNY38oKWyNmMj8Qcg1BowtIdKee7gnvLi+AnZ44idrH+Ee3QUvhO1ubXTdQ+0wSQJ54dUkAHylm5HoMGp5EnfU0U9OUs3Nw8V9p1tGcG6m2HHUKBkkfpTL7V4dLu4ra7ZnE28dMj5Rx+ZxUdiEn122vyfkBa3twfTu34mszxjBcLq2n3CMqNbEuxI3dckAj32mlVajFsdOPNNR/rzNeO7uLfTzd3LnhWcqB1A9PyqzFJ9r0uwvGj8o3cAlKf3c54qGVnuPD+meegR7m3xge5NaZT92lm4w6KPKz0OByKcdkyKm7SOG8ZXd1ZrYwQXJgUuXVwM7mH3U/E4rd0LXJtYSaw1JGGraeTvJ/jjH+GRWZr8kKappyaqTPaNN5m3b/qgOM8fWq2spHpniiTXtAvI5LUMBJA8oDSp0br7U5QV+a2v9aXLjJtcstv61/rodMe+etNk5FWLlVR02nMboJFIOflPIqu3+RWkXdXMGrOzKc0RZs/pUka9AM1IV//AFU9RgfLVXENcYHNRnqMDpUjHJHOaj6+xpIZGeAcmkPABbp6Gh2XDSOf3Sen8TegpsjpBHJdXsiRxxjLFj8qD/GhtJXY7X0ES2jVgUU7uwJzj6CoLu+t7YuJJ1Eo6IvzN9cf41QnmvtUhSS1D2lnI+E3Kd8w9SR90e1YmsaSkMEZvthikmxJJGuCq9Bz6CpanNaO35lw5PU7TSCsmmSX9xZzwW5P7t9wZ5fU1hXNpPrs8kWoBrWyjfaLTPzSY5yxrp9OR5NFggi8wxW4xlRyMdPqKydTN6b+N7G2SdWTLySvt2emQOvfpUUtV3a8/wDMl6OzditILezjWIIFhjG3y4h8y+mB/WqPiC3lutKcQwx2zgeZG88oDfLz0q9PBqUnmSy38ULHG4wxAYA9zzWcfDdrqFyb3UGubkyfxyEhT9K2Sm3dtL73/l+Y+aK2u/w/P/IZ4f8AFerzXMn2K0gdZFVzGQCZGxyR6V1kH2prcy6jGgvJfvKo+WNfT6+9ULXTLW1i8u2iWFf9nirKQbejtj0Jz/Os1QpwfNFailUc9JIlXgnlQfQGkYZz1oBI44OO2KkijknuVt4VBcqZGJ4CqK0btqyV5DAvzc0pB5Ofwptk0t40wtYy8cHEknYU4vvQMvQ0X1sDFIFBHHHSmFiDyTz2p4J4piI8DqaUH0HFB6Y5pM4+lMYrDd2qDysNxUxOBntSZ59adxWJojjHGMU/d3zzVcHLZBp27LY5x61IIlJzRkDtTM9PakzQBMGJFCgsc7sUxASMjNSouKQwmQleDz6Uq7gh+UCkZwDg9akjIPfikBFuxznBqH+z7VnnnEKCaRNrY6N9RVtkHXODRt4/wpPVWBaO5kDXzBq9tFd2rQ2wbZK4ORtrbnnieaYacwNrxsfOcis2/tjIpKhQ3Xkda47UtZv9DtjAqDaCQGxk4NQ4pao0h7710OtOyV5JYX2yw8k9m9jWZY6vJpaLPdlP7KlmMcbDOYT6H2qPQPNSyR9XIhjP7wxtwXz3PtS6klvq06XCKBEnSMdD9R0pcrk02XFprT4TqbUj7O2xg0aynYwOQVPIxU2RWF4ZgksbPyg5ltpJGYIOWgP9VrYz75B6Ed6cXfcznGz0JfXFN7UinnPWnduKokVSPwrMvhNc6rZ20MfmWsDCe7AOPl6KD7Z5/CtPOG9qy/DU1pcSa1cX8l1bXX2jygEzjyV4U4x9aiTt0Glc2bh3d/3WoCEL90CHgD096xbrXri4lk0lzG5+ZHmRcFkZeOOxyQK3n0ZtQVZtN1YSx+gVSa4rxTaxeFpEv7triS4uZo42J/ujnj8QKyfJLrr/AF5GkW07WsdU9lO9zfW9hsFxp2xl3EKoj29T+R/KuYgkPifQtX1W8LRXaypJHt4wVBwAD2wOfrU9tqlxJOJb7ybSC/kPnkgjLCPkE+mGGB7Vch1KO5mGi3c6SbYpFMkMW0ZK7WX8OD+NYtzm1Frf7/6udVFKkud7f1ovluO8Pv8A234cmt0WZbvTXBR0GSRIc8D2Ofyq/b6tJb6RNbXzC4vrWBpI/MTy3Lq2APxrA8Cz3dr4zvovPRmhTYtuDjzWBOcdsnqKsa/5Wq+Ik0iZmt7a4AeMMcyxvGQSM9uc0OTjeD2WvmjOonrL+n6F3TJ7bUr+aX5Ybq7KrbQyjqVHzrnsc1FqIlcut3p1ncxQ5IjLcgj04qzdWuonWyyQxCW0uN4cjhjsAJwPXg/WmzW2qCQzTfZFVRk7z1rqjfeT09TCST9f68ir4b10+INPla5iWC/tCEkhC7cRk/Kce3Sr7daw7OaMeOHm+0RP9ptRbXCRLhYmJ+QknrzxW8ykMQ3DA4I96dJx1UdhT1tIi45zTGJ78CpGGeeKjRmdmBHA71qZCYqOUMxVEOGk4B9B3NSnr7VmalqD2979msQkuptFiJG+7EWP32/AHilJ2KirjNSvxbX8FpaQrPeBcW9uxwN3d39gPzNWtR0WS/0u0j1OZvOVizIuArMPWuNuLe70a9ttSkc3iPKJLpz1bHT8OteoWd9a63YrcxOpjmPJXpG/9Kxk3CopS26M0ceaN47f1uc6lwystvcIEZRhCO49qS7smvLeWImNlKY2vHux7ires6fcSIFSFvtCH91IThSff2rMTSbmWNkv76Rg3WOD5F+mepFbXv8ADYi6tqYHhPUtX/tFoNMYTPaL5GckxkZzl/THSuwE80lsn2mSIzljvCLtyfYegqC10y1s4VjtIvIA5zHwSfU1OiyqTslYn1cBqPZQUuaK1B1JSXvEdxD59rLDnaXGAfSpWn1C4tLS1uxCkNsML5Y+99aeN5OWYNx2AFOI6Yz71TSdrom7WwmBjtxQF55ocrGmT0/nSgk9VK+xoENA+al8tGZXYHcvGQcEj0pw5bmnN7daAILaKe1iuILW6aK2nOXjC/yNP8vZGFUYUDFSpwOeD70hbnvR1uNttWbICtSYyoPf9aeRlc96BjGehPFMkpXMyxCIE7Q7bS3pTgBuYB96jo1R+bEZfKuGCoykqSu4M3p7Uu4AAYCgdhTKFbO7A5oJ96Acjjg96Q8HJGM0APU+/WnKefemD3p24A5oESA8c05FBGRUYlDcU5OCcUhkyjYT6GlL8HFM3ZGKVB60gFBJIJqUMO9NAA7U/OBnjikwDqKRs84p4YHqOfagn6UgGLkLhqzdd0uDU7Xy5FUEHORWnkDNNJVzt7+tCA821yHU7m5WP55o4BsznjA6c0/Rbt1nCGN8KfuHoT/hXeXNgJo5VQAeYNpwcZFN0nSNMt/OiLok6R+Z5bdSP9k96fPGC1NOeUtCCwuyl7ZSS5gtYnzIyD7o9APSrtiQnmWwmWeNGLwzKeHQn+hqo7m6RgqmLaPlVuN30PQ0aWcLJBdSraXEC+cskikqytgMv14zWMk4y5180VG0lys1xxTwfbmq1zMItQ0/T4sLcXr7YZZJAUYdST+FWLpHtL1rS5YCdRuB/vD1pe1hflvqL2UrXQuMjGKuLZx3tgwQvFPGvEiHBH+NUx29atabdLazgyZMZ4Yf1p1E7XjuiI6M56Vby2uVktnzdKfm8tcFh79q4bxR4j/tDUbS01UzSXVpIxl2kFVPVMdjxgGvVPE1m4hbT7C6RJdQbzDNI4B8vPIH05rzbxJ4f0mLSLi4tp2+1M3mKQ2CwXoD7k5NYuVKs9HZr7zojzw6XX4WOgtTBrHw61xCn2m+H7+2jk5YSAYfHr64pvhbWNIHgiK7ihMl/ZzpG/m4DPu68CuRsvEe9Bb2wnhcvHMk0S5Abbhs+5OOK6PULRJLu6nMccM1zPEzqowAAANwH1JrKnTm3q/T8LltR+Eb4KmOoeNdUXUbRrWcXTTpLjARGHRvbgEGro1mw1D4iy6pfFIbSzkMCORy6gcHP4D865hLhpdek1m9nMentc/ZZCD1ZVGAfbg10NnoB1zU4PKmt0spZZJAZuTt+UZA7nrRJWm3e11b07kXvdSV/wDgdFubcPiiW68UySEbNMuIdqlckbxn5iccE8fhS6nFc3ILzP5cTDgock+tOvNDGjXsccLFdIn2Q+YTuMMoPyk+oP8AXFLcRNpi3UVw4WJH3nceE4559O/0NbUVCDte4pp1Fzdexxmu6fbJqGmRWKul5eXCDduO4qrAszfhXe3Db5ncd3J/WuW8M2cl7q9xr9ypClDBZoegXPLgdge34104Ut8q5zXW/M52+i2GP0IphBAI5FPtbizuLsWonJbds8xQNm/+6D3P0pfEMtvoFnJcah5mFO1VQB95/oPc1n7WN7dQ5WjD1vVvstxb6faSquoXDLyf+WSE4J+p7Vqav4disdSlurIswuFUu+7JfAxwf6VlRaC13pK3V0BHqdwxujIpztx91R7AVo6VrU0EQt9TXCjjd/D9c9qeqfPHXuOPvbbleMwsq210U2/cVnOAfYmua89/C+uQpYXKva3shBt4/nO7HYd+1db4iisnjhNtfwx3k7qkXljexJ9vpUEGkWtpeSTnN1d5Km4lOWP+72A+lJSjWjZPRju4PzJ4TqT3f2/UwY5ygSOAcRxD+8R3b9BUpzkktmo1Ro+IZ5UB7bsj8jTz5/Qyg+5QVSio6JEt33Aj5Rzg0U4AgDcQTjsMUo+lWIYBz0p/Uc0qjIxQeD9aBEcqMTGY8F4nDgN0PtUksktxM804VXP8K9BSgv5SK7byufmIAOCaaPrSQCYwTSn7vp7mkYgDJOBUJ/eYLjCAnC0wJvMTgKCxPHHAprjp0B9jTlAA4zjrTSRkHtnmgBxcKmWIH1pAwdcA5pjhob5ZXtzPEoxtB6VNNL585kEPkpjATvTEZgOB160q9OtRE4+lPQ5z0qih68nmnn0poP40oOfakAtRnzJZHSFGdkGWwOlSjFRqtxBdvcWdwYWkXZIpGQRQBXjn546VfhkDCqohAPGSc1PCu3OKbsIs5zTxxg4qJRzT930qAH7iaQ5xzS5IoJyMZoGEbkketTYPeohGewP1p/PSkwHFc0xV2noPrTx9aCOtIAGR0GfpVW/t3uVjaJUjuImDRyv8231GO4NWgc/WggAetAEd28cqpHdxqgcY3Afu8/Xt+NV9KtJF1C7t0uJBttTIpzuVeeOueKtkZHbB9fSsq804x3CXNgsisF2vHHIV8xf7uDxUOLtZMuMl9pfcZNjo9xquopILuZEs5QEGwDDdSRxV/U9KvEuPOgvJZJlfJ81sg/59qm+H1+bfT7nTrywuLbUw7MpkORIGJzt+gxWne+fbxF/KZsHGHGCfoKm6cnFx1NXeL5oy06akWjyzS2+Lojz0baw/kavEEHnINZ2g6zYSNPDes0ersWk27MKkY+VQp7nnn611lj5Wt6Q06ADaT5Ug9uv4Vz/WFCXJJf8AACcHKz6s838d6XPqNxp06XE8UduHXMTYKbh69hV228LGzs1iuVW4ByY3zkFRgc/zrU1kqNNuYpo2ZZF8oqP9rjr7VneG5jZJb6Je6ksV1bZkTzvu3ERHy7T6+tbVJ+y9/oKCc7pt3MG7jtdJ8ST3jWbHStgjYJwA2PvD05q9Pqo1HVNNtLG3e7ht4GSY5CyEMD1z1xgEH2rV1OAyG8tpRGbZIWkTuGJH61xSJeanr1z/AGeTFLDaRxRrGOT1B/ADNTVi5R5k9S9lZpf1/wAAb8P720vdK1uwvprbaZHmhWfnfIcgceox+td7pK2dz4XtTPHIGSQSlhxtyMYHpiuZ8B+HNNgtobvUbdZWnLEY6gbcE/nzWjcSNo0VpqTTM1k/7qSMdXKg4IHvimocjbv5gmpa2s+4a54Z1fUb+3ittXYWbITKrtnaoOQRjuK27/Rone0kvbyS9d41aSNyNpIGAxA69utcOPFQ0eXWLvUDMnmwN9ntpMqRngDPfHtVv4aeJNN1HSp1hLyagnzyxSt1HbB/ugdqiM03zNJW8hcknHmu2n/XzO1A6YwF7egFctq17q+tRi20GL7PYNLse9Y4MgHXHov0rora8TWvBurXtmxuHwY9sa4eIjrtH0JpPC1/bX2nf2fZKr2ljFsjkbhmOfut71oq0ZK9r62MuSSWjOP0Cxnj8RkRSG1hstkksKnKygH7656e9dz4lsxPqonu8yxTLlIyewGelYPiG1/s67XUFjlMSo0UrBeMEdPzqvpUlt4o0CCwJmsL6BRItymW/wB5WJ6fSqk1GalBf15lNc0bs244/wCzbRJJnjiiAIO98BFbnHNcz4jmTVoDpmihryZ2USyoCIlTOTl/p6VuTaZDdTQy6pJJfyQqFjWb7i4/2RxmriqsaYjVUX0UYFapPdmTl2+8ztL0+w08+aGJuiCu8xH5F/ur7e/erwkiPRnb6RmpO3GKXH+RVMS0GdRwG/HFPwM8Cg5AyaXGPpSGNA5FL3xinY96P4qBDV756UNjtThjH6UEcdaAGnOCDSYwMYpzcjikBwP8aEJkTA5zj86TALbsc+tSZ4I7U0jAyDVCBe/XjionU5bP3SKmUHHBxQefvEEUCuPb5hlWB6ZpPT1piIsQYgnLU5CdvPPFFhmUaVeRx3prEZ60q1ZRJn0FOXr2po6cGn5HtUsB/QjFL3FRlueKTzBu5oAl4xmnCofMHrQkm4mkBYFPPFRL71IORxQBIDxz1pQFyPmQe26mjb36fTNEktrGmWgnm/2UQD+dQ3YaVyYqQM44x1HSnLVOCaISsYILy2AHUsrBvqtWTKskanfLG3dQmBSUr9BuNh7Drj8qAe1Mt3EmVSXzGH8LcNUhyOWwB78UxCZAoGOKV/u5wCp7g5FIrDGMUCAHsKBxmkbI5yBQDkd8UDI720S/tGt5TIFboyNhlPqp7GubTxBqlvYW+luw1DUS8kUcrA+ZFFn5Sx9an8aanqFjYxRaSHjuJ2Ia4Vd3lKOpArK8C65cWVneWg0+y1D7NmSaYNtmlXqWGeTjPQVhV0s3G5vBNRun/l/w5cuNAvNQWI306Wfk9HiX5m9QD3HrUGn67d+ANUsrdLqS80m5LF0x/q+mSPbmuumuvP1W5aAB9LEMclvkfONwBxWLrunQ3i8jMqg7B/OidKFaHJNaDTlB2udJ4n+za9bSw6DMsksyruZDlVypOQRxuwMYrziK9XNvoutxhb61lUWkwOZBk/db/ZNdf4WtIbe0lTQSQsBSZ41YgLJnBJPoRniub8UaJLaahc6vvim3SCSVozkr7gexrOFP93y812tn1Kcru7Xy/U73VrvUJIDP/Z6SRyQoFRVB2kcMMj3Fcl4cuJLbxHrk4i8uUacXQMuCG+YYH51u6Ncy3WlNbSSSRzXANxaMo4fHLp9e/wCNRxQNdXFyYWYssO12cYJ9qqmk4crB6O/9aFe10u7s4bO2dWJ+xoQQejnkj9a4nxZrsk0FvpVrIJXicwtIvJ8wk4x+gruvEF1eabo8l3K0j/JsVgME5GABWJ4U0GG5aytbm0aG0siJ7ybHMsn3ljB74J5rTSW5HNpbcxtS8C3Ws2jS+KNRWG5ji3ib+ADHc/hXmfhHRdUuPEbx+HAbjynOZQdqso9a9r+JT6hrl3aaBp8Qje/fe3sg6fStHwV4LsfC1jLIzh9QyUmeOXJAPtUys4pOyXYmXMnZO76szdNvZ/B1tb2Gr2zWscwExe0fKOx7MT0rsbeDT9fsPM8OvBaalGMiDG0S47MPX3rOFvHqNpqVtq0gFjaDPmsPmYen1rzSLWWXXxb6RbXrKsgEDl9pwBxk1MoNa09Gt+xpFK2v3nZw6RqOrWN1FrkjJaxXBXyUl557Y/PmttIoraFYLWNIoUG1UQYFU/BXi0+K4byy1CFLfVIGyCBgTY7E92q8CZJGSNS7KMt7VtTe6asYVI2d738xpHPPSgDjg0HJ7cjrQoPtitCBuDzS449KeVJXp0pMelADSCRxSheetPOBj0oIPJA470mMQYBpDjPTrSlvbmmdTmmIeCcY7imseRzilTpxTT+goGB6Z7UlD9OOtBOAeaEAz9aZdny7SSQdFIJ+lPBOTTmwRgjIPBHrVIliWRtJbm8F5MsMMUSvCyyZMjHqMVEhygPOD0zUiQQL92GMe+KHzntj6UJakthzjp+dKueOtBPHPSpAOOeDQJMxSe1KOQcU3vzQM9q0NCTPHFSZ9ajUZ5qTbJj5Ac+mKQhCc1WlcoeBmryJdHgW4lJ7AYNR3yWtsgbUZo9OJ6ee4OfwHNS5RW7Gk3sUDc4PMTlT3BqW3ubdyB5pjb0kGB+dV4NW8NiR0l1kBl6bYWIP403UNdtLS1FxpelvrEZHJeMoPw9al1F0T+4r2cuuhueW6AFx97oQeD+NOB5965rw543m1S5ax0+0tLKRlOVkgLqh7A5rR+2eJXdoU1bTorpMFovsPAB6c+lQpSa2K5I7X/B/5GnJcTRn5LaOf2zioJfEmnWk4g1EWdpOf+WZmZm/ICmtd+Kkt3V7jTWnC4LG2AH1BFUF0WHWWtrLWIFdxEP3qgBmY+v41MlOS10+dxLlW+pd1HxEsfkmw0e5uYpTt88P+7z6cc02TVtZa3eSz0W1iZOCbmb5WPoKteDFe28MXNq8Zj8iOVdp/wBk8EVZggR9FtmfaZJEDEPyTn60lGOz1t5v9B3a7denb1uc5Za9qd1qJt72w08vJHmGOIAkN6EgjFbmn39w90LDWtCuIrpFJNwkmUx25PWqngaxNxquoP5QkhWYxpkA49a0tVjOnx3TwkqZGbbgngelSoxb0f4jbbly/ovmV9L1HTruyju4LgWrtI0bwSHKsFOCcjp+NaF5E1nEZZVZocblMfzbx7VzOl6Iuk209xaHbcygvzyM+4q7odt+5nju7meT7SQ8K7iDCeuAfTrx6VfLNddP6/rUV4vVIz9I8X3Wra3NpFosFozD90ZUDEfXPJqXUdW8SaRqcdjcaZY6huXe01spRlT154zS6vp8VkY57W2H9oq3mwtt7dCc+ldBAjW+lL5z+ZcsczSe3XH0qPZRWm6/Evmf9Jf5GXqV1BrFrLLpSfZ9T09RPLazngoOrAjt2NZaeGdM1DxBFfm9t9HimiWZoBLxnHzLnoM8HFLomu6daeINVu9UcQzyeXDAuwkPB/F9cng1x3imOdteuo9HuFn09WSRAp5UJyPxGcfhUuVRLlh+Jooxabfp/X4nqhaQai7NHGFmIUeWcowAwCp9MVUvgbYXAdXMrggKw+6K4XSvG0/hK98qZW1XS5zkxuu3Y/bHoea6M/EfSdS1C3tYpnsxK2WS7Tcqe2eoFZKvNO0oady/ZqTun8ix8NUmstW1a3kuA0E0LF4NvIYcYPtVrU7TzLaeGWHYVjwGQ87WH61oafZrb3d9rEcZCXEe1pIzujJxjIIrF8R6pLY6NJPborT7lXPX5a0g1a8dbiSd9StoXiO20LS7TT/Ef2yN7Cbz7O6ij3b/AGP4HFWtH8ZWF1qV617YXtvZStlJ1jOefar6Pb3el2V5JGjOqjco5HSoI38+VAEXZjABHA9Kn2cXqm0JN2tZGbq95ceJ9TsrDRprmTToZhJNPOuAMHpXeT6ktvHb2NpGhgBwrEZLHqxP1ri73WNR03XbSC2hUWcrhZXGNpPeunvljhm8uFckqXGB7dqaitmgerv/AEjk9EnufEHxUub5dx03TozGWXjcQORXUCXy9Ra7CpFDOrRSSd07oSPY/wA6zPhykWg+HdRm1YfZY7iZn8yTjIpur+MvDMNsYZ7ozR87hCv3j2yahzim42v6CjBvUkOnTzeFNRtL/DXN2hEdzCxIZ88bl7Vi6TpGpad4LupdT8oahvCJbhQXwO9UdZ+Kd5qGnix8JacYLWADzZ2Xc5X+lc7D4l1bxJqlla+WYjDwkcYPzHHUnrk1cZzSS5bXfUGlvKVz12xOnpo9jrV+I7FlXKu67dq4xux3JrnNP+IOhRX19DYG+laQcYjGXHqAareO9Xt9Tl0jS7+bbZWIVHVfvuwxuzXQ65ptjpPiKGbRbWLMtqvlkqOFIrSm4ySTvr06b9zNx5Ht/XoVtF8W+H9S1CPTzDfWs8hwJJMEA+9dBqOmS2UmOJIz92ROQa4TTvBl9YFtauriEM8o/dMvQZ659a1PFfjq+8PxPbaFpjXKkfvLlgXUE1TjNS9x3RHuy12Ni7sNQkeIwjy4B993IAq68FrEU+16hZwlhwGkHNeZ6zpniMXOm3mp38s1jdBTOiMR5IPtW/408KaSptpUeZ4fI42ucs3bmrs20m/uQLke13+B00t5YLOILO4tZX4y+8EVb/s25kBffEwA58twRXm/w/8AC0uoyT215HKlqgLRfNg49yKypLXxBHqlza6G8rQwuVYl8jrUqEtk9VuF4ddPxPUJoWQ4IIx69KgAwTVDRZ/FljbGG/jtJ4+zd60EkuZtxuYo4z/sVav1IdujuC88etNOQT0xmlO7AweaR+P5UwEboM0nrjmhugOeaOhoQCAkHgc9uKQndtJPU8mnEc8Uh5FUJkNqb8awXku0/ssRFRbhBkt65qc9qFP5YoHQUWV7oh3FIBA6808AYGKTtx2pw4x0/KgRhkwqQJZkjz0zUxh+TfFiZfVDVOSOB5F8yITS9lqGcNpzfaA6QxqMtEjda0ehdi8pm/gg4/3sGqmsa1Fo0KNex33nSHEUML53H3qca3pzQwXMdo7GTgl+FWsxtW0KLUzd3uo5lH3FjTdsrNtPQpK2rKV7rviWe3cDzLGM4KIUCZX3Y81YtPDelyWkGp+IfnaTpGbjeT7mqXiDU9LmktTDqv8AaDMSXEynao7DFadx4g09tCgtbmN5kjkGz7Pb8j9KFzRV4q3yLktVGT0+4ranp2gvqsMVoHFtLHwFXgMp9fpXa6pbltPhvLMstmsYQRx/KvFcpdao13ZS22h6HdwMR8t1KQm33q1odvrFtoT2SahKGbgbxlff61LjLf8AMlOKktfu6FK0gksfEbSLEkPmxN5io3HtwO9dtdS20FpZ3V29vA7w/vBK+GYevrXDWHhu7sdZGqXOoxvedtqEkn1xnFba6NDNcSXmpvLd3En/AD1bgfhScG7Xl9w3ON27X/D5lManf6ndzHSjHFZgbRdSodvH9wdSfek1GDWZ4NiSQTO0ZQ3DZif8AK3o40jQBVAA4UAcD6U4jPXmnyx2sJTkncxdEj1iy0L+z5ZYvObKm5di7BT2A6fjU8serx2kcNvqSzlei3MQZfwxjFaW3qKAAgJYgKOpNDjF9AjKS2Zz/h7TtW0Xa6X6jMhZ+MqCx5bHf8av6veag0EkUkAvgg/d3MZEYPsy9/wrQWdm4t4t3+3JwPy70CNiwaZzK46dgv0FJwi+lhqcl1uQWmsh9MgF7ot/9rUYk2bUjb8zVVtbuJ4rqNfD84HBt5ElXMZFaTKHyzlm+pqQNgcDg0vZx63+8SnJbW+44y41LxFDovlSafNJdhw6ysQxfnkHHQe1b+p+L7dLe3jfRLzHlg3TBdqocdBitM5xx1pY5ZoBcrD5bR3Aw+8cr9KTpR6K3zKVR9bFEyWMmkT6xa2uLVbMsvmAbw3PH8qg8JaRLL4av7i5VVnYxsFYDOztWZ4o02C00K7ktJXtnkTy9kZwspPbHT8aTwnb65KbcatcLE00UaBN3VUzjOPWlLnXwvQpKNl95dmsINYubuzaCJpzCJkXbgnH865278NWWvhzqiyQX4kEET7cMAP73rXT38sLaha3MrS6XeW7YSXqjj0z6UPBqFrJZa5ZmO7dpy8keflft+HFTJtaI1ik/iOE0PxDrfw51qOK6Y3OhvJ5bhgSpH0PQ16RrM+mXdvFqOiKt3o0uGkjAz5Ten0rO1K8tfEcV4uq2CW0MgOYz2PqPeqPwwhk0HULzSJC7aZONwaZeQCOP51g4cr5lo+qLUmtJa+ZuXWEskawIETZLBf4BUMMsUsSyhsueM9B+VTzQW1reXdvBPvhU7VI6YPaqjQvA8YtsSwk8q3BWtV3F5FiaKSd4YSuQ38XXHvWd458cab4c0z7Bpjm51boxIzspPFGsy6XbwW1lGZL+4+RABziodB8F6Ta+XqevI91qLndsY8A+9ZyXN6AnZrq/wCtTntO0fxH4u02OTVLz7Pp6ncVY4PPtWxpvw50C2icarLcXTk5Ta2FNdMnnSW9xE+1UZt0SZxjHYmpLdWeURyEbY03FmOec84NWnyqy0IlG+snf8iSxs7HT4XsdNto4bGWLbJsGWIbj+ZrmvA3huODxdqUbRyqunKzSyl8KD/CB7461raxq4tW2aefPeRREzr0UZzn6g1gXd3f2WtW4uZHKMxkuMkqsrDlQ3seKu0mn5kOK9DqvFHhTR5dQtdT+zeWUXBJOV8wDOW9TU2o39nrsEFzYahbrcxw5Qt8oI7gE1YtLm+1u0gtbz7NAL9Huz5By2R90DsM9KxYfCOjQRKjRyzFM/6xz8uewHaim+ZK7s18xStG+l7j77xJY6rf6Zp1/deVp0SjdIq7RLJ6E+lb+p2Wj3U0af21YxWaABIVcZc+5rGt9A0i3tWiFijhju+c5xVe58L6NP8Afsk49OKtU0tpNfIhzu7tfidDqS2drpYN3e28sH3SUYMT6VW16O307wstxcyK0JxsK8sPwrkL3wPpzmN4BdE7wqQxsTuPXpXRafoFvY20M9yk0qS5CRzvuA/Ci3K1eX4ApJ9DnvAnit9P8atZXo32c4wkgHHPQ11uNO0jVtXRL63LyfOik9Q1ZN54csLgnCtFk5OzirMWkaZBGqJbKzL/ABvyTQ6aUnKL3H7TmVmtTRl3JBAquWBXdnOajY8Z6n60gCgDAHHAA7UxySRg49qtEXHZwKY/I7+tKfmHPSgjgUCGUDnJpSueTSrk0DGikI49BT1GDg0hHFMQJ0NNJqRFyePTmg49aZLFHIFKBgUbfl+XHtzThjjqcUEnLh3it3Kcysfve1K9nD5QAJZ2GSxpVOTjinKR1rUtlGXQrWUgTtJKo/hzgVdt9LsowAlrCijjhRzUi8HqaeD65ouL1Int7a3nia0sbZ2RgdrKMH8cVfSNTIJXRd3ZFHyr9KhTA+70qRWOM56VLAlY5OW/+sKdukbOHCr7VHmnA8c5qbBcfHGqZKjJPc8mnIW3tuHHb3oXtzj2p2DnOaTGLjvQWG3PfoPej1GfwpHDEKUO1lIZfSkMXkEgqQ3oaTYrnLnNSSPJI5klK7zx8vSkH4UDFt4nnuHjgXc4Te3sKapygIH4Uxow0gcM6OBtJQ4yPQ0owOFzgUgHZx9aTJ7AkGg4NJ0PWgQ4N1o4H3iMetNA9eKjunCQNlSzMMIgPLGh7FIxdMJ1md7+ePfAJPKt4ycg4PpU19qFjofiEvrGoRWzqgUQAb2H4DpWXqWuW2j+HbXRvDga71jaBLcj7lu+ckD396zNL0OZNXtl8QRC5u74bmuG+bH596ybc/h0RvpFu+76eX9dDpL3xX4ZuIjFLdSsknBLxgj+fFT2On2s8CHwvq6TbBn7OxwT+Brm/EXg+yu5riDToBAsbD98OMjvioofDr6RYxajplzN9rt2Ac5+V19R/hWVn0ZstFt9x08moWkxlttXYW04+UjaBkVT0G7mj1x/tVy8+lKu2NtmScdq19QtrS9Gn6k0Syl0/wBIjccOR3HvWbPrLx6stlaWG21k5UBRgUnZ6Wv+gW0uaM9xDLI4TCKDnBGOKRDFujdZsx4zuzS3csYnEMkI6dcdqasNjHGJJ0U46BTxiq0sIzNUzD4g07VyA8EJ2svoPWt3Ur5DKZFuYmWc5Qf3axU1TTrvUm09LZjAwwWxwD6Vai0XSg7YgbcvzLubg0rdQ2NG1gm1VXQ4QNnO3gH8e1T3ekWxMK3V7DHGi4ZfMzn61yVxq2tavdmw0RUto4+DJ2xVG58Dav8AZ3xqIluJWCncxxTUW+thNxXn6HZPY28jpHYXFptzuVEf096fqVjJNPE1xDkgbSjjPmr6Z9u1eb3XhO/8PRSPPdMzDgskhBHpxV3wn8TrzQb1LHxNAbrT3PyuR8yD1FJynDXcXLGSstPU7DVbedgtxZo8BjUeXsOAqg9q3bW5/tLSYr1lCXCv5FymMfvB0P4inTWVj4r0iSbwzfxyhlB8kkb1Oc9KbpqXMFrq4trl4pRJG7RzRhsHOCMHtT9op2cen9amU4uPutCAZOe1Ix2rmmvcXmT5lvp8/uFaI/oSKGmZVVpdOuUVxlWinV1I9s4ra76r8jAguhuiyryxvHl1aJsMDjH8qbCosLXS7ETpco4+XaSzlm6A+9SR3UMbzZiuxvI2yPBnYPTg0yWOzuwBuDMpDjETo24d89jTev8AwxSaRYlBR9rjDg4IpjH060KMIFpCfXrTEGfemE/N0NPzTG//AF0xAvPNOJ/n6U0DoRSnj3pgO5PA71HMxjt5XQbmUZAp5654oUlTnrSQC3MD2c8UUs0cskib8J/DTG4HvTUjjRtyIFY9TTjzQtNxsfxj+dROe9SAgj8KifJA4/DNUiWSxnI46VJjuDUAYDI6hRkgVKHhONsjqc9GWkTY5gN09qcpqIHHFPStyiUE9Qak96iXp6U8c0hEy+1LkVGp296JH2ANxkkKM9qQFgHmnbqS5iazkVZnUlxkBaQHPQ1O4DvMIxirEb5zmqhXJz2qxFkCkwJk3yTiKFDJLjO0elJuIJDcEcEEUimaK6S5tJvKnA2kkZDClGckuxZm5Jx1NSUIH55qTccelQkc5Bp55XNACgk80jcc0i5DU5j60DG5pTnikJ5pkxIT5SRk8kUAO3/OEXDSHt2HuT2FcLrHjKBL9ldZXtIpdkrwEBmHfHcD0Irs7lreK2K3lzFp9pMMF5mw8vso61xK+GdBv5YbSCW7j1TexjgmGFmAOcK3Y+maym4vdm0FaNzvvDNroF7GJfDaxKLVzcRGT5w5IyVfvWYJJ552nuADKGLZTouewFN8Oa3o2ma09heRy2WwrHgDBVtvIap/EG23v5v7Emgu4JOTMDzGQOQw9azi+WXI3dlRi7XsSKqvpdxJdyJtIzHInQntmsuWd10fyQ6ySMAWReme1RGxNhBa3aPNcJsDSQk/J+VWdNdLvTWvo7m3hmaQRCEjDAE9Kluyu2bJN6LqPvVksrXT2mTcko2+WTho27GoEkn0qKS6kKSKGwwPVVPf603WNa0y21eK0lEkzIRvcktt9q29QlkS3t/sscb2dwRvYrncOwrO7srmnup26Gfp81vdXhV5wq7CwYnlqYYYrm6TzNxjQkYBxUF1b28c9vIYtu5SgVT+VW/N8q8jQQMGZA28HIGe2a0T1JaurlwLAsxiigVfl+8QM1UvZijooTcznYc9PrUmUCOH+eU9CDzn0p4dmkgiktwUJw3tmmRZLYh09xpkk2nPsF2QJFKnII+taqvcNCksJVmYkkA8risKLTlW/ugG3TxMU356AcgVYVbwoJ7J2Dg/6tsc+tLVockltsXILWC4t7q7vArMOoZtxHOOR6Vna/oWm6laeXNCqGMDyigwFJ7CrkL29zcQz3StbXM2YpYs4ViORxWtdaGhtp2vCxU4bCtyAOc+1XGdnZsza0ucARpHgtnhuReW+tBQYmtZPkwR8rH+tdp8PNcGuwrZalei61C8RpEkVQGAQ8BvXNeaeKNPvr3ULXUoZI8RMtshccOuTsf+hr2LwD4fNtINQltbGO72pHF5OA4AHzHHuTWFZcvvN6hzX91bEMyYZlIwehB7VBaw/ZbZbaN5DChJRXctt9hnoKv6gjrdS7xtbcSQeMc1V9ea61qjlba0GnPXNGTjrQc5OaMAjn5RzmqENJBHFNPX8KEZnit3ZoirrlVj7L2zS9Dj9KYDPY9KMevcU7BxzTcce1MBAOcUv8qM889RSk89KBFe8muIYlNtGjuSBhvSrLdSM+h4qNgTyaBxnvSsUO6Hr9KaRxxQD82fSlJyKYApOevWkPvTs8E8mmoPOuhAJI48LvLP6Ubai3dkJEQ4n4+46jPtipcr0IJ+lVIS637qiCaKWIsV3bQWXgVaiBVQGxkd6fUhrqctgZ9qeowKaSAAScfWhXXP3ufatyyYH0p4xnrUQ55zUi8nFIRIDz6GjAdSrjKnqKZk5pw9eppCHIpglhmgHmPEc7JDncKsvI087zSRrEzfwjtUQOTT/wCVS+4EqgYqQYHWolJNTLUsYoYHkd6kHpUfenE479eKkYMNqFsjqAPqanmhkt5FSULkjPFViQ2UYZU9amVAOdzMfVzk0gE6fSo3Pp+NPPSoZXI9hTAUnqajvroWNlcXLKSII97YGcelGd2CD9aqTRHVNfh0tb9LaJ4xLdKw3ZUdOKibSWrsVHuYfh3TW1+KTxBrsck7uClrFcnIA6EgelT+DbM6LrLXV/dbbW13GKOVciPPQhj2HpXaX0NlBBbQRPOFhTaoCiuU8e+VLpP9n2YllvZ2QFSu0YJ6fWpunGyXki7W+P1f+Rl/Eq10/wATWB1HRZPNvoXC3LopQNH/AHz9PWneBdMvrHwzdfbIHVZEcnzON46Db6+ua7JIEstMSykjh8wxhbgouFIx936Cs3wzNL/wiAS5z5bu/wBnDH5jGScAZ7AUlou44ttpsyoRc28VuqiSaPy84PULjrT7vTjJcabeWSW5YjEsf3Qw7N9atWMN1cWnnRxAWq8ZZ+QelWbd4Ybi1hnCBl3DYW4xUSa5bnQpe9dHETeHrptfuDDMrtK3zLy3T0rpJ7s2llp1uA/k7siXBC5Hao9W1i4ne2/s2FYgkjeaWADKDxkE1buLq3FrBpquZYeWWeRckP1wKylO9kawhFSb6kepGK4s3d1ZmibcFUYK8dQf6U/fCsRmtnkBKD5G5AY0WfmyWaETwzJuKOrD/PamI0IgVFQpHE+1T1PJo32K+Falm0uEWZIyyfa3GAD/AAn1qdEaOJ3kcyTA7TnnmofD+mLHb3t3NmR43OGbilv7sxajFJGyp5sZyoHGa1cephza2EuhPFN9ttVZjIu10J6sOn51JpTTC6T7UBbyIpZkQhlB9jVfUpSul+SkirJM20k8496hsI5r7ToYrh5IL61kKjyVyJVHfPoalLUv7Opev7QapaCRJJY722JnRinUjsR6V5mJvEv/AAlNs6z3M8rkbwpJBXPII9MV7FARKscqECRDg+rdqZaSJayXXlRILjBw+OWXsM1okuqMHJ7Jk90+l3kuk2um3NpJbOhWdDwwHUsPQjFcnpOpeILr7bpWn6e0ckLMI752KhFB4bPfNM8LeH4dK1OLVbi48wmZhLDj5UjZST+vFek69C8cQttLCbXjDRnOAyHofwqIuMZcj1YtWrrQ5XwT4qk8RGfRdUKyazag7ZhwZcdQfWthlKkgjFcD4k8Mah4Tis/ENmSbmOcPcMh6A/0r0SadLy3tr2L7l1EJeOxPWtUlF3jszOT5lfqViAe1AAx/Shh3FMjLFCZURGDHG3PK/wCNWYiJHHEMRRqgPUKKU4zk9aCen60dulMY3PH9Ka+B1708j1qO2ngjkuDdQySyEYjAHApiEzwPpSnnimop2/Mopw7dRQMGX86QjGaceQKaRwRSQCdaDyKWmlwGKnJYYzgdM9M0xjk6801wrkF0VgOm4UZ680wtg4HFNCaCUYKOgxsI6VYY5GR3qEDcuO1KWKgfePIHApkM5VZYIddthqG/7LjcdoyBWhPeaat1cJp1uZY5D8snYVCLq9hMyQxQyxTLty45T3FR2sIhhEa446kd60tfVl31JY1woz19KkxzimihqYh3Hf8AKlGMj1pFOcZFBGTxSAnQj8akHvmqqDmrYHy0mA9RgfXpUowFJdkRQMkswFQqYFvGW9keKIR7kKj759KFjjk2SSIGK5KFh0qALJG04Pp1BoJx2pAR3+lNkyelIYbgW4qwvTrVRBtNWAcj0NDAXg5xUMybhU3H+FIcFehpAVYwd5HauB8R6ZeyeMi0Fy1uZYt6uDyQOCo/z3r0YJlhjkegrmvG/l2E+mzPG0l2smVgTPmNGep9qmaT3NKb3R0d/pls9nYWSJhordQ88jlffJPrWX8Pra8TX7gPqtnqljE3nDzOZVC+mew4rT1mBtRSCcRsyPErbJmIEPH3Svc+9c/4QgC+L9avIGJisrcW7PjAaV+uB7Cs3G6K0cUvQ2NenMWmXtx/EI2P51RSA/2JY3t67+dHCFgUcbB0qXxM2NBve37up5CHtNKWXd5SoGY+oAz/ADq5aII3bMS1srq2L2sWpvGhbPluRyev5U6bRkEby3kxeZMydTjFNsrWDW9cnvJy0dvE+UCHBc1peWj3EwO5YcdWPzEH+H6VHLpY3ctdzJttN0+aPzra4DfNtkUsScepFSakglvreRxiGByUWP5d5x0NTw+XaAiK2XyyfmIHJ/GpbmUxBZZUDxL0jzzUVIJlQnZ6i2sFrGLkiZxvyYkXBdCeoNUr++e00h4dKiFxeOQGGOnqak0vSha2/wBrSRJTcEsWUkleelbdpbPZQtcSPyDwMDNZ01d81y6krRs0Q6NcOlnNHeAx5jDMp7t6VmajqCWV5ZzXdtNKszgQ4GQuexrRudZcyqq20wd+jOg8tv8AgXb8aWZL6dA8phWEjcAuDtI9K2mrGMGTw3M1pJFHc2flvcMyOzJuAFRTPJp07Xlte29zBBgOveMHPAHfrWhNIfsdtcyvKwVOVxkN6HFYvhmy06HV7qWCKSSG+GGWXkKaza01Kv1NCJpQLeSBWlEhy7dAAeelaSy3KTwrFbCTyyc5xnaRxz9aqwyMInEigTQMYmHsOh/Krdg2BNcByQEOM9xWi1WpjPfQzVuoprC9fywS0TGaPGDE24jafbng0ngYaxJ4alXVkaPyJP8ARGJ5I6ED2p0tu2zUZoFC3LWQYn+EoW6N/StOBG8N6JYWlxHNqmlzqJVlU/vIc9R9BUNe8/X9ATvHscTrXinUI72Xw9PB+8mG1pGOVdT3rufDFnJb+BrAXJHmxSvGuOm3PFZfiHQtN1q/tDYT29xMvGUb99HnpnHaumv5Fhs7SxTpbRhWI7t61TfM1yeplqm7mac803HBP86c5z3xnpTRyea2IGMOM5zSjP40MOmaWqENPT3pCeBQBz6mkcYPuKAEHSgY4z2pR7ijHPWgAIzz/KgDrkU4dOetIWVRywGTxzQgGY9u9MVZh5iC4cW0kgleDaOXAxnd1x7VNjH0NIeox0zQO4hXrxzUDD1GfpVkc5zUcox8oyWPPHNCC5GV6GnAd+tO6pkClA7mqIZzwHOD3pQvBxilwMcijcK0NBVX1FDDFOUgjikPfNAhuORT+3+NJ1NKPagQ5Ey3+FWApHBzUONylehIxwelTIcIFyTgY5pMCQEkDIBHvzT+c1GnTvTzUgPU5xSnk1GCc8U8nIGe9IAx+dPAwtNHTgUo9D1pDAHnFO9u9R554Gafk7c+lAEctwQZQsogtoRuuLjuB/dWsbwG9nrmvavxMGliDxXPm52bTwuffvU3iBvL0aO0jj8+5uplUxBcjBPOfwrSl0CztZJLvw4Vi3riVIV2hCOCu2spWfUtWeg/VpPsFjczz+dtVSWyc9uxrN8HQm38IWTuCLi+ZruZm4LZPy5/DFYHjXUNTaKy02Vd8N1MEQKxDF+2R6V3M8Yt0gtQcrbxJDn12jFNL+vQp7/11MjxAiyaPdoTlmibH1qh9ol1Ozg8oFIUtwDg+tbrKjcMobHXNYvh91jj1HRAgW4MpKHqSnUfQU2h03Zip5UNrHDCCoQBmb39aSNZHLJKwZBjkVPfWN7bDEi7AyZQ8EN9KiAS4tlV3wwIJKnr7Gk+5aGW0iSzSjY3lK2C4BwCKjuopwqzMEkdZflTopB4pHYW11NiZkt9ynZjgEjk028unF3BaQrueY+YZGH3VFQ721LS7F+O4SNRcSBY/KwzAdCB2psepz3tjcXlohVXU4V+ciqeqp9lljtTbeYL4YBLZzjr9Kvyo9lpyQRIwYx9EPIx2zS322KtZ6kQjee9tbSR5pIpIyziI7QTxgH268VLptxczQzQpZ7PKLIS3QbTg1dgkhsYlyGFxIARnkg+lUgkmnanKrmSRL5N7heQXB7+nBrOd7XiVDlbs0bJYQW1ujEEleAPmGKrqY21C3Ubd6tlkAxT4JEitg2wR5GCoAOT9ah0t5bbUHmaKCVJw5G8cqVH8qp6K7MlvZFm7hP2g3KZaQcMg6Ov+Ip8u02ubdt0TdfVfahLd3QS2spMp+bB9fYU2TybYSXl+32SKFcyE9HPsK0SMmzUvJoBpi2cdq9x9vja2eaNuIdoyM03Tbh9U8GRSIQJIi0TbfUcH/Gk0u4I8JwXIQK10ZbrA4yOQv8AKsnwbqMFvoktm4jee1U3alDkOCeVPv2rO1o38yb6peRzFpaTfDfVY9dlzdQTzhSM/MM9a9K1Aw3Q+2WZDW8yiUeq5rzbxeb3xLrumy6Vay3GmIh/dICQSepPuK7/AMOXLz+HLNHszA0Ba3YHuB0zVTVpKfVgtU49iF0FIB17mpXGARjpTFGADjHHT0rW5kRsvHTmmkYzUp6d6aRzz2pgR89xTW4qSo3GcUwEApRxTgMdelJtyf8AGgBSOPWmqssczyQtEd8flMJY9+B6r6GpSOP1pDznHFK11ZjvYYqgDGc4oK/L6GhV/TvS445HFMBq5IUEIoUAfL39zQGkjkZonUb1w24fyp656d6Y4x+fWgVyLIA25J98U4dB70rqcdeKaOOOv0pgYJppzipwufejy/WtblDIge1OZeakVccYpdtK4iID2owMjnrUoUdxxS7QTggYoEAWngYHPXtQAzSrHGpeQjOB2oGQSGG0g4IpAOXPQ08+2cUxTwSc8U8DuD1pALjJp4pq0/A5xSActDDnPNKo4paQxkqM8bCM4Y4xk4z7Ul05DstvCYXkIWNC27B9c1KMY6UxR/pDOekaZHsTSYLcxo9dhsPFkCfZGuLazKrJKUJRHbq7Ed/SuwmvtIMryrcfZsAuZhyufUjvXIeDtL+2aLqNzJcPMt1cuJY1+UoQSBg/xA1l634Ye3spLqxvJUMZ3GGblGxzj61jKN7u+prG1tP6sdJpXmai51C/ZLi6F06Ry+XtCxKBt2jtnOatOS7kn1yaXSbuabQbaS5hMMkxZ1RlwyrgAZH4UjnaMngVcVbQndJjCMGsfVJLnTLtdSsQGd18iZNm4sh7geo5/CtnGcZqOIb9SY9Vt4t3/AmOB+macnoOK1KtvBF5LCyd5tOl+eJA24Qkjnb7d8Vm2hSO2jjm0+SKVpGVrpJt6NtOOnVasDTrqwlaXRZxGrNva2f7hP8AsntVzSpLXUY721vGWz1COUz4f5QVI5z7e9TJKNuxpGV7ohNq8t+jeaPs00R/eEAhWX61T8Oh5557m/JIiLRqMY47Gq3iay1GOay+y3KLZSNjzIiHT35HStjUBL9iSC0dXdoyA/C5IqErs1v7thkcYe6Ml6EcxJuj+bkVCk7X9xdW0dxHA5UGNWBJYEdvx4qGWATxWtwbK6hDxlXM0gIORxjH0rX0u3Wz0CGSMr5u7GTycfWmvImTvuLCEs8LM6yXBUBnbt7VBPiOa2uCSyoxjYBuDu6UtxGomeWQfMccNzmqOp61FYTwWcsSRG5HEsiFlDA8AY70OKSEnrobMSgmRCML1A75p4YNqdgmODHKMk9TtpUcy2sLwgtKwIzsK7h6kGoZkeGaxubjYsaSkEk9MqaTV4sV7SVghu7eQpHa3CCeOTy3ReZAMcnHSqD+d4ruv7GksJIcyfNNI55jU5ZvTkdqNO1C51N7+HRLFELSqv2x12xqgH3s/wARyT0rSvYP7H06F7CRpZ4JBNNO33pj3HsMZ4p+89nqQ7N8pr63PGIRDaKEiCiGFQOiDisTS/s/hPV0tY7E3sWr48xMgGNh3B9Oa2ZVjuLqO4h5tigkjPbBrifiLdpHIA0rRO4RI3B5XnJNVCKceVbGbdmmd9rukazDBdJpccVkrIWGHAJOOv1rk/hJqVzNper2Gozea6zBw5bJU9D+tW7u6vdR8O2kNrc+ZOITGZZifmJFcr8KVuNJ8SXei6hHH9oZWZmRtwYEE5/lWaTdP3t/8jSL963Q9HmRlkYNgMDg1GRU0sgljik7suG/CoXOFOK0RjJWYFeOOKjdWD53fLjGMd/XNMaTJ64FSBtw7VViRh7UmPpjtTyOcU3bzmqAQCl2jr1oAwc9qcB+dACAcc4FAxg5OaVug9Kru+Dk9KSAmwCeODSEdaZG2WHpU5UtwKBkajjk0xlIzjg1KjRFiA2SPypJAAMjJHX60xERHH1puMU4nKqcEEjkHnFL2zmmgMdFBHXmnMhA4IxVNp9vU4FOhut3GavUssYPSjH51IpDjgU0D1oAABn+lAFLjoR0pT+GKBWIppDbq1xFI0ciDAI6GrGnQabHFcSaxf7rl13Rop61GwBUqwBUjBBpsVtBFnZCob1xmk1fyAWLLRAnPPTPpUq89aM5NKOvOaGIcoxjmlYbsggEehoPbnFKpyeOeaQDhnFR3L7UjJO1WcK7f3R61LxyRS4GDkAqeoIpAS3aW8U4S1m81duS1Z2qnZp9y3mCNNmWc9hVtUVAQihR7VheML6Oz0O8uJBmOPbGB/eZj/QVL0RUU29DW0qzTT/Clk+iyyEP87CVerZ/lUdrrkkniDSdNvrZoIZ5sTYxJHM2PlHtirMHiSb/AIR3TL+G2u/sxhCMEiXC477c5xis/SJ/+En1HRruBVdrOeSeWbGw4Cthdv5Vk3fSXmVFLlVjYuNzO+WOckZqLAwQeexzUj5LMcdSTzUMm4SwsIvOjVwZIg20svoDWoPcfjjIxiq9gMnUJMctOsf4Kmf61YIUySNGnlqxyEznaPTNQWP/AB6vxjfcysT+Q/pUvoOOlyUcd+tY3iTTre8NtNcs0a7vIkkU4Ko3Gc+xrY7c4qG9t1u7OaBukilRnt71UtUKLs0c+kCeD7W1hDpqFncuDJLEpbbg919fcVrWut6JqeoajY6e00UixNJGZVwCcc4HUetNsNtz4f0aaKNUZLlo5FHZgef5Vcn0+y1TVNZtby2R2EUcyOBtZSODgjkdaz3szduxj67per6jYaOmmXCrbeShfB5yBzWnp8U9ppfkSo0s2771V9MstRt9Otzp+pkojNE0F2nmKCD2PBFNlOsNLtuPs1svQTwMzL+KnpVRWiRMpXZqm2mcKZIwARk1l+IAV0+Ao6R7bmImRjgKd3qanOkT7g9xqU85xnb0X+dVfE9pBFohnvgZiroI4ycgfMO1KSurCpu0kxdd8VXsT2dv4WmW8kUFbqZYt4HPQMeBVvU9Iur+OS48SOiiKMOmnwn5WZRkM5HXPoKteKL2PQ/CcZNqg824UvHEuAAT3xWjrm25S08nKC9CAgnlR3/QVEHZJ2CerFgkP9n2QG1UaFW2oMAEjoB7dKZKoljeM9CMU4jEjquNm4lfalJwM9aqEeWKRnOV5XKnh8n+wjBk7rO4aE5OcKfmFUfEcVrCbHUJIvOvIp1W3iJ/1jE9PpVzRht1HV4B924hS4jHYspwf0NU9SFpPrthHqtyLWyibLzkcqSOAPSnC0b32Qp76dTr9RFnEHe9DQxFMmNSCQ2OxrzD4ax2+o/ELWdRsVMC2UTfJISS+TjNeotbaRY2U88Ugkj/AIJZ23A8e9cT4C0u5j8S+J9RuoVgjukCR+XyjE+9ZQknTl8ildS1OiCskIR+TuPPpQ4BHWnHJC7vvAYP1pvtWxk9TLvQVkyv41LaynIyamuYt4qC3iZGOavdCTLzYY574qM+54pykFc9sU0kD3pIAHrRj0pN3NL65NMYp6D+tRmMHnHSpT26UcYwcUgGIvPSpHO3B59DSDGfakbOaAKgaRIlhMkfkocrtGGP1qVJC3U0yRMgnsKWFCDVaCQ9wAwHagj2p0oAwM9KToeuPc0Bc5S8ty4+U1WtopEchs1uNHnuKYIRngCtFIsLb7oznNTY5NCqB9Kdg9KkBqj8vWg+nvSnggDuelJ3OaAACl7Ud+lOA96BBjNOHGOv0pADT1HpxSEA9P0pwGPpTOQ2fWnhh0pAAG3PvUmMjNMz607qO3WgBe4561jazYx39jfRzECK3Bm+YZGQMjP4ito9ax/EYY6YbSLh7+VYM+xPP6Ub7DjLl1Zb024ibRLO/vJ0gaVBMTIuEjUdQAOfpTtF0iDTJ7jVYSwkvFPlIp+Uq3PmEepFQeN7VI9NuLfy5PstvAIgqpxwOtaOnXaaj4b0a7hzsNssZz2ZeCKyerutmWk0lcVjntz0pp6gHqelPzxSYz9f5VYgFRpGEUqvTJbH161KBj3NIeMUCGMDkf0o4zjrTiOOeuaidsHdTGUvD/GsatYZGwSpeIv90kYbFX4Ds8YKA3y3VtLF07jBFUdETyfFjTP0ngaP8uamuGKavpUx4xcBPT72RWclZM1vr/XqWLQeXJfREYG5Z1/EYP8AKp3KkEEAg9aWWMC6dxgMMoeOozTSo59qtGTZAkQBxHJIinsp4FU9biS9mjsIiWbbuYtyeOa0FBVvf3o0yDyryS4mGS3FN9wTsL4ik+021rhVZZDHkdc5xV29YtrKnqIomI9uAKyGjaW70eyI+ZJWdiO6g5U/rWrcESXUkmBnJAPtWSjbQ0nIQYFMncJBIzHgKaUZ7GodSQvYygDPGfrWi3MSHS43g1GznUGRYQUkLcHDDn61xvi5brWPEX2KxdIoWHmRmQ/fZeCK6+0uVbT/ALQwIRxuGD69KxfEzNo+gQyWzomqzTB48DLruPSmlrpuynbqSTa3d23hZW1y0Es8JMcEQXqR6irXw/u9YvNHm1W7uhFAtwDJbMv3uOcfpUHja7uINJ8M2kpj+2XdwDPOBjn/ACa7PWraG2tFsbIjykUEkcFj6msLLlUO/wDmW9NSK5IMpZRhX+YCoGODmnFsxxhuoXFMBz0IrRKxixC2ceh96MAnmkdcHjmlXgcdaoQ44AA61CxqRyfxqFs5poaFRh8wJwR0GOtPH0zUWSehqVeevWgGOP3acDz14phPGDyDSjnr+VIQuMH3pG4GaVcZoPPQcUwEXn3oIxz3oAx2oOT0/GgRE/IyMUAblwR1p7DK8jmgcDpTAx888DFOH60g6cinY44pmgUoPvSDqfSjv60ACq0l1FDGyqXGSzdqSRNkroWVtpxuB60ksSSgCRScdCDg0KqoAFXAoAfbRy3Vy8NrEXaMZY+lCdTkAMDg1GFmjuGmtbhoXcbXAHBFPjQKuMknuTQBIPXtR1P/ANekIOMikVuOlAh/U9eKXv8ASlABPvRj8hSAAO/anr1/xpF9BTyB+P0oFYcvPesfWhdnUNITT1U3Cz7xvGVGO5rZjGT149a5nXdWt4/FGmWjCQxDDOV/i+Yf4UhWumbfjSe/k03U0EjLdGIlx149R6Vj/C+4abwhcW7Ef6NOHHsHHP6it+HXbW813WpLuKIK5+zJEXGTkdcdqxvhpa/ZLPWrV1ALMnlEdCMk1nHSLuuxs2rqz7/kbhx2pQKQ8E+ooTPNWSLkHIB5FIRyOce5pxHTNBHrQIjIyOmfrUbpuH1qc9uvPpSgcDIGf50AUVgCzRzYPmRnIIptzFJOIXKnfHMjjHoGBNX2UH2xUZJAIH1pvUdyaRt0zt2LEigL+RqMGpF75oEIR17/AIU7PGOlNwfXpS4PvQIhtE/4nE93ICBHDsjPuanBOCaQDHbA/nSjOSR0pDbuO6ntzRyW2Y3MRyPakodCGZo5CrsMEYzQI5/VPs3h+1lvr27LQxsWhgC9GPb6VZ+H9pHrofXvEEMmyI7rVH4XPr71meKtJfX9f03S4VJRTvlIrv8AVLB7TSlihMcdnbx8hj94gVNSeijfV/kNLW76HK+Knjv/ABZ4ctrXZKolMrr1KV0+pP5l3OevzcVxPwudtT8RXupTIoigRljb3zjFdfKSzE55JzSceWfL2Q27xIzk84qOaRYYpJXOFUZOKlAqK4t1mt5IWJw4wfaqW+pA5obtbKO7khKW8mNrd6U4Gc96hjOofY4bO5uQ9rD9wDrj3pzk4wORQr9Qdug7g1GwIJBpEb5ualYBh0xVC2IhxknsKVCSivsYI3QkcGldQYyp6EYpVe5a2igldDFH93A5P1psQ49MihSCPahvTHFC9+1IAGMnFA3OX2jhOtGeOTTGUNJkNsLHnnrQMkXkZpG4+tKzxq+1WGR2zTWIIzQIXtjvQemaXjAoBGMmgDFHOKktYJJ7KS7VkWJDgDPJpnQ8daiS2i3sw3jPJUHgmqNCZW4yO9Opp9OABSjOD296BCsQoJY4AoUhsdvaiRGZFwQXUhgG6NiprqeS6mEksSRbRgKvegCLHPuKUDvzS4OM0ox0oAOKQKM0M3PApByetADgc96UHJxSAZpyjnjvSAcO9KevFCjvTivqPegVyO4c4WJDlpDg+wrF0/T/ALR4rvrl2iWO2gUxq/Vx0yPxrbHyiWUrlgMKOlZGk6hbWnjhPtEBmR4vJ259qTW/oDaS1Mzxd4QX+yZbyyE0V5IQ5cZOB3/D3rX8JQXGneDjPcKUladVjBOSVXqfx5pvjPxXPY2N3FaWzrAWESsDkBT2Nb1/cRXuiWU0K7EaBRs7A45qFzW12bNL3kr7q4ydg0odcYcBqah7jr71GrHyIT320+PoCeuaoVyQHmg9MdjSjIPSlAyOetIQmBSgc0Dj0pevXrQA0qSBSbc96fx/+ukYY9BTAYBSjrxQOTmlPH0pgwA56YpeSOKTuDTiBj3pCEB657UvakPSgkY6daAAD1prsqNgMQcZJAz+FPHUUqqFbdgE9KAR5n/wlGox+Iml0f8AfMjZcEYJ5+7Wr8RtU1S68OLNOzwOJA8kSHqvv611TafYxn91axpcXDYLgc/Ws/xVodzqifZYtpjAC7/QUaOXMXpy2L/wuhtofAs1zGpVppMjI7VqscEniotCiSy0FLCL7sGB9TUrnnNZxu22+pMrbITHHSj+HOKTqDSRblDbjnNWSK3QZphAx7GnvwBxSHoM0CIggzkU5j8vFLnHQ00nmqEH+c0dhS44pigqoDNubuSMZpgPJHFJnjqaRjj6UZ60hgDzzRkbxkg0zPNI3J6GmMj068htBeR3lpLNcSN+6kUfKBT4zgZkQlsjAzxTkYnIHQcU3ndx1zRbW4iV2yueAfQVGr5YYzQjmVWZEZ40O1nxwD9acqA9PrQKxlE470ozjikXp604VRY7mlwO9NBzTx1pAKT70cH60nBNA60AOx7UHpilyePejtQIhYnIqSIUrICemadGMEcUASwwTXImeBAYofvEmmIcgGmvDl2KSyxh/vqp4b609RjgcKKQEgxincHpTF5B/nTwScBgOOhFIBGAKEHhaz/ByWF34h1hb20WXyl+V27cdqu3JPleWv3nOKoaXef2X4ivxBGJGQKSp7nFDV4yXkLa3qZt/Lby+HtfgeALEq5Qk55zwa6S1t1i8K6TCmSwgUsT3zWDqlst3pN55n7oXsw2HGAeeQPauwv1jt4YIIzxFEqfpUyey/rYu92/67GUVGFU9qkjGMUjEBuTTl7c0xjh24pe1A+vFKfakIbzkU4e1IO9LjnmgQEDGO1J79cU+koGRfpS59e9OIx1NNC8Z/SqAT6GlJ5AooGB6GgQoP4GjOBQOeaTsaQD+gAHSgZ55pvaj3zxQAijdfRE9EGan3dwcVEqgSF/UYpy9AO9AXHxgIDtGM8mnds01eBxQKQhC6rNEsgcK5wXVdwX6gU/AycdKQ8g44+tKp+lAA2cU1hjpnHtT8/WgigkiYdxTTjNSN1qPIIyOhqkID7dKaQKUEn8aD0x6UygPQc0gBANB+71pAMbiCT7GkAN1zwabmlx680hFMYi+1KTgg9cUi9CSOlKfU/TimJiQfbIrd7WO4QWTOXKbfmyeozVhcBQBTMZAxnpTxxjFTYL3MMN+VPU5HWoefWnr04rQokyCadk9qjHX3p4pAL+vNDhnhZVYqxGAw7e9Lil7mgQkSssSKzl2AwXI5Y+tSr9etNB4olfyoS+OcgD2zSsA88Z9KetNuIWtnRJJEcuu75T0oU8+9LcB/1zTelO+tAH60AKM4p46+lNx0/WnD7vXmgBYU33QLfdHSsXwneC48beIIFhSSFEyXb1rZkYpCdv3m4FY/hiBINc16FCA5j3ue+SKl7P0C17eqKurPbX3i3w9ZpkReYXKhiVyPauv1UbLqdV6BuK4zQtPkk8b6S7rmKCJmz6murvpd9xI3XLE0PdJdinuyDqetOU4OD2Gc1HkZp6nseQRg/SgokXc0aybSEboTTj+NRIrKqgys6L91SOlSdaRLHDpRjmkGfXilHXNAh3TPtTQQSygdPWnDk8cUih5UkeCN5Io+GcdFNArjfaj+dKDkBhznvSjqfWqHcjbpSd6ee+P0pCpIz2oAZjoe9L275o4yc0vGCaBCCgcHnpSDg07rigBVIPbNPHFM6cfyp46UgHZpMkHpzQeuKRCSoyMe2c0gJOCM+tAHOcU30pc8d8UCHZoPf6Uh5xSseuPxoEMPTkVG3UmpG9Ka3WqQWIx6YpCc8U7+dIwzTGBwBgnHpQoOaFLIzlY0kDqB83VPpSxJkbc9KQCKpY8LmjbjjFVr28cTLbWgzLnk1bfIVQ5yw602A3HGQKTHYc05eASaQjpjpQIcCdvA5p2O9N+gpy9Mc0AYCj1qRQMDrxTduBinqMdetaFDgKcB3pkRk8xgxTyccDHOad09cUgJO3NBxTRjApR19qQCgcZzzTyAVKkAqeo9aZx0OaUHsKQDVjjjJMakZ9TmpAe+KQD86cR+VABaRfbtdTT/OEI27tx71PNCtvey26v5gTgNmqdzZw3TK8u4OvRlODU8ESxLtTOPU0uu4EwGBTh1pqinY5PNIRDdv5aJ3ZmwKwtUC6PraX0jNGl3GUkYdPxrd2ibUIwwbEZz7Y/wAaxPiQXOhqI495aUcY7ZovZouOuhqeDSk1t9uZtzAFE+narEpySfenaEEi0K2SFNuANwqNzyfzoS1ZHNd3EBp6Hng81H7inJgZPeg16FhecfrSg9qYn047U4HpnpSJFz0PalU96bj1pVxQSSqeQcGm2wlghlgW5cWznJjA5/OkJ579fWnA8/SlYBvHAUYAoXpkGgZ6Chvu0xijB6VGUCys4zuZdp5OCPpQpIPNPPOPWgBmOMZpOtOb8jTe3NMAOM0vpjGKGGBRwKBDvqeKM8YwaackCjv6UgHg9hSjtTSaB196BDwDjnrTh+lMBPP5U4c9KAHNyPajI5ppPfFOznikMTmo2POM/lRMheJ0VyhYEBh2pEaZoYkuWiYxoE3RptzjufemIQZyc9aTt1Gaf1HFMPU8VQCEevNMnV2icRNtY9Keeg+tA6GhAMsIFtY9z/NMerVI7EtknrTe/NKwOR/OjqA5TzwfxpCT3oSk79M0CH9snmnA5Pek/hxR6e9AGEDinj86jXjH1qZRWjGKPzpfSk7kU5gBmkAq+/egUoo/ioAdEjT3kVukixl1LFmNNAw8ibg4Rsbh0NElvFcAeauSvQ9CKXasYCoAAPSkA/oPWn856Cmr9BT+1IYYyKcvT3o/hzRnBGO9ICQYAzS7s9OtNBz1pTxtNILDTIlskk8v4D1rmNe/tLVxFJCvlQRN37it2ZRPqcUMn+rAzgVJq3y6aVXgB8cUdUVYsWa+RpsaE5cjk4qu2R9at3Jxb2xHGUqrnjNNGMdxh9aep5FNY8gU5PvAUjo6D3O1Fz8oLAFvQetTP5azFYZPMjA+8fWmAAZ7/WlAAUYAA9qRAvfp+NLuoHQUjcUAVI3uftwBV9hJyf4QvbHvV7nnoDTacBnGeaSVgHL24oIGMUi9DS5piGFM5x0pwwqgdgKX+IjtSHnOaBjSeM8Ypvf/AAp7DqKYo60ALyfXBo79Pxo/xpAOaYhQeKO3fnvRjIHvR6UAKcd6M4HXNNbgEilbhMjg4oAcvOR0p69OelMXkVJHzSACOB6UhBIPNKw5IpFPAPqKAFPSo3znvT36VGfvU0SJyO5ozQvNIDlSe9MBT0FMBySD1p38IppOc0IYqjn3pW4HNIv3sUrcqT70AKmD9aQjDU5RSPQIXPyjpTx93k/Wos4GalX09KAP/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The larval stage of Trombicula alfreddugesi is the most common chigger to affect humans in the United States. Larvae demonstrate only six legs (rather than the eight of mature forms) and a light coat of hairs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of JF Butler, Professor Emeritus, University of Florida.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29618=[""].join("\n");
var outline_f28_59_29618=null;
var title_f28_59_29619="Chronic osteomyelitis light microscopy";
var content_f28_59_29619=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F53767&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F53767&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic osteomyelitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 314px; height: 222px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of chronic osteomyelitis of the tibia. Against a background of inflammatory cells (blue arrow), there are thickened bony trabeculae (white arrow) lined by plump osteoblasts which are actively forming bone. The accumulation of small dark cells (lymphocytes) (black arrows) represent sites of perivascular inflammation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jon Mader, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29619=[""].join("\n");
var outline_f28_59_29619=null;
var title_f28_59_29620="Mitotane: Patient drug information";
var content_f28_59_29620=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Mitotane: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/58/16293?source=see_link\">",
"     see \"Mitotane: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F197498\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lysodren&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F197499\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Lysodren&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10016438\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a bad crash and are harmed, have surgery, or any type of infection, talk with your doctor. You may need extra doses of oral steroids. These extra steroids will help your body deal with these stresses. Carry a warning card saying that there may be times when you need extra steroids.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016440\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691770",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer of the adrenal gland.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691715",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat an overactive adrenal gland.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016439\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702538",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to mitotane or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016444\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016445\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016447\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016442\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016448\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016449\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11799 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-83C710A96E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29620=[""].join("\n");
var outline_f28_59_29620=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F197498\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F197499\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016438\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016440\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016439\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016444\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016445\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016447\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016442\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016443\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016448\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016449\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?15/58/16293?source=related_link\">",
"      Mitotane: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_59_29621="Telmisartan and hydrochlorothiazide: Patient drug information";
var content_f28_59_29621=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Telmisartan and hydrochlorothiazide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/20/15687?source=see_link\">",
"     see \"Telmisartan and hydrochlorothiazide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F225117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Micardis&reg; HCT",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F225118\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Micardis&reg; Plus;",
"     </li>",
"     <li>",
"      Mylan-Telmisartan HCTZ;",
"     </li>",
"     <li>",
"      Telmisartan HCTZ;",
"     </li>",
"     <li>",
"      Teva-Telmisartan HCTZ",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10022049\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022051\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022050\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702992",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to telmisartan, hydrochlorothiazide, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3915366",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes) and are taking aliskiren.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022055\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697207",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), this drug may sometimes raise blood sugar. Talk with your doctor about how to fine tune this.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a salt substitute that has potassium, potassium-sparing diuretics, or potassium, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Watch for gout attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022056\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Kidney function that gets worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022058\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022053\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695872",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause you to pass urine more often. To keep from having sleep problems, try to take before 6 pm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022054\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022059\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022060\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11072 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-22DD962998-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29621=[""].join("\n");
var outline_f28_59_29621=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225117\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225118\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022049\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022051\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022050\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022055\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022056\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022058\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022053\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022054\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022059\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022060\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?15/20/15687?source=related_link\">",
"      Telmisartan and hydrochlorothiazide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_59_29622="Magnesium hydroxide: Pediatric drug information";
var content_f28_59_29622=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Magnesium hydroxide: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?31/6/31847?source=see_link\">",
"    see \"Magnesium hydroxide: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?18/49/19220?source=see_link\">",
"    see \"Magnesium hydroxide: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F190917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Fleet&reg; Pedia-Lax&trade; Chewable Tablet [OTC];",
"     </li>",
"     <li>",
"      Little Phillips'&reg; Milk of Magnesia [OTC];",
"     </li>",
"     <li>",
"      Milk of Magnesia [OTC];",
"     </li>",
"     <li>",
"      Milk of Magnesium [OTC];",
"     </li>",
"     <li>",
"      Phillips'&reg; Milk of Magnesia [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1023043\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antacid",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Laxative, Osmotic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1023064\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/6/31847?source=see_link\">",
"      see \"Magnesium hydroxide: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Liquid: Dosage based upon regular strength liquid (400 mg/5 mL); when using concentrated magnesium hydroxide solution, reduce recommended dose by",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children &lt;2 years: 0.5 mL/kg/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 2-5 years: 5-15 mL/day once before bedtime or in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 6-11 years: 15-30 mL/day once before bedtime or in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children &ge;12 years and Adults: 30-60 mL/day once before bedtime or in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 2-5 years: 311-622 mg (1-2 tablets) once before bedtime or in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 6-11 years: 933-1244 mg (3-4 tablets) once before bedtime or in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children &ge;12 years and Adults: 1866-2488 mg (6-8 tablets) once before bedtime or in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Magnesium hydroxide and mineral oil",
"     </b>",
"     (Phillips'&reg; M-O) (infant dosage to provide equivalent dosage of magnesium hydroxide listed above):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children &lt;2 years: 0.6 mL/kg/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 2-5 years: 5-15 mL/day once or in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 6-11 years: 15-30 mL/day once or in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children &ge;12 years and Adults: 30-60 mL once or in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacid: Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Liquid: 2.5-5 mL/dose, up to 4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Tablet: 311 mg (1 tablet) up to 4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Liquid: 5-15 mL/dose, up to 4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Liquid concentrate: 2.5-7.5 mL/dose, up to 4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Tablet: 622-1244 mg/dose (2-4 tablets) up to 4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"     Patients in severe renal failure should not receive magnesium due to toxicity from accumulation. Patients with a Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;25 mL/minute receiving magnesium should have serum magnesium levels monitored.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F190904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, oral: 400 mg/5 mL (30 mL, 473 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Milk of Magnesia: 400 mg/5 mL (360 mL, 480 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Milk of Magnesia: 400 mg/5 mL (355 mL, 360 mL, 473 mL) [mint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Milk of Magnesia: 400 mg/5 mL (480 mL) [ethanol free, sugar free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Milk of Magnesium: 400 mg/5 mL (3.78 L, 473 mL) [contains magnesium 165 mg/5 mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Phillips'&reg; Milk of Magnesia: 400 mg/5 mL (120 mL, 360 mL, 780 mL) [contains magnesium 167 mg/5 mL; fresh mint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Phillips'&reg; Milk of Magnesia: 400 mg/5 mL (120 mL, 360 mL, 780 mL) [contains magnesium 167 mg/5 mL; original flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Phillips'&reg; Milk of Magnesia: 400 mg/5 mL (120 mL, 240 mL, 360 mL, 780 mL) [contains magnesium 167 mg/5 mL, sodium 2 mg/5 mL; cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, oral [concentrate]: 2400 mg/10 mL (10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Little Phillips'&reg; Milk of Magnesia: 800 mg/5 mL (120 mL) [contains magnesium 333 mg/5 mL, propylene glycol; strawberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Milk of Magnesia: 800 mg/5 mL (100 mL, 400 mL) [contains sodium 20 mg/10 mL, sucrose 0.8 g/10 mL; lemon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Phillips'&reg; Milk of Magnesia: 800 mg/5 mL (240 mL) [contains magnesium 333 mg/5 mL, propylene glycol; strawberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, chewable, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Fleet&reg; Pedia-Lax&trade; Chewable Tablet: 400 mg [contains magnesium 170 mg/tablet; watermelon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Phillips'&reg; Milk of Magnesia: 311 mg [mint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Phillips'&reg; Milk of Magnesia: 311 mg [contains magnesium 130 mg/tablet; mint flavor]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F190891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Liquid",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1023069\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution: Mix with water and administer on an empty stomach.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: Take with full glass of water.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1023044\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Short-term treatment of constipation; treatment of hyperacidity symptoms",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1023046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to magnesium salt(s) or any component; serious renal impairment, myocardial damage, heart block; patients with colostomy or ileostomy, intestinal obstruction, impaction, or perforation, appendicitis, abdominal pain",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F3416708\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with impaired renal function (accumulation of magnesium may lead to magnesium intoxication)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1023047\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Multiple salt forms of magnesium exist; close attention must be paid to the salt form when ordering and administering magnesium;",
"     <b>",
"      incorrect selection or substitution of one salt for another without proper dosage adjustment may result in serious over- or under-dosing",
"     </b>",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299634\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6221407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Antacids may decrease the serum concentration of ACE Inhibitors.  Management: Separate fosinopril administration from antacids by at least 2 hours. US and Canadian recommendations for use of other ACE- inhibitors with antacids may vary. Consult appropriate labeling. Monitor for decreased therapeutic effects of ACE-inhibitors.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Enalaprilat; Ramipril.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alfacalcidol: May increase the serum concentration of Magnesium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Allopurinol: Antacids may decrease the absorption of Allopurinol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists: Antacids may decrease the excretion of Alpha-/Beta-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dipivefrin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Antacids may decrease the excretion of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticonvulsants (Hydantoin): Antacids may decrease the serum concentration of Anticonvulsants (Hydantoin).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): Antacids may decrease the absorption of Antipsychotic Agents (Phenothiazines).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atazanavir: Antacids may decrease the absorption of Atazanavir.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisacodyl: Antacids may diminish the therapeutic effect of Bisacodyl. Antacids may cause the delayed-release bisacodyl tablets to release drug prior to reaching the large intestine.  Gastric irritation and/or cramps may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: Antacids may decrease the serum concentration of Bisphosphonate Derivatives.  Management: Avoid administration of antacids containing polyvalent cations within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Pamidronate; Zoledronic Acid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: Magnesium Salts may decrease the serum concentration of Bisphosphonate Derivatives.  Management: Avoid administration of oral magnesium salts within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Pamidronate; Zoledronic Acid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: Antacids may decrease the serum concentration of Bosutinib.  Management: Administer antacids more than 2 hours before or after bosutinib.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcitriol: May increase the serum concentration of Magnesium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: May enhance the adverse/toxic effect of Magnesium Salts. Magnesium Salts may enhance the hypotensive effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Polystyrene Sulfonate: Laxatives may enhance the adverse/toxic effect of Calcium Polystyrene Sulfonate. More specifically, concomitant use of calcium polystyrene sulfonate with magnesium-containing laxatives may result in metabolic alkalosis or with sorbitol may result in intestinal necrosis.  Management: Avoid concomitant use of calcium polystyrene sulfonate (rectal or oral) and magnesium-containing laxatives or sorbitol.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Polystyrene Sulfonate: Antacids may enhance the adverse/toxic effect of Calcium Polystyrene Sulfonate. The combined use of these two agents may result in metabolic alkalosis and/or loss of efficacy of the cation exchange resin.  Management: To minimize this interaction, consider: a)separating doses by 2 or more hours; b)rectal administration of the exchange resin; or c)alternatives to antacids. Monitor for metabolic alkalosis and attenuation of CPS effects. Avoid magnesium hydroxide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefditoren: Antacids may decrease the serum concentration of Cefditoren.  Management: Concomitant use of cefditoren with antacids is not recommended. Consider alternative methods to control acid reflux (eg, diet modification) or alternative antimicrobial therapy. If antacid therapy can not be avoided, separate dosing by several hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefpodoxime: Antacids may decrease the serum concentration of Cefpodoxime.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefuroxime: Antacids may decrease the serum concentration of Cefuroxime.  Management:  Consider administering antacids and cefuroxime at least 2 hours apart.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chloroquine: Antacids may decrease the serum concentration of Chloroquine.  Management: Separate administration of antacids and chloroquine by at least 4 hours to minimize any potential negative impact of antacids on chloroquine bioavailability.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Oral): Antacids may decrease the bioavailability of Corticosteroids (Oral).  Management: Consider separating doses by 2 or more hours. Budesonide enteric coated tablets could dissolve prematurely if given with drugs that lower gastric acid, with unknown impact on budesonide therapeutic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Antacids may decrease the serum concentration of Dabigatran Etexilate.  Management: Dabigatran etexilate Canadian product labeling recommends avoiding concomitant use with antacids for 24 hours after surgery. In other situations, administer dabigatran etexilate 2 hours prior to antacids. Monitor clinical response to dabigatran therapy.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: Antacids may decrease the absorption of Dasatinib.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferiprone: Antacids may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferiprone: Magnesium Salts may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Delavirdine: Antacids may decrease the serum concentration of Delavirdine.  Management: Separate doses of delavirdine and antacids by at least 1 hour. Monitor for decreased delavirdine therapeutic effects with this combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dexmethylphenidate: Antacids may increase the absorption of Dexmethylphenidate. Specifically, antacids may interfere with the normal release of drug from the extended-release capsules (Focalin XR brand), which could result in both increased absorption (early) and decreased delayed absorption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eltrombopag: Magnesium Salts may decrease the serum concentration of Eltrombopag.  Management: Separate administration of eltrombopag and any polyvalent cation (e.g., magnesium-containing products) by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elvitegravir: Antacids may decrease the serum concentration of Elvitegravir.  Management: Separate administration of antacids and the elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate combination product by at least 2 hours in order to minimize the risk for an interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Erlotinib: Antacids may decrease the serum concentration of Erlotinib.  Management: Separate the administration of erlotinib and any antacid by several hours in order to minimize the risk of a significant interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fexofenadine: Antacids may decrease the serum concentration of Fexofenadine.  Management: No specific recommendations concerning the time required between their administration are provided. Separate administration of each agent by as much time as possible to decrease the risk of an interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gabapentin: Antacids may decrease the serum concentration of Gabapentin.  Management: Administer gabapentin at least 2 hours after antacid administration.  Monitor patients closely for evidence of reduced response to gabapentin therapy when both of these drugs are being used.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HMG-CoA Reductase Inhibitors: Antacids may decrease the serum concentration of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Salts: Antacids may decrease the absorption of Iron Salts.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ferric Gluconate; Ferumoxytol; Iron Dextran Complex; Iron Sucrose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: Antacids may decrease the absorption of Isoniazid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Itraconazole: Antacids may decrease the serum concentration of Itraconazole.  Management: Administer itraconazole at least 1 hour after and 2 hours before administration of any antacids.  Itraconazole oral suspension may be less sensitive to the effects of decreased gastric acidity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketoconazole (Systemic): Antacids may decrease the serum concentration of Ketoconazole (Systemic).  Management: Administer oral ketoconazole at least 2 hours prior to use of any antacid product.  Monitor patients closely for signs of inadequate clinical response to ketoconazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mesalamine: Antacids may diminish the therapeutic effect of Mesalamine. Antacid-mediated increases in gastrointestinal pH may cause the premature release of mesalamine from specific sustained-release mesalamine products.  Management: Avoid concurrent administration of antacids with sustained-release mesalamine products.  Separating antacid and mesalamine administration, and/or using lower antacid doses may be adequate means of avoiding this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methenamine: Antacids may diminish the therapeutic effect of Methenamine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Antacids may increase the absorption of Methylphenidate. Specifically, antacids may interfere with the normal release of drug from the extended-release capsules (Ritalin LA brand), which could result in both increased absorption (early) and decreased delayed absorption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Misoprostol: Antacids may enhance the adverse/toxic effect of Misoprostol. More specifically, concomitant use with magnesium-containing antacids may increase the risk of diarrhea.  Management: Avoid concomitant use of misoprostol and magnesium-containing antacids. In patients requiring antacid therapy, employ magnesium-free preparations. Monitor for increased adverse effects (e.g., diarrhea, dehydration).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): Antacids may decrease the serum concentration of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, antacids may decrease the absorption of orally administered iron.  Management: Separate dosing of oral iron-containing multivitamin preparations and antacids by as much time as possible in order to minimize impact on therapeutic efficacy of the iron preparation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Antacids may decrease the absorption of Mycophenolate.  Management: Separate doses of mycophenolate and antacids by at least 2 hours. Monitor for reduced effects of mycophenolate if taken concomitant with antacids.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Magnesium Salts may decrease the serum concentration of Mycophenolate.  Management: Separate doses of mycophenolate and oral magnesium salts. Monitor for reduced effects of mycophenolate if taken concomitant with oral magnesium salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents: Magnesium Salts may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nilotinib: Antacids may decrease the serum concentration of Nilotinib.  Management: Separate the administration of nilotinib and any antacid by several hours whenever possible in order to minimize the risk of a significant interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PenicillAMINE: Antacids may decrease the serum concentration of PenicillAMINE.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Antacids may decrease the absorption of Phosphate Supplements.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Potassium Phosphate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Magnesium Salts may decrease the serum concentration of Phosphate Supplements.  Management: Administer oral phosphate supplements at least 1 hour before, or 2 hours after, oral magnesium salt administration.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Potassium Phosphate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ponatinib: Antacids may decrease the serum concentration of Ponatinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: Antacids may decrease the absorption of Protease Inhibitors.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Darunavir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Antacids may decrease the excretion of QuiNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNINE: Antacids may decrease the serum concentration of QuiNINE.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: Antacids may decrease the absorption of Quinolone Antibiotics. Of concern only with oral administration of quinolones.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: Magnesium Salts may decrease the absorption of Quinolone Antibiotics. Of concern only with oral administration of both agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rilpivirine: Antacids may decrease the serum concentration of Rilpivirine.  Management: Administer antacids at least 2 hours before or 4 hours after rilpivirine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Polystyrene Sulfonate: Laxatives may enhance the adverse/toxic effect of Sodium Polystyrene Sulfonate. More specifically, concomitant use of sodium polystyrene sulfonate with magnesium-containing laxatives may result in metabolic alkalosis or with sorbitol may result in intestinal necrosis.  Management: Avoid concomitant use of sodium polystyrene sulfonate (rectal or oral) and magnesium-containing laxatives or sorbitol.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Polystyrene Sulfonate: Antacids may enhance the adverse/toxic effect of Sodium Polystyrene Sulfonate. The combined use of these two agents may result in metabolic alkalosis and/or loss of efficacy of the exchange resin.  Management: To minimize this interaction, consider: a)separating doses by 2 or more hours; b)rectal administration of the exchange resin; or c)alternatives to antacids. Monitor for metabolic alkalosis and attenuation of SPS effects. Avoid magnesium hydroxide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Strontium Ranelate: Magnesium Hydroxide may decrease the serum concentration of Strontium Ranelate.  Management: Separate administration of strontium ranelate and magnesium hydroxide by at least 2 hours whenever possible in order to minimize this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: Antacids may decrease the absorption of Tetracycline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: Magnesium Salts may decrease the absorption of Tetracycline Derivatives. Only applicable to oral preparations of each agent.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trientine: Antacids may decrease the absorption of Trientine.  Management: Separate trientine dosing from other oral drugs (eg, antacids) by at least 1 hour. Monitor for decreased therapeutic effects of trientine if an antacid is initiated/dose increased, or increased effects if an antacid is discontinued/dose decreased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trientine: Magnesium Salts may decrease the serum concentration of Trientine. Trientine may decrease the serum concentration of Magnesium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vismodegib: Antacids may decrease the serum concentration of Vismodegib.  Management: Carefully consider the need for any medication that increases the pH of the upper GI tract (PPIs, H2RAs, antacids), as these could significantly reduce vismodegib systemic exposure. Vismodegib dose increases are unlikely to compensate for this effect.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14081348\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Magnesium crosses the placenta; serum concentrations in the fetus are similar to those in the mother (Idama, 1998; Osada, 2002). The American Gastroenterological Association considers the use of magnesium containing antacids to be low risk in pregnancy (Mahadevan, 2006).",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1023059\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Promotes bowel evacuation by causing osmotic retention of fluid which distends the colon and produces increased peristaltic activity when taken orally. To reduce stomach acidity, it reacts with hydrochloric acid in stomach to form magnesium chloride.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1023061\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Up to 30%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Renal with unabsorbed drug excreted in feces",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12980 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-617C8121F3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29622=[""].join("\n");
var outline_f28_59_29622=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190917\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1023043\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1023064\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190904\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190891\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1023069\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1023044\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1023046\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3416708\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1023047\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299634\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6221407\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14081348\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1023059\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1023061\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12980\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12980|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/6/31847?source=related_link\">",
"      Magnesium hydroxide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?18/49/19220?source=related_link\">",
"      Magnesium hydroxide: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_59_29623="Systemic effects of perinatal asphyxia";
var content_f28_59_29623=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Systemic effects of perinatal asphyxia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/59/29623/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29623/contributors\">",
"     Lisa M Adcock, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29623/contributors\">",
"     Ann R Stark, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/59/29623/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29623/contributors\">",
"     Leonard E Weisman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/59/29623/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29623/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/59/29623/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 24, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perinatal asphyxia results from compromised placental or pulmonary gas exchange. This disorder can lead to hypoxia (lack of oxygen) and hypercarbia (increased carbon dioxide levels) in the blood. Severe hypoxia results in anaerobic glycolysis and lactic acid production first in the peripheral tissues (muscle and heart) and then in the brain. Ischemia (lack of sufficient blood flow to all or part of an organ) is both a cause and a result of hypoxia. Hypoxia and acidosis can depress myocardial function, leading to hypotension and ischemia. Ischemia can impair oxygen delivery, causing further compromise, as well as disrupt delivery of substrate and removal of metabolic and respiratory by-products (eg, lactic acid, carbon dioxide).",
"   </p>",
"   <p>",
"    The systemic complications of perinatal asphyxia are reviewed here. Hypoxic-ischemic encephalopathy (HIE), including pathogenesis, pathology, diagnosis, prognosis, and treatment, is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30953?source=see_link\">",
"     \"Etiology and pathogenesis of neonatal encephalopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2442?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of neonatal encephalopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TIMING OF INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asphyxia can occur before, during, or after birth. Based on a review of multiple studies that have examined the temporal relationship of obstetric events and neonatal outcomes, predominantly HIE in term infants, the proportion of conditions that occurs in each time period can be estimated [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antepartum events, such as maternal hypotension or trauma, account for 4 to 20 percent of cases. Intrapartum events, such as placental abruption or umbilical cord prolapse, are seen in 56 to 80 percent. Evidence of intrapartum disturbance (eg, meconium-stained amniotic fluid or severe fetal heart rate abnormalities) occurs in 10 to 35 percent, usually in association with an antenatal risk factor, such as diabetes mellitus, preeclampsia, or intrauterine growth restriction. In approximately 10 percent of cases, a postnatal insult occurs, usually caused by severe cardiopulmonary abnormalities or associated with prematurity.",
"   </p>",
"   <p>",
"    However, the timing of injury often is difficult to establish for an individual infant, in part because antepartum and intrapartum events may not lead to signs that are detectable in the fetus. In addition, a fetus who has suffered an antepartum insult may be at increased risk of incurring further intrapartum injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of maternal, obstetric, and neonatal conditions predispose the fetus and newborn to asphyxia. These risk factors are associated with reduced blood flow",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    oxygenation directed to the tissues. Examples of conditions or events in which perinatal asphyxia may occur are listed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Antepartum conditions",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abnormal maternal oxygenation (eg, severe anemia, cardiopulmonary disease)",
"     </li>",
"     <li>",
"      Inadequate placental perfusion",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      gas exchange (eg, maternal hypertension or severe hypotension, placental insufficiency caused by vascular disease)",
"     </li>",
"     <li>",
"      Congenital infection or anomalies",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Intrapartum events",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Interruption of umbilical circulation (eg, true knot, cord prolapse, cord avulsion)",
"     </li>",
"     <li>",
"      Inadequate placental perfusion",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      gas exchange (eg, placental abruption, uterine rupture, severe maternal hypotension, abnormal uterine contractions)",
"     </li>",
"     <li>",
"      Traumatic delivery (eg, shoulder dystocia, difficult breech extraction)",
"     </li>",
"     <li>",
"      Abnormal maternal oxygenation (eg, pulmonary edema)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Postnatal disorders",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Persistent pulmonary hypertension of the newborn (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=see_link\">",
"       \"Persistent pulmonary hypertension of the newborn\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Severe circulatory insufficiency (eg, acute blood loss, septic shock)",
"     </li>",
"     <li>",
"      Congenital heart disease (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33482?source=see_link\">",
"       \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/56/20359?source=see_link\">",
"       \"Cardiac causes of cyanosis in the newborn\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Infants at increased risk for perinatal asphyxia include those born to diabetic mothers or with severe intrauterine growth restriction (IUGR). In diabetic women, vascular disease, manifested by nephropathy, may contribute to the development of fetal hypoxia and subsequent perinatal asphyxia. Infants with severe IUGR who are deprived of oxygen and nutrients may have a difficult cardiopulmonary transition with perinatal asphyxia, meconium aspiration,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    persistent pulmonary hypertension. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44809?source=see_link\">",
"     \"Infant of a diabetic mother\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/23/9593?source=see_link\">",
"     \"Small for gestational age infant\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Fetal biophysical profile",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fetal biophysical profile score (BPS or BPP) is a noninvasive and accurate means of predicting the presence of fetal asphyxia. This test involves the sonographic assessment of four discrete biophysical variables (eg, fetal movement, fetal tone, fetal breathing, amniotic fluid volume, and the results of nonstress testing). A compromised fetus typically exhibits loss of accelerations of the fetal heart rate (FHR), decreased body movement and breathing, hypotonia, and, less acutely, decreased amniotic fluid volume. If fetal asphyxia is detected, appropriate intervention may prevent adverse sequelae. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/41/11928?source=see_link\">",
"     \"The fetal biophysical profile\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ORGAN INVOLVEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;All organs can be affected by perinatal asphyxia. HIE is the most widely studied, as it has the most serious sequelae. In contrast to the persistence of neurologic injury, dysfunction of other organs can resolve before hospital discharge [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30953?source=see_link\">",
"     \"Etiology and pathogenesis of neonatal encephalopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2442?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical features, diagnosis, and treatment of neonatal encephalopathy\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Information on the systemic effects of perinatal asphyxia can be extracted from data from the control groups of clinical trials studying the effects of hypothermia on the outcome of HIE. The scope of organ involvement in perinatal asphyxia varies among studies depending in part upon the definitions used for asphyxia, as demonstrated by the following trials in infants with gestational age &ge;36 weeks.",
"   </p>",
"   <p>",
"    In the first trial, inclusion criteria were Apgar score of 5 or less, need for continued resuscitation, or severe acidosis (umbilical cord blood pH less than 7.0 or a base deficit of 16",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    or greater), and evidence of moderate to severe HIE by neurologic assessment (eg, lethargy, stupor, coma, hypotonia, or abnormal reflexes) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/2\">",
"     2",
"    </a>",
"    ]. Systemic effects and their incidences in the control group during the hospital course included the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Respiratory distress (78 percent)",
"     </li>",
"     <li>",
"      Abnormal renal function (70 percent)",
"     </li>",
"     <li>",
"      Elevated liver function studies (53 percent)",
"     </li>",
"     <li>",
"      Hypotension (52 percent)",
"     </li>",
"     <li>",
"      Hypocalcemia (43 percent)",
"     </li>",
"     <li>",
"      Prolonged coagulation times (42 percent), platelet count below",
"      <span class=\"nowrap\">",
"       100,000/microL,",
"      </span>",
"      coagulopathy (14 percent)",
"     </li>",
"     <li>",
"      Metabolic acidosis (23 percent)",
"     </li>",
"     <li>",
"      Hypoglycemia (17 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the second trial, inclusion criteria included severe acidosis (cord blood pH less than 7.0, or a base deficit &ge;16",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and evidence of HIE by neurologic assessment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/3\">",
"     3",
"    </a>",
"    ]. In this study, the incidence of systemic effects during the hospital course in the control group was lower than the previously discussed trial.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hypotension requiring inotropic support (33 percent)",
"     </li>",
"     <li>",
"      Persistent pulmonary hypertension (22 percent)",
"     </li>",
"     <li>",
"      Oliguria (22 percent) and anuria (4 percent)",
"     </li>",
"     <li>",
"      Hepatic dysfunction (15 percent)",
"     </li>",
"     <li>",
"      Hypoglycemia (15 percent) and hypocalcemia (19 percent)",
"     </li>",
"     <li>",
"      Disseminated intravascular coagulopathy (11 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the third trial, inclusion criteria included ten minute Apgar score &le;5 or 10 minutes of resuscitation, severe acidosis (cord, arterial or capillary pH &lt;7.0, or a base deficit &ge;16",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    and moderate to severe encephalopathy (defined as lethargy, stupor, or coma), which were accompanied by hypotonia, abnormal reflexes,",
"    <span class=\"nowrap\">",
"     absent/weak",
"    </span>",
"    suck, clinical seizures, or an abnormal amplitude-integrated electroencephalogram (aEEG) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/4\">",
"     4",
"    </a>",
"    ]. Systemic effects and their incidences in the control group included the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Persistent hypotension (83 percent)",
"     </li>",
"     <li>",
"      Intracranial hemorrhage (50 percent)",
"     </li>",
"     <li>",
"      Abnormal coagulation (45 percent)",
"     </li>",
"     <li>",
"      Pulmonary hypertension (6 percent)",
"     </li>",
"     <li>",
"      Pneumonia (3 percent)",
"     </li>",
"     <li>",
"      Air leak (2 percent)",
"     </li>",
"     <li>",
"      Pulmonary hemorrhage (2 percent)",
"     </li>",
"     <li>",
"      Arrhythmia (2 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Reported variations in systemic effects of asphyxia might be related to changing practices in the management of these infants (even when controlling for hypothermia) as well as differences in the criteria used to define asphyxia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ENCEPHALOPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoxic-ischemic encephalopathy (HIE) is the most serious complication of perinatal asphyxia, and the neurologic sequelae often persist [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/1\">",
"     1",
"    </a>",
"    ]. Issues related to HIE are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30953?source=see_link\">",
"     \"Etiology and pathogenesis of neonatal encephalopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2442?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of neonatal encephalopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MYOCARDIAL DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asphyxia may cause myocardial ischemia, which usually is transient, but may rarely result in cardiogenic shock and death. This condition typically presents as impaired myocardial contractility, decreased cardiac output, and tricuspid insufficiency, although some infants have signs of respiratory distress, heart failure, or shock [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical examination in affected patients shows tachypnea, tachycardia, and hepatomegaly consistent with heart failure. Systemic blood pressure may be low and capillary refill delayed, reflecting reduced peripheral perfusion. However, normal blood pressure can be present in infants with poor cardiac output, a phenomenon related to elevated peripheral vascular resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/6\">",
"     6",
"    </a>",
"    ]. Many infants have a systolic murmur that is loudest at the lower left sternal border, typical of tricuspid insufficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chest radiograph typically shows cardiomegaly. The appearance of pulmonary blood flow depends upon whether the left or right ventricle is predominantly affected. If left heart failure predominates, the lung fields usually are diffusely hazy, with pulmonary venous congestion. If the right side is more affected, pulmonary blood flow may be reduced by right-to-left atrial shunting and pulmonary congestion may be absent.",
"   </p>",
"   <p>",
"    The ECG may show signs of ischemia, with diffuse ST-T wave changes. The most common finding is ST depression in the midprecordium, with persistently inverted T-waves over the left precordium. ECG abnormalities still present at 72 hours of life may be associated with an increased risk of mortality.",
"   </p>",
"   <p>",
"    The diagnosis of myocardial dysfunction may be confirmed by echocardiographic findings of decreased left ventricular ejection fraction and decreased shortening fraction [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/7\">",
"     7",
"    </a>",
"    ]. Echocardiography (ECHO), which should be obtained in all infants in whom myocardial dysfunction is suspected, is essential to exclude structural heart disease. It also distinguishes right-to-left atrial shunting caused by myocardial dysfunction due to persistent pulmonary hypertension of the newborn from asphyxia, which is important since management differs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=see_link\">",
"     \"Persistent pulmonary hypertension of the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Functional echocardiography and other advanced echocardiographic techniques (myocardial performance index or Tei index) appear to be more sensitive than routine ECHO measurements in identifying cardiac impairment in asphyxiated newborns, but their influence on long term outcomes remains uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/6,8\">",
"     6,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No laboratory test reliably detects cardiac damage in perinatal asphyxia. Cord blood levels of creatinine kinase and its MB fraction do not distinguish infants with and without asphyxia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/9\">",
"     9",
"    </a>",
"    ], are not specific for cardiac damage, and neonatal levels may be elevated in the first day of life due to gestation, weight, and type of delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/8\">",
"     8",
"    </a>",
"    ]. However, elevation of cardiac troponin T levels is specific for cardiac damage, occurs early following asphyxia, and appears to correlate with the severity of asphyxia and neonatal outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/7,10-12\">",
"     7,10-12",
"    </a>",
"    ]. In one study, troponin T levels in asphyxiated infants were not only significantly higher than in control infants (0.17 versus 0.03",
"    <span class=\"nowrap\">",
"     ug/L1),",
"    </span>",
"    but a troponin &ge; 0.15",
"    <span class=\"nowrap\">",
"     ug/L",
"    </span>",
"    predicted mortality (100 percent specific, 70 percent sensitive) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management is supportive. Patients with respiratory failure require mechanical ventilation. Ventilator pressures should be as low as possible to minimize limitations to venous return and cardiac output. Metabolic abnormalities, such as hypoglycemia, hypocalcemia, and acidosis, should be corrected. Fluids are restricted, and diuresis is promoted. Inotropic agents usually are needed [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/5\">",
"     5",
"    </a>",
"    ]. Severely affected patients may require afterload reduction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     RENAL DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal dysfunction often accompanies perinatal asphyxia. The presentation and course depend upon the severity and duration of the hypoxic-ischemic event. Severe asphyxia results in diffuse tubular dysfunction with impaired reabsorption of sodium and water and decreased glomerular filtration rate [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/13\">",
"     13",
"    </a>",
"    ]. A milder insult may cause a transient loss of renal concentrating ability.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute renal failure, or acute kidney injury (AKI), can be difficult to diagnose following asphyxia for a variety of reasons, including the lack of a consensus definition. AKI should be suspected if the serum creatinine concentration is increased (&gt;1.0 to 1.5",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    88 to 133",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the urine output is reduced (&lt;0.5",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per hour). However, renal failure after perinatal asphyxia may be non-oliguric in up to 50 percent of neonates, and serum creatinine levels can be highly variable in the first days of life [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one report, renal function was evaluated in 66 asphyxiated infants with gestational age &ge;36 weeks and five minute Apgar scores &le;6 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/15\">",
"     15",
"    </a>",
"    ]. Acute renal failure, defined as serum creatinine level &gt;1.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (133",
"    <span class=\"nowrap\">",
"     micromol/L),",
"    </span>",
"    occurred in 20 of 33 infants who were considered to have severe asphyxia. Of these, renal failure was nonoliguric, oliguric, or anuric in 60, 25, and 15 percent, respectively. In another prospective case controlled study of 70 asphyxiated infants, 33 patients (47 percent) exhibited renal failure, of which 7 were oliguric and 26 were non-oliguric [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis, evaluation and management of AKI are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27114?source=see_link\">",
"     \"Acute kidney injury (acute renal failure) in the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Information is limited on the outcome of renal dysfunction after perinatal asphyxia. The prognosis of patients with intrinsic renal disease depends upon the extent of the injury. In infants with asphyxia, urinary excretion of protein and uric acid are elevated and may correlate with disease severity and short-term outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/17\">",
"     17",
"    </a>",
"    ]. Oliguric renal dysfunction is associated with greater mortality than non-oliguric AKI [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/14,16\">",
"     14,16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27114?source=see_link\">",
"     \"Acute kidney injury (acute renal failure) in the newborn\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27114?source=see_link&amp;anchor=H37#H37\">",
"     \"Acute kidney injury (acute renal failure) in the newborn\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PULMONARY DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several pulmonary disorders are associated with perinatal asphyxia. They include pulmonary edema and acute respiratory distress syndrome, which are presented here, and meconium aspiration syndrome and PPHN, which are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21768?source=see_link\">",
"     \"Clinical features and diagnosis of meconium aspiration syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=see_link\">",
"     \"Persistent pulmonary hypertension of the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Pulmonary edema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary edema may occur due to myocardial dysfunction. Infants have signs of respiratory distress, including cyanosis, tachypnea, nasal flaring, and grunting. Signs of cardiac dysfunction typically are present. &nbsp;The chest radiograph shows an enlarged heart, normal to increased lung volume, and prominent hilar vascular markings. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Myocardial dysfunction'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Infants with respiratory failure may require oxygen supplementation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mechanical ventilation, and treatment of the underlying myocardial dysfunction. The disorder resolves in a few days in most cases [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/18\">",
"     18",
"    </a>",
"    ]. Occasional infants develop hemorrhagic pulmonary edema.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Acute respiratory distress syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some infants develop severe respiratory distress after asphyxia that is not associated with myocardial dysfunction, although it may occur with PPHN [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. This condition is similar to acute respiratory distress syndrome (ARDS) that occurs in older children or adults. The mechanism appears to be increased pulmonary capillary permeability to plasma proteins, which leads to inactivation of surfactant.",
"   </p>",
"   <p>",
"    Infants present with signs of respiratory distress and cyanosis. The radiographic appearance is similar to respiratory distress syndrome in premature infants, with reduced lung volumes and diffuse bilateral alveolar opacification with air bronchograms [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Treatment is supportive, with supplemental oxygen",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mechanical ventilation, using increased levels of positive end-expiratory pressure. Some infants may benefit from surfactant treatment, although this has not been well studied [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     GASTROINTESTINAL DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal complications after perinatal asphyxia include feeding intolerance, necrotizing enterocolitis, and hepatic dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Feeding intolerance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Feeding intolerance may present as abdominal distension, delayed gastric emptying, and gagging. These abnormalities appear to be caused by transient disturbances in intestinal motor activity patterns, which may result from loss of neural regulation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inhibition of motor control [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Necrotizing enterocolitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alterations in intestinal blood flow can follow perinatal asphyxia and persist for up to three days [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/23\">",
"     23",
"    </a>",
"    ]. These changes may lead to ischemia and subsequent development of necrotizing enterocolitis (NEC). The incidence of NEC increases with decreasing gestational age. NEC typically presents after one week of age in premature infants, and in the first few days after birth in term infants [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/24\">",
"     24",
"    </a>",
"    ]. Signs include bloody stools, often with mucus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41591?source=see_link\">",
"     \"Clinical features and diagnosis of necrotizing enterocolitis in newborns\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/28/28105?source=see_link\">",
"     \"Pathology and pathogenesis of necrotizing enterocolitis in newborns\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;After perinatal asphyxia, feedings often are delayed for five to seven days, or until intestinal motility appears normal and stools contain no blood. However, the efficacy of this approach in preventing NEC has not been evaluated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Hepatic dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemia can interfere with synthetic, excretory, and detoxifying functions of the liver. These functions should be assessed.",
"   </p>",
"   <p>",
"    Transaminases frequently are elevated for several days after birth [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/25\">",
"     25",
"    </a>",
"    ], and reduced synthesis of clotting factors may result in prolongation of prothrombin and activated partial thromboplastin times, sometimes associated with clinical bleeding. Severely affected infants may develop hypoglycemia, and serum glucose values should be monitored. Cholestatic jaundice or hyperammonemia may occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     HEMATOLOGIC DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with perinatal asphyxia may have bleeding disorders. Causes include disseminated intravascular coagulation (DIC), impaired synthesis of clotting factors, and thrombocytopenia. In particular, perinatal asphyxia is an associated risk factor for thrombocytopenia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/3,26\">",
"     3,26",
"    </a>",
"    ]. The most important mechanism of thrombocytopenia probably is related to increased platelet destruction caused by DIC [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/27\">",
"     27",
"    </a>",
"    ], although decreased production may contribute [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29623/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8697?source=see_link&amp;anchor=H19#H19\">",
"     \"Disseminated intravascular coagulation in infants and children\", section on 'Neonates'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The platelet count should be monitored, and patients with thrombocytopenia or clinical bleeding should be evaluated for DIC. Platelets and fresh frozen plasma can be provided as needed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8697?source=see_link&amp;anchor=H23#H23\">",
"     \"Disseminated intravascular coagulation in infants and children\", section on 'Neonates'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8697?source=see_link&amp;anchor=H29#H29\">",
"     \"Disseminated intravascular coagulation in infants and children\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1124046816\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perinatal asphyxia results from compromised placental or pulmonary gas exchange, which may result in neonatal hypoxia and",
"    <span class=\"nowrap\">",
"     tissue/organ",
"    </span>",
"    injury. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A variety of maternal, obstetric, and neonatal conditions predispose the fetus and newborn to asphyxia that can occur before, during, or after birth. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Timing of injury'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Antepartum factors &ndash; Maternal conditions (eg, anemia, hypertension, diabetes, severe hypotension, or trauma), placental insufficiency, congenital infection or anomalies, or severe intrauterine growth restriction.",
"     </li>",
"     <li>",
"      Intrapartum conditions &ndash; Traumatic deliveries or abnormalities of umbilical circulation, placental perfusion, or maternal oxygenation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Perinatal asphyxia can affect all organs. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Organ involvement'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Hypoxic-ischemic encephalopathy is the most serious complication of perinatal asphyxia, and neurologic sequelae may be persistent. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30953?source=see_link\">",
"       \"Etiology and pathogenesis of neonatal encephalopathy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2442?source=see_link\">",
"       \"Clinical features, diagnosis, and treatment of neonatal encephalopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Asphyxia may cause myocardial ischemia, which usually is transient, but may rarely result in cardiogenic shock and death. Myocardial ischemia typically presents as impaired myocardial contractility, decreased cardiac output, and tricuspid insufficiency, and in severe cases, respiratory distress, heart failure, or shock. The diagnosis of myocardial dysfunction is confirmed by echocardiography. In affected neonates, the management is supportive with the use of mechanical ventilation in patients with respiratory failure, correction of metabolic abnormalities, the use of inotropic agent and diuretics, and fluid restriction. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Myocardial dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute kidney injury (AKI) often accompanies perinatal asphyxia, The presentation and course of AKI depend upon the severity and duration of the hypoxic-ischemic event. Severe asphyxia results in diffuse tubular dysfunction with impaired reabsorption of sodium and water and decreased glomerular filtration rate. A milder insult may cause only a transient loss of renal concentrating ability. AKI should be suspected if the serum creatinine concentration increases",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the urine output is reduced. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Renal dysfunction'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27114?source=see_link\">",
"       \"Acute kidney injury (acute renal failure) in the newborn\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Several pulmonary disorders are associated with perinatal asphyxia including pulmonary edema, acute respiratory distress syndrome, meconium aspiration syndrome, and persistent pulmonary hypertension of the newborn. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Pulmonary disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gastrointestinal complications after perinatal asphyxia include feeding intolerance, necrotizing enterocolitis, and hepatic dysfunction. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Gastrointestinal dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants with perinatal asphyxia are at increased risk for bleeding disorders, primarily due to thrombocytopenia and disseminated intravascular coagulation. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Hematologic disorders'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Volpe JJ. Hypoxic-ischemic encephalopathy: Clinical aspects. In: Neurology of the Newborn, 5th ed, Saunders Elsevier, Philadelphia 2008. p.400.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/2\">",
"      Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005; 365:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/3\">",
"      Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353:1574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/4\">",
"      Azzopardi DV, Strohm B, Edwards AD, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009; 361:1349.",
"     </a>",
"    </li>",
"    <li>",
"     Levene MI, deVries LS. Hypoxic-ischemic encephalopathy. In: Fanaroff &amp; Martin's Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant, 9th ed, Martin RJ, Fanaroff AA, Walsh MC (Eds), Elsevier, St.Louis 2011. p.952.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/6\">",
"      Kluckow M. Functional echocardiography in assessment of the cardiovascular system in asphyxiated neonates. J Pediatr 2011; 158:e13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/7\">",
"      Wei Y, Xu J, Xu T, et al. Left ventricular systolic function of newborns with asphyxia evaluated by tissue Doppler imaging. Pediatr Cardiol 2009; 30:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/8\">",
"      Matter M, Abdel-Hady H, Attia G, et al. Myocardial performance in asphyxiated full-term infants assessed by Doppler tissue imaging. Pediatr Cardiol 2010; 31:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/9\">",
"      M&ouml;ller JC, Thielsen B, Schaible TF, et al. Value of myocardial hypoxia markers (creatine kinase and its MB-fraction, troponin-T, QT-intervals) and serum creatinine for the retrospective diagnosis of perinatal asphyxia. Biol Neonate 1998; 73:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/10\">",
"      Szymankiewicz M, Matuszczak-Wleklak M, Hodgman JE, Gadzinowski J. Usefulness of cardiac troponin T and echocardiography in the diagnosis of hypoxic myocardial injury of full-term neonates. Biol Neonate 2005; 88:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/11\">",
"      Costa S, Zecca E, De Rosa G, et al. Is serum troponin T a useful marker of myocardial damage in newborn infants with perinatal asphyxia? Acta Paediatr 2007; 96:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/12\">",
"      Rajakumar PS, Vishnu Bhat B, Sridhar MG, et al. Electrocardiographic and echocardiographic changes in perinatal asphyxia. Indian J Pediatr 2009; 76:261.",
"     </a>",
"    </li>",
"    <li>",
"     Seri, I, Evans, J, Tulassay, T. Renal insufficiency and acute renal failure. In: Avery's Diseases of the Newborn, 7th ed, Taeusch, HW, Ballard, RA (Eds), WB Saunders, Philadelphia 1998, p. 1158.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/14\">",
"      Durkan AM, Alexander RT. Acute kidney injury post neonatal asphyxia. J Pediatr 2011; 158:e29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/15\">",
"      Karlowicz MG, Adelman RD. Nonoliguric and oliguric acute renal failure in asphyxiated term neonates. Pediatr Nephrol 1995; 9:718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/16\">",
"      Gupta BD, Sharma P, Bagla J, et al. Renal failure in asphyxiated neonates. Indian Pediatr 2005; 42:928.",
"     </a>",
"    </li>",
"    <li>",
"     Clin Biochem 2008; 41;968.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/18\">",
"      Thibeault DW, Hall FK, Sheehan MB, Hall RT. Postasphyxial lung disease in newborn infants with severe perinatal acidosis. Am J Obstet Gynecol 1984; 150:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/19\">",
"      Faix RG, Viscardi RM, DiPietro MA, Nicks JJ. Adult respiratory distress syndrome in full-term newborns. Pediatrics 1989; 83:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/20\">",
"      Pfenninger J, Tschaeppeler H, Wagner BP, et al. The paradox of adult respiratory distress syndrome in neonates. Pediatr Pulmonol 1991; 10:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/21\">",
"      Khammash H, Perlman M, Wojtulewicz J, Dunn M. Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics 1993; 92:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/22\">",
"      Berseth CL, McCoy HH. Birth asphyxia alters neonatal intestinal motility in term neonates. Pediatrics 1992; 90:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/23\">",
"      Akinbi H, Abbasi S, Hilpert PL, Bhutani VK. Gastrointestinal and renal blood flow velocity profile in neonates with birth asphyxia. J Pediatr 1994; 125:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/24\">",
"      Andrews DA, Sawin RS, Ledbetter DJ, et al. Necrotizing enterocolitis in term neonates. Am J Surg 1990; 159:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/25\">",
"      Karlsson M, Blennow M, Nemeth A, Winbladh B. Dynamics of hepatic enzyme activity following birth asphyxia. Acta Paediatr 2006; 95:1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/26\">",
"      Castle V, Andrew M, Kelton J, et al. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986; 108:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/27\">",
"      Bauman ME, Cheung PY, Massicotte MP. Hemostasis and platelet dysfunction in asphyxiated neonates. J Pediatr 2011; 158:e35.",
"     </a>",
"    </li>",
"    <li>",
"     Mongale, P, and Andrew, M. Developmental hemostasis: relevance to newborns and infants. In: Nathan and Oski's Hematology of Infancy and Childhood, 6th ed, Nathan, DG, Orkin, SH, Ginsberg, D, Look, AT (Eds), WB Saunders, Philadelphia 2003. p. 121.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29623/abstract/29\">",
"      Suzuki S, Morishita S. Hypercoagulability and DIC in high-risk infants. Semin Thromb Hemost 1998; 24:463.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4975 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-5849588C53-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29623=[""].join("\n");
var outline_f28_59_29623=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1124046816\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TIMING OF INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Antepartum conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Intrapartum events",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Postnatal disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Fetal biophysical profile",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ORGAN INVOLVEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ENCEPHALOPATHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MYOCARDIAL DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      RENAL DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PULMONARY DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Pulmonary edema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Acute respiratory distress syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      GASTROINTESTINAL DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Feeding intolerance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Necrotizing enterocolitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Hepatic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      HEMATOLOGIC DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1124046816\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27114?source=related_link\">",
"      Acute kidney injury (acute renal failure) in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/56/20359?source=related_link\">",
"      Cardiac causes of cyanosis in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21768?source=related_link\">",
"      Clinical features and diagnosis of meconium aspiration syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41591?source=related_link\">",
"      Clinical features and diagnosis of necrotizing enterocolitis in newborns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2442?source=related_link\">",
"      Clinical features, diagnosis, and treatment of neonatal encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33482?source=related_link\">",
"      Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8697?source=related_link\">",
"      Disseminated intravascular coagulation in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30953?source=related_link\">",
"      Etiology and pathogenesis of neonatal encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44809?source=related_link\">",
"      Infant of a diabetic mother",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/28/28105?source=related_link\">",
"      Pathology and pathogenesis of necrotizing enterocolitis in newborns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=related_link\">",
"      Persistent pulmonary hypertension of the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/23/9593?source=related_link\">",
"      Small for gestational age infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/41/11928?source=related_link\">",
"      The fetal biophysical profile",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_59_29624="Clinical manifestations and diagnosis of rabies";
var content_f28_59_29624=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of rabies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/59/29624/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29624/contributors\">",
"     Charles E Rupprecht, VMD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/59/29624/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29624/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/59/29624/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29624/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/59/29624/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rabies is one of the oldest and most feared human infections with the highest case fatality rate of any infectious disease.",
"   </p>",
"   <p>",
"    The epidemiology, clinical manifestations, and diagnosis of rabies will be reviewed here. Management of patients with active rabies and prevention of infection are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20088?source=see_link\">",
"     \"When to use rabies prophylaxis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/58/33703?source=see_link\">",
"     \"Treatment of rabies\"",
"    </a>",
"    .) Rabies guidelines can be accessed on the Centers for Disease Control and Prevention's website at",
"    <a class=\"external\" href=\"file://www.cdc.gov/rabies/\">",
"     file://www.cdc.gov/rabies/",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2006908\">",
"    <span class=\"h1\">",
"     VIROLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rabies is caused by a number of different species of neurotropic viruses in the Rhabdoviridae Family, Genus Lyssavirus [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Previously, it was thought that a single virus was responsible for all rabies cases. However, antigen detection techniques have demonstrated that several viruses within this genus cause diseases clinically similar to rabies. Genetic sequencing of virus from an infected human can also help to determine the probable vector of transmission, such as a silver-haired bat or a raccoon [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The bullet-shaped virion contains a single-stranded RNA genome encoding five structural proteins. One of these genes encodes for an outer glycoprotein, which is a primary target for virus-neutralizing antibodies. Nucleotide sequence analysis of the gene that codes for the inner nucleoprotein enables the identification of the various rabies virus variants and their associated host species.",
"   </p>",
"   <p>",
"    Rabies virus infects the muscle spindle and the nerves that innervate this structure. Each virion is surrounded by a lipoprotein envelope studded with glycoprotein spikes [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/1\">",
"     1",
"    </a>",
"    ]. After inoculation, these glycoprotein projections attach to specific sites, such as the nicotinic acetylcholine receptors of the plasma membrane of muscle cells [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/4\">",
"     4",
"    </a>",
"    ]. However, neurons do not express acetylcholine receptors, suggesting that other unidentified receptors may exist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2006933\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2006958\">",
"    <span class=\"h2\">",
"     Viral tropism and dissemination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lyssaviruses have a predilection for neural tissue and spread via peripheral nerves to the central nervous system (CNS). &nbsp;",
"   </p>",
"   <p>",
"    Virions amplify near the site of inoculation and subsequently enter local motor and sensory nerves [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/5\">",
"     5",
"    </a>",
"    ]. Viruses then migrate centrally in a retrograde direction within the axoplasm of peripheral nerves at approximately 50 to 100 mm per day until reaching the dorsal root ganglia of the spinal cord [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/6\">",
"     6",
"    </a>",
"    ]. Rabies viruses then ascend rapidly up the spinal cord to the brain, initially infecting the diencephalon, hippocampus, and brainstem [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Centrifugal spread of viruses along somatic and autonomic nerves results in widespread dissemination [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/8\">",
"     8",
"    </a>",
"    ]. Productive viral replication and shedding occurs in highly innervated areas, such as the salivary glands [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/6,9\">",
"     6,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism by which rabies causes severe CNS disease is unclear. Although many neurons are infected by virus, the neuropathological findings are quite mild compared with those caused by other infectious etiologies of encephalitis, such as herpes simplex virus [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/10\">",
"     10",
"    </a>",
"    ]. On autopsy, gross non-specific findings include mild cerebral edema and vascular congestion. Microscopic changes include perivascular cuffing with mononuclear cell infiltration and microglial activation; occasional neuronophagia (destruction of nerve cells by phagocytes) may be seen. Dense, ovoid, intracytoplasmic inclusions, (ie, Negri bodies), may be observed within neurons of the CNS in areas devoid of inflammation or degeneration. Lyssaviruses may produce neuronal dysfunction, such as autonomic instability, rather than neuronal death.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2006965\">",
"    <span class=\"h2\">",
"     Host susceptibility to infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient's susceptibility to rabies infection is related to several variables [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/9,11\">",
"     9,11",
"    </a>",
"    ]. As an example, a bite with prominent salivary contamination on exposed skin of the face and head is more likely to result in a productive infection than a bite through clothing where saliva may be absorbed.",
"   </p>",
"   <p>",
"    Other factors that may increase host susceptibility to infection include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The infecting variant &nbsp;",
"     </li>",
"     <li>",
"      The size of the inoculum &nbsp;",
"     </li>",
"     <li>",
"      The degree of innervation at the site of the bite",
"     </li>",
"     <li>",
"      Host immunity and genetics",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All mammals are believed susceptible to rabies virus infection although species differ in their relative susceptibility. For example, foxes, coyotes, wolves, and jackals are quite susceptible whereas opossums are relatively resistant [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2006280\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9913634\">",
"    <span class=\"h2\">",
"     Geographic distribution",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rabies has a worldwide distribution with few exceptions, including Antarctica, New Zealand, Japan, Taiwan, Sweden, Norway, Spain and some Caribbean Islands [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/12\">",
"     12",
"    </a>",
"    ]. Rabies is found throughout the United States except Hawaii [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the development of the first",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/55/16246?source=see_link\">",
"     rabies vaccine",
"    </a>",
"    in 1885 by Louis Pasteur, the World Health Organization estimates that between 30,000 and 70,000 people die worldwide of rabies each year [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/14\">",
"     14",
"    </a>",
"    ]. Most of these deaths occur in developing countries because of inadequate control of rabies in domesticated animals.",
"   </p>",
"   <p>",
"    In the United States, there has been an average of three fatal human cases per year since 1980 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/15-22\">",
"     15-22",
"    </a>",
"    ]. Some of these cases were related to imported rabies from endemic areas [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most rabies is acquired through exposure to saliva from an animal bite. In rare cases, rabies results from a non-bite exposure (eg, aerosolized virus in bat caves) or transplantation of tissue from a donor with unrecognized rabies [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/25-27\">",
"     25-27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No transmission of rabies has been documented from infected patients to healthcare personnel or household contacts or by fomites or environmental surfaces [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/12,13,28\">",
"     12,13,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9913641\">",
"    <span class=\"h3\">",
"     Animal reservoirs",
"    </span>",
"    &nbsp;&mdash;&nbsp;In developing countries, dogs account for 90 percent or more of reported cases transmitted to humans. Canine rabies was responsible for most human deaths in the United States prior to the 1950s, but was largely eliminated as an endemic source by the 1970s [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/9\">",
"     9",
"    </a>",
"    ]. By the late 1960s, wild animals emerged as a major source of human exposure.",
"   </p>",
"   <p>",
"    During 2008, rabies surveillance in the United States identified four major animal reservoirs as bats, raccoons, skunks, and foxes [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. The leading source associated with US cases has been the silver-haired bat (Lasionycteris noctivagans) rabies strain, although many patients do not have a history of a bat bite, or only recall being in the same vicinity with a bat.",
"   </p>",
"   <p>",
"    As a general rule, small rodents, such as gerbils, chipmunks, guinea pigs, squirrels, rats, mice, and rabbits are susceptible, but cases of rabies are uncommon in these animals [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/30-32\">",
"     30-32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9913648\">",
"    <span class=\"h3\">",
"     Organ transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2004, an unusual mode of rabies virus transmission occurred through transplantation of tissues from an infected donor.",
"   </p>",
"   <p>",
"    Encephalitis developed in four recipients of kidneys, an arterial segment, and a liver from a common organ donor who died of encephalitis of unknown cause [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/33\">",
"     33",
"    </a>",
"    ]. Immunohistochemical and direct fluorescence antibody staining demonstrated rabies virus in multiple tissues from all recipients. Histopathological findings in brain tissue from the transplant recipients demonstrated intracytoplasmic viral inclusions, suggestive of Negri bodies (",
"    <a class=\"graphic graphic_picture graphicRef59999 \" href=\"UTD.htm?34/48/35588\">",
"     picture 1",
"    </a>",
"    ). Antibodies against rabies virus were present in three of the four recipients and in the donor, who had a history of a bat bite.",
"   </p>",
"   <p>",
"    Another series of rabies cases related to solid organ transplantations from an infected donor was reported in 2010 where all the recipients died except one with history of rabies immunization in the past [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/27\">",
"     27",
"    </a>",
"    ]; during the course of the investigation, two additional recipients of corneal transplants were immunized against rabies and have remained healthy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4962721\">",
"    <span class=\"h1\">",
"     INCUBATION PERIOD",
"    </span>",
"    &nbsp;&mdash;&nbsp;The average incubation period is one to three months, but can range from several days to one year after exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/11,14,34\">",
"     11,14,34",
"    </a>",
"    ]. There are rare case reports of longer incubation periods that may be related to inadequate rabies prophylaxis or an unknown new exposure. In one series of 32 patients with rabies, in which a definite animal bite was reported, the median incubation period was 85 days (range, 53 to 150 days) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/35\">",
"     35",
"    </a>",
"    ]. The incubation period is shorter in patients with an exposure that occurs in richly innervated areas, such as the face, compared with the extremities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4962713\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the patient has exhibited clinical signs of disease, rabies usually leads to progressive encephalopathy and death, with rare exception [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/58/33703?source=see_link\">",
"     \"Treatment of rabies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/58/33703?source=see_link&amp;anchor=H5102970#H5102970\">",
"     \"Treatment of rabies\", section on 'Case reports of survival from rabies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4962773\">",
"    <span class=\"h2\">",
"     Prodromal symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rabies is usually unsuspected during the prodromal phase, which starts with non-specific symptoms, such as low-grade fever, chills, malaise, myalgias, weakness, fatigue, anorexia, sore throat, nausea, vomiting, headache, and occasionally photophobia. This stage lasts from a few days to approximately one week [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If a bite wound is present, reported paresthesias radiating proximally from the site of the wound would be suggestive of rabies infection [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/37\">",
"     37",
"    </a>",
"    ]. The patient may describe a variety of symptoms including pain, tenderness, tingling, itching, burning, abnormal localized temperature sensation, or numbness [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On physical examination, there may be signs of local infection, such as erythema and purulence of the wound. This presentation would be more commonly seen among patients living in developing countries with a history of a dog bite; as noted above, bites from bats may be imperceptible by the patient, such as during deep sleep.",
"   </p>",
"   <p>",
"    Percussion myoedema (mounding of the muscle at the percussion site) may be present during the prodrome and throughout the illness [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4962794\">",
"    <span class=\"h2\">",
"     Clinical rabies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection may evolve into two major forms of disease including encephalitic (furious) rabies or paralytic (dumb) rabies, both starting with nonspecific prodromal symptoms as described above [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/3\">",
"     3",
"    </a>",
"    ]. Encephalitic rabies is more common (ie, 80 percent of cases).",
"   </p>",
"   <p>",
"    Occasionally, atypical cases have also been described in association with bat rabies [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/7\">",
"     7",
"    </a>",
"    ]. Atypical features include sensory or motor deficits, choreiform movements of the bitten limb during the prodromal phase, focal brainstem signs, cranial nerve palsies, myoclonus, and seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/7,40\">",
"     7,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The course of disease is heavily influenced by the extent of the bites, proximity to the head, and amount of secretions that were encountered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4962763\">",
"    <span class=\"h3\">",
"     Encephalitic rabies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic presentation of encephalitic rabies includes fever, hydrophobia, pharyngeal spasms, and hyperactivity leading to paralysis, coma and death [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/3\">",
"     3",
"    </a>",
"    ]. The following symptoms and signs are classic for this form of rabies [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/3,38\">",
"     3,38",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hydrophobia is the most characteristic clinical feature of rabies, occurring in 33 to 50 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/3,38,41\">",
"       3,38,41",
"      </a>",
"      ]. After some preliminary feeling of discomfort in the throat or dysphagia, the patient suddenly develops an overwhelming terror of water based on involuntary pharyngeal muscle spasms during attempts to drink. Later in the disease, even the sight or mention of water may trigger these involuntary spasms.",
"     </li>",
"     <li>",
"      Aerophobia is also pathognomonic of rabies although it occurs less often than hydrophobia (approximately 9 percent in one series) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/41\">",
"       41",
"      </a>",
"      ]. Pharyngeal spasms are triggered upon feeling a draft of air and can last approximately 5 to 15 seconds. Painful inspiratory spasms of the diaphragm and accessory inspiratory muscles can lead to aspiration, coughing, choking, vomiting and hiccups; when severe, these spasms can lead to asphyxiation and respiratory arrest [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/7,11\">",
"       7,11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The facial muscles may contract leading to a grimace and the neck and back can become hyperextended with muscle spasticity (referred to as opisthotonos).",
"     </li>",
"     <li>",
"      Autonomic instability is observed in approximately 25 percent of all patients [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/41\">",
"       41",
"      </a>",
"      ]. Signs of overactivity of the autonomic nervous system include hypersalivation, lacrimation, sweating, &ldquo;goose flesh&rdquo; and dilatation of the pupils. Hyperpyrexia alternating with hypothermia has been described. Tachycardia and cardiac arrhythmias are common and may be related to myocarditis from direct viral injury [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients may exhibit dysarthria, dysphagia or may complain of diplopia or vertigo. Dysphagia was reported in approximately half of all cases in one retrospective series [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Agitation and combativeness are also commonly seen (approximately 50 percent of patients) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/41\">",
"       41",
"      </a>",
"      ]. Intermittently, the patient may display symptoms of generalized arousal or hyperexcitability associated with disorientation, fluctuating consciousness, restlessness, agitation, and visual or auditory hallucinations. Patients may become aggressive and maniacal followed by periods of calm.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The physical examination is notable for mental status changes, increased muscular tone and tendon reflexes with extensor plantar responses and fasciculations. Nuchal rigidity may be present. Once the patient develops coma, flaccid paralysis with generalized areflexia is usually noted. Patients usually die as a result of respiratory and vascular collapse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4962891\">",
"    <span class=\"h3\">",
"     Paralytic (dumb) rabies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fewer than 20 percent of rabies patients present with an ascending paralysis, which can mimic Guillain-Barr&eacute; syndrome. These patients have little evidence of cerebral involvement until late in their course of disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/22/5481?source=see_link\">",
"     \"Clinical features and diagnosis of Guillain-Barr&eacute; syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    After the prodromal symptoms described above, the patient develops a flaccid paralysis. Paralysis is usually most prominent in the bitten limb, and then spreads symmetrically or asymmetrically. The physical examination is notable for fasciculations; deep tendon and plantar reflexes are lost.",
"   </p>",
"   <p>",
"    The patient may complain of headache and pain in the affected muscles with mild sensory disturbance. Nuchal rigidity and cranial nerve palsies are occasionally seen while hydrophobia is unusual.",
"   </p>",
"   <p>",
"    As the paralysis ascends, there is onset of dense paraplegia and loss of sphincter tone with subsequent paralysis of the muscles of deglutition and respiration, leading to death.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4962899\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with rabies die within two weeks after the onset of coma, although longer courses have been described with intensive care support [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/27\">",
"     27",
"    </a>",
"    ]. In addition, a few cases of survival after clinical rabies have been reported since 2004.",
"   </p>",
"   <p>",
"    Patients often die of complications, such as asphyxiation and respiratory arrest secondary to muscular spasms or uncontrolled generalized seizures in encephalitic rabies or respiratory paralysis in paralytic rabies [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/43\">",
"     43",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Supraventricular arrhythmias, atrioventricular block, sinus bradycardia and sinus arrest with non-specific ST segment and T-wave changes have all been reported. Myocarditis has been found at necropsy with evidence of viral invasion and lymphocytic infiltration.",
"   </p>",
"   <p>",
"    The management of rabies is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/58/33703?source=see_link&amp;anchor=H5102970#H5102970\">",
"     \"Treatment of rabies\", section on 'Case reports of survival from rabies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4962926\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine laboratory tests are non-specific. A peripheral leukocytosis is often noted. When a constellation of clinical features suggestive of meningitis or encephalitis is present, a lumbar puncture is often obtained, which demonstrates a lymphocytic pleocytosis (mean 60",
"    <span class=\"nowrap\">",
"     cells/uL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/41\">",
"     41",
"    </a>",
"    ]. CSF protein is characteristically elevated with a normal glucose concentration. A hemorrhagic CSF is not characteristically seen with rabies infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H831871\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT scans are usually normal in the early phase of the illness. In later stages, cerebral edema may be seen. MR imaging may show areas of increased T2 signaling in the hippocampus, hypothalamus and brainstem [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of rabies requires a thorough patient history and a high index of suspicion. Paresthesias surrounding an animal bite are suggestive of possible rabies infection. Before death, the diagnosis can be made by virus-specific immunofluorescent staining of skin biopsy specimens, isolation of virus from the saliva, or detection of anti-rabies antibodies in serum or cerebrospinal fluid (CSF). The clinical evaluation also centers on ruling out other often more treatable illnesses (eg, herpes simplex virus encephalitis) (",
"    <a class=\"graphic graphic_algorithm graphicRef79957 \" href=\"UTD.htm?30/11/30896\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H4962934\">",
"     'Diffferential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Clinical diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical diagnosis of rabies is more straightforward in developing countries when a nonimmunized patient presents after a bite by a known rabid animal.",
"   </p>",
"   <p>",
"    In developed countries, some patients may have an unrecognized exposure (eg, to a bat) or are unaware of the risks of exposure and did not receive postexposure prophylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/45\">",
"     45",
"    </a>",
"    ]. In the 52 cases of human rabies reported in the United States since 1990, approximately 50 percent were diagnosed postmortem [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/21,22,30\">",
"     21,22,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rabies should be considered in the differential diagnosis of patients presenting with acute progressive encephalitis, regardless of a history of an animal bite or known exposure. Encephalitic rabies may be suspected based on pathognomonic symptoms of hydrophobia and aerophobia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Laboratory diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antemortem diagnosis of rabies requires several specimens (eg, saliva, skin, serum, CSF) and multiple testing modalities, since the sensitivity of any single test is limited and viral shedding can be intermittent.",
"   </p>",
"   <p>",
"    Serum antibody titers, for example, may not test positive until rather late in the course of illness, if at all. However, the sensitivity of a combination of tests approaches 100 percent, depending upon specimen quality, timing of collection, and diagnostic expertise.",
"   </p>",
"   <p>",
"    The accuracy of testing various biologic specimens in the diagnosis of rabies was assessed in a prospective longitudinal study of 51 patients with encephalitis from Madagascar, Cambodia, and France [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/46\">",
"     46",
"    </a>",
"    ]. A total of 425 samples (including saliva, urine, serum, and skin biopsies) were obtained during the acute hospitalization or postmortem. Polymerase chain reaction (PCR) testing of skin biopsies was associated with high sensitivity and specificity (98 and 98.3 percent, respectively), followed by saliva (63.2 and 70.2 percent, respectively). The sensitivity of saliva specimens was improved to 100 percent when at least three samples were obtained. The overall sensitivity of urine and serum samples was poor.",
"   </p>",
"   <p>",
"    The interpretation of antibodies to rabies will depend on the specific specimen and the history of immunization. For example, serum antibodies to rabies virus may not be present until several days after the onset of clinical signs and may appear even later in the CSF [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/35\">",
"     35",
"    </a>",
"    ]. If no vaccine or rabies immune globulin has been given, the presence of antibody to rabies virus in serum is diagnostic of infection. A patient who has been immunized will have rabies antibodies in serum. Thus, in the immunized patient, a second specimen should be obtained a few days later to see if antibody titers are rising, which would be indicative of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/6\">",
"     6",
"    </a>",
"    ]. However, antibody to virus in a CSF specimen, regardless of the immunization history, suggests virus infection.",
"   </p>",
"   <p>",
"    Routine analysis of the CSF does not distinguish rabies from other encephalitides (",
"    <a class=\"graphic graphic_table graphicRef76324 \" href=\"UTD.htm?13/55/14204\">",
"     table 1",
"    </a>",
"    ). Findings that may be seen include a modest lymphocytic pleocytosis (eg, 5 to 30 white",
"    <span class=\"nowrap\">",
"     cells/microL),",
"    </span>",
"    a normal CSF glucose concentration, and a small increase in CSF protein concentration, typically less than 100",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9914422\">",
"    <span class=\"h2\">",
"     Sample collection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Collection of samples for diagnosis of rabies in the US should be performed only after consultation with state health department staff or with the rabies program at the Centers for Disease Control and Prevention (",
"    <a class=\"external\" href=\"file://www.cdc.gov/rabies\">",
"     www.cdc.gov/rabies",
"    </a>",
"    ). All samples should be considered potentially infectious. &nbsp;",
"   </p>",
"   <p>",
"    If immediate shipment and testing are not possible, samples should be stored frozen at -80&ordm;C and shipped on dry ice by an overnight courier. The following samples and tests should be obtained:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Saliva &ndash; All saliva specimens should be collected and placed in a small sterile container and sealed securely. Laboratory tests to be performed include reverse transcriptase polymerase chain reaction (RT-PCR) for the detection of virus RNA and viral culture for the isolation of infectious virus.",
"     </li>",
"     <li>",
"      Skin biopsy &ndash; A section of full thickness skin (ie, five to six mm in diameter) should be taken from the posterior region of the neck at the hairline. The sample should contain a minimum of approximately 10 hair follicles and include the cutaneous nerves at the base of the follicle. The specimen should be placed on a small piece of moist sterile gauze (without immersion in diluent or transport media) and put in a sealed container. Laboratory tests to be performed include RT-PCR and immunofluorescence staining for viral antigen.",
"     </li>",
"     <li>",
"      Serum and cerebrospinal fluid &ndash; A minimum of 0.5 mL of serum and CSF should be obtained for testing. If the patient has been immunized, a second serum specimen should be obtained a few days later to see if antibody titers are rising [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/6\">",
"       6",
"      </a>",
"      ]. Laboratory tests for rabies antibody include indirect immunofluorescence and virus neutralization assays.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9914429\">",
"    <span class=\"h2\">",
"     Postmortem testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postmortem testing involves examining brainstem and other neural tissues directly, utilizing immunofluorescence staining for viral antigens. Mononuclear inflammation with abundant rabies virus antigens may be seen distributed diffusely [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/37\">",
"     37",
"    </a>",
"    ]. Negri bodies, eosinophilic neuronal cytoplasmic inclusions (",
"    <a class=\"graphic graphic_picture graphicRef51471 \" href=\"UTD.htm?34/32/35328\">",
"     picture 2",
"    </a>",
"    ), are pathognomonic for rabies, but are not present in all cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4962934\">",
"    <span class=\"h1\">",
"     DIFFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nonspecific prodromal phase may be confused with a multitude of infectious disorders, such as a nonspecific viral illness, mononucleosis, early bacteremia, or meningitis. The differential diagnosis will very much depend on whether the patient develops encephalitic or paralytic rabies.",
"   </p>",
"   <p>",
"    In patients with a constellation of symptoms and signs of encephalitis, other more common infections (eg, herpes simplex virus, West Nile virus) and other noninfectious disorders (eg, central nervous system vasculitis, toxic or metabolic encephalopathy ) should be ruled out (",
"    <a class=\"graphic graphic_algorithm graphicRef79957 \" href=\"UTD.htm?30/11/30896\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/34\">",
"     34",
"    </a>",
"    ]. One series that compared patients with confirmed rabies with patients having other forms of encephalitis found that rabies cases were distinguished by the presence of hydrophobia, aerophobia, dysphagia, and localized pain, weakness or paresthesias [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29624/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/62/1001?source=see_link&amp;anchor=H8#H8\">",
"     \"Herpes simplex virus type 1 encephalitis\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/47/22264?source=see_link\">",
"     \"Clinical manifestations and diagnosis of West Nile virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other causes of muscular rigidity that can be seen with rabies include tetanus, phenothiazine dystonia, and strychnine poisoning. Although patients with delirium tremens can demonstrate agitation, experience hallucinations and have tremors, they do not have exhibit hydrophobia or aerophobia.",
"   </p>",
"   <p>",
"    Paralytic rabies may be confused with Guillain-Barr&eacute; syndrome, poliomyelitis, West Nile virus and acute transverse myelitis. Patients with poliomyelitis do not have sensory disturbances and fever does not usually persist with the onset of paralysis. Other acute polyneuropathies, neuromuscular junction disorders, and processes affecting the spinal cord should also be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/44/36553?source=see_link\">",
"     \"Polio and infectious diseases of the anterior horn\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/22/5481?source=see_link\">",
"     \"Clinical features and diagnosis of Guillain-Barr&eacute; syndrome in adults\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9913584\">",
"    <span class=\"h1\">",
"     TREATMENT AND PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, rabies cannot be effectively treated, so most efforts need to be focused on prevention. Topics addressing prevention and treatment of rabies are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/58/33703?source=see_link&amp;anchor=H5102970#H5102970\">",
"     \"Treatment of rabies\", section on 'Case reports of survival from rabies'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20088?source=see_link\">",
"     \"When to use rabies prophylaxis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?2/23/2418?source=see_link\">",
"       \"Patient information: Rabies (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?29/55/30578?source=see_link\">",
"       \"Patient information: Rabies (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2005829\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Despite the development of the first",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/55/16246?source=see_link\">",
"       rabies vaccine",
"      </a>",
"      in 1885, the World Health Organization estimates that between 30,000 and 70,000 people die worldwide of rabies each year. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rabies is caused by a number of different species of neurotropic viruses in the Rhabdoviridae Family, Genus Lyssavirus. (See",
"      <a class=\"local\" href=\"#H2006908\">",
"       'Virology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lyssaviruses have a predilection for nerves, along which they spread. Virions are first amplified near the site of inoculation and subsequently enter local motor and sensory nerves. Viruses then migrate centrally in a retrograde direction within the axoplasm of peripheral nerves until reaching the spinal cord and brain. (See",
"      <a class=\"local\" href=\"#H2006933\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Almost all cases of rabies are transmitted from rabid animals through a bite. In developing countries, dogs account for 90 percent or more of reported cases transmitted to humans, whereas bats account for most rabies cases in the United States. In rare cases, rabies results from a non-bite exposure (eg, aerosolized virus) or via transplantation of tissue from a donor with unrecognized rabies. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Transmission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Factors that may affect host susceptibility to infection include the size of the inoculum, proximity of the bite to the central nervous system, and host genetic variations. (See",
"      <a class=\"local\" href=\"#H2006965\">",
"       'Host susceptibility to infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The average incubation period is one to three months. (See",
"      <a class=\"local\" href=\"#H4962721\">",
"       'Incubation period'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prodrome consists of nonspecific flu-like symptoms including malaise, anorexia, irritability, low grade fever, sore throat, headache, nausea, and vomiting. There may also be specific neurologic signs and symptoms at the site of virus entry that are suggestive of rabies infection, including paresthesias, pain and pruritus. (See",
"      <a class=\"local\" href=\"#H4962773\">",
"       'Prodromal symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An acute neurologic syndrome of either encephalitic or paralytic rabies follows the prodrome and typically lasts for two to seven days. The manifestations of encephalitic rabies, which occurs in the majority of patients, may include hyperactivity, persistent fever, fluctuating consciousness, painful pharyngeal or inspiratory spasms, autonomic stimulation (hypersalivation), hydrophobia and seizures. Paralytic rabies is characterized by quadriparesis and sphincter involvement. (See",
"      <a class=\"local\" href=\"#H4962713\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Atypical rabies, which is less common than either classic form, has been most often described in patients with bat-associated rabies. Atypical features include neuropathic pain, choreiform movements of the bitten limb during the prodromal phase, focal brainstem signs, cranial nerve palsies, myoclonus, and seizures. (See",
"      <a class=\"local\" href=\"#H4962794\">",
"       'Clinical rabies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical diagnosis of rabies is straightforward in developing countries when a nonimmunized patient presents after a bite by a known rabid animal. In developed countries, many patients have an unrecognized exposure (eg, to a bat). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Before death, the diagnosis of rabies can be made by virus-specific immunofluorescent staining of skin biopsy specimens, isolation of virus from the saliva, or detection of anti-rabies antibodies in serum or cerebrospinal fluid. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Since the sensitivity of any single diagnostic test for rabies is limited, antemortem diagnosis of rabies requires several specimens of saliva, skin, serum, and cerebrospinal fluid and multiple testing modalities, depending on the specimen type as described above. (See",
"      <a class=\"local\" href=\"#H9914422\">",
"       'Sample collection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis varies, depending on whether the patient presents with encephalitic or paralytic rabies. The main diagnostic possibilities to consider in a patient with encephalitis rabies include West Nile virus and herpes simplex virus infections. In a patient with paralytic rabies, the main differential diagnoses include Guillain-Barr&eacute; syndrome, transverse myelitis, and polio. The evaluation for these alternative diagnoses typically includes a cerebrospinal fluid analysis and brain imaging. (See",
"      <a class=\"local\" href=\"#H4962934\">",
"       'Diffferential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Fauquet CM, Mayo MA, Maniloff J, et al. Virus Taxonomy. Eighth report of the international committee on the nomenclature of viruses, Elsevier Academic Press, Inc., San Diego 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/2\">",
"      Kuzmin IV, Hughes GJ, Botvinkin AD, et al. Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition. Virus Res 2005; 111:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/3\">",
"      Hankins DG, Rosekrans JA. Overview, prevention, and treatment of rabies. Mayo Clin Proc 2004; 79:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/4\">",
"      Lentz TL, Burrage TG, Smith AL, et al. Is the acetylcholine receptor a rabies virus receptor? Science 1982; 215:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/5\">",
"      Murphy FA, Bauer SP. Early street rabies virus infection in striated muscle and later progression to the central nervous system. Intervirology 1974; 3:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/6\">",
"      Warrell MJ, Warrell DA. Rabies and other lyssavirus diseases. Lancet 2004; 363:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/7\">",
"      Hemachudha T, Laothamatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol 2002; 1:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/8\">",
"      Wilson JM, Hettiarachchi J, Wijesuriya LM. Presenting features and diagnosis of rabies. Lancet 1975; 2:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/9\">",
"      Fishbein DB, Robinson LE. Rabies. N Engl J Med 1993; 329:1632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/10\">",
"      Jackson AC. Recovery from rabies. N Engl J Med 2005; 352:2549.",
"     </a>",
"    </li>",
"    <li>",
"     Bleck TP, Rupprecht CE. Rhabdoviruses. In: Principles and Practice of Infectious Diseases, Sixth Ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia 2005. p.2047.",
"    </li>",
"    <li>",
"     World Health Organization. WHO expert consultation on rabies. WHO Tech Rep Ser 2005; Abstract 931, pg. 88.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/13\">",
"      Human rabies prevention--United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/14\">",
"      Knobel DL, Cleaveland S, Coleman PG, et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005; 83:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/15\">",
"      Messenger SL, Smith JS, Rupprecht CE. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clin Infect Dis 2002; 35:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/16\">",
"      Centers for Disease Control and Prevention (CDC). Human rabies--Tennessee, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/17\">",
"      Centers for Disease Control and Prevention (CDC). Human rabies--California, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/18\">",
"      Centers for Disease Control and Prevention (CDC). Human rabies--Iowa, 2002. MMWR Morb Mortal Wkly Rep 2003; 52:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/19\">",
"      Centers for Disease Control and Prevention (CDC). First human death associated with raccoon rabies--Virginia, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/20\">",
"      Centers for Disease Control and Prevention (CDC). Human death associated with bat rabies--California, 2003. MMWR Morb Mortal Wkly Rep 2004; 53:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/21\">",
"      Centers for Disease Control and Prevention (CDC). Investigation of rabies infections in organ donor and transplant recipients--Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/22\">",
"      Centers for Disease Control and Prevention (CDC). Update: investigation of rabies infections in organ donor and transplant recipients--Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/23\">",
"      Centers for Disease Control and Prevention (CDC). Imported human rabies -New Jersey, 2011. MMWR Morb Mortal Wkly Rep 2012; 60:1734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/24\">",
"      Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases--United States, 2010. MMWR Morb Mortal Wkly Rep 2012; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/25\">",
"      Davis AD, Rudd RJ, Bowen RA. Effects of aerosolized rabies virus exposure on bats and mice. J Infect Dis 2007; 195:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/26\">",
"      Winkler WG, Fashinell TR, Leffingwell L, et al. Airborne rabies transmission in a laboratory worker. JAMA 1973; 226:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/27\">",
"      Maier T, Schwarting A, Mauer D, et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis 2010; 50:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/28\">",
"      Helmick CG, Tauxe RV, Vernon AA. Is there a risk to contacts of patients with rabies? Rev Infect Dis 1987; 9:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/29\">",
"      Murphy TV, Slade BA, Broder KR, et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/30\">",
"      Blanton JD, Hanlon CA, Rupprecht CE. Rabies surveillance in the United States during 2006. J Am Vet Med Assoc 2007; 231:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/31\">",
"      Halpin K, Hyatt AD, Plowright RK, et al. Emerging viruses: coming in on a wrinkled wing and a prayer. Clin Infect Dis 2007; 44:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/32\">",
"      Centers for Disease Control and Prevention (CDC). Human rabies--Indiana and California, 2006. MMWR Morb Mortal Wkly Rep 2007; 56:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/33\">",
"      Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/34\">",
"      Rupprecht CE, Hanlon CA, Hemachudha T. Rabies re-examined. Lancet Infect Dis 2002; 2:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/35\">",
"      Noah DL, Drenzek CL, Smith JS, et al. Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med 1998; 128:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/36\">",
"      Hattwick MA. Reactions to rabies. N Engl J Med 1972; 287:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/37\">",
"      Centers for Disease Control and Prevention (CDC). Imported human rabies in a U.S. Army soldier - New York, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:302.",
"     </a>",
"    </li>",
"    <li>",
"     Transactions of the Royal Society of Tropical Medicine and Hygiene Vol 70 No 3. 1976 (Accessed on March 16, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/39\">",
"      Hemachudha T, Phanthumchinda K, Phanuphak P, Manutsathit S. Myoedema as a clinical sign in paralytic rabies. Lancet 1987; 1:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/40\">",
"      Centers for Disease Control and Prevention (CDC). Recovery of a patient from clinical rabies--Wisconsin, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:1171.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.intechopen.com/books/non-flavivirus-encephalitis/human-rabies-epidemiology-and-diagnosis.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/42\">",
"      Metze K, Feiden W. Rabies virus ribonucleoprotein in the heart. N Engl J Med 1991; 324:1814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/43\">",
"      Rubin RH, Sullivan L, Summers R, et al. A case of human rabies in Kansas: epidemiologic, clinical, and laboratory considerations. J Infect Dis 1970; 122:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/44\">",
"      Burton EC, Burns DK, Opatowsky MJ, et al. Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients. Arch Neurol 2005; 62:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/45\">",
"      Anderson LJ, Nicholson KG, Tauxe RV, Winkler WG. Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention. Ann Intern Med 1984; 100:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29624/abstract/46\">",
"      Dacheux L, Reynes JM, Buchy P, et al. A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis 2008; 47:1410.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8322 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-89.32.226.102-5846377118-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29624=[""].join("\n");
var outline_f28_59_29624=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2005829\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2006908\">",
"      VIROLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2006933\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2006958\">",
"      Viral tropism and dissemination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2006965\">",
"      Host susceptibility to infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2006280\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9913634\">",
"      Geographic distribution",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Transmission",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9913641\">",
"      - Animal reservoirs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9913648\">",
"      - Organ transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4962721\">",
"      INCUBATION PERIOD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4962713\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4962773\">",
"      Prodromal symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4962794\">",
"      Clinical rabies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4962763\">",
"      - Encephalitic rabies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4962891\">",
"      - Paralytic (dumb) rabies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4962899\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4962926\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H831871\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Clinical diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Laboratory diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9914422\">",
"      Sample collection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9914429\">",
"      Postmortem testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4962934\">",
"      DIFFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9913584\">",
"      TREATMENT AND PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2005829\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8322\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8322|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?30/11/30896\" title=\"algorithm 1\">",
"      Differential dx rabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8322|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/48/35588\" title=\"picture 1\">",
"      Histopathology rabies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/32/35328\" title=\"picture 2\">",
"      Negri bodies in rabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8322|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/55/14204\" title=\"table 1\">",
"      CSF analysis in CNS infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/22/5481?source=related_link\">",
"      Clinical features and diagnosis of Guillain-Barr&eacute; syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/47/22264?source=related_link\">",
"      Clinical manifestations and diagnosis of West Nile virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/62/1001?source=related_link\">",
"      Herpes simplex virus type 1 encephalitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/55/30578?source=related_link\">",
"      Patient information: Rabies (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/23/2418?source=related_link\">",
"      Patient information: Rabies (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/44/36553?source=related_link\">",
"      Polio and infectious diseases of the anterior horn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=related_link\">",
"      Rabies immune globulin and vaccine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/58/33703?source=related_link\">",
"      Treatment of rabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20088?source=related_link\">",
"      When to use rabies prophylaxis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_59_29625="Principles of burn reconstruction: Face, scalp, and neck";
var content_f28_59_29625=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Principles of burn reconstruction: Face, scalp, and neck",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/59/29625/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29625/contributors\">",
"     Jorge Leon-Villapalos, MD, FRCS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29625/contributors\">",
"     Peter Dziewulski, MD, FRCS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/59/29625/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29625/contributors\">",
"     Marc G Jeschke, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/59/29625/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29625/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/59/29625/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H39975411\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of reconstructive surgery for the burn patient are first to restore function, then to restore esthetic appearances. Nowhere else in the body is it more important to achieve good functional reconstruction matched with perfect cosmetic appearance than in the head and neck, and specifically the face.",
"   </p>",
"   <p>",
"    Following resuscitation and stabilization, management of the burn wounds becomes the next priority. The later effects of burns, which are related to loss of normal tissue and scarring, include limitation of movement, pain, disfigurement, and social embarrassment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following are the basic tenets for reconstruction of burns to the face, scalp, and neck regions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Replace like tissue with like tissue (eg, the best replacement for scalp tissue is the scalp) when possible.",
"     </li>",
"     <li>",
"      Multidisciplinary, realistic, well timed reconstructive plan discussed with the patient",
"     </li>",
"     <li>",
"      Prioritize function over cosmesis, but combine whenever possible.",
"     </li>",
"     <li>",
"      Reconstruct areas of paramount functional importance first, specifically those surrounded by sphincters such as the mouth and lips to avoid microstomia and the eyelids to avoid exposure keratopathy and cicatricial ectropion.",
"     </li>",
"     <li>",
"      Consider early release and reconstruction of the neck with pliable tissue to avoid further secondary contracture.",
"     </li>",
"     <li>",
"      Respect the principle of cosmetic subunits in the face.",
"     </li>",
"     <li>",
"      Tissue expansion increases the amount of skin available for reconstruction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H1453206#H1453206\">",
"       \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Tissue expansion'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Meticulous attention must be paid to operative details.",
"     </li>",
"     <li>",
"      Tailor the reconstruction with regards to patient comorbidities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Reconstruction of burns to the face, scalp, and neck areas is reviewed here. An overview of reconstructive procedures, local treatment with topical antimicrobials and dressings, and emergent care of patients with moderate to severe burns are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29225?source=see_link\">",
"     \"Local treatment of burns: Topical antimicrobial agents and dressings\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/53/17242?source=see_link\">",
"     \"Emergency care of moderate and severe thermal burns in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44201?source=see_link\">",
"     \"Emergency care of moderate and severe thermal burns in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1941101\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns are classified according to the depth of tissue injury (",
"    <a class=\"graphic graphic_table graphicRef61540 \" href=\"UTD.htm?2/1/2076\">",
"     table 1",
"    </a>",
"    ). Burns to the face, with the exception of a sunburn, are never considered minor as even small burns affect function",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cosmesis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/14/4326?source=see_link\">",
"     \"Classification of burns\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29225?source=see_link\">",
"     \"Local treatment of burns: Topical antimicrobial agents and dressings\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111243691\">",
"    <span class=\"h1\">",
"     BURNS TO THE FACE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns to the face are particularly challenging because of the functional impairments and esthetic disfigurements caused by the burn. Burns to the face are best managed initially by daily gentle washes, followed by the application of a topical cytoprotective or moisturizing agent. Excessive drying or desiccation of the wound should be avoided. Dermal regeneration templates (biosynthetic skin substitutes) can be used, especially for intermediate partial-thickness wounds [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. These issues are discussed in detail separately. Evidence for reconstruction of the face and its components is based upon observational studies and the clinical setting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29225?source=see_link&amp;anchor=H21593997#H21593997\">",
"     \"Local treatment of burns: Topical antimicrobial agents and dressings\", section on 'Dressings'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H8044936#H8044936\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Dermal regeneration templates'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111243698\">",
"    <span class=\"h2\">",
"     Ear",
"    </span>",
"    &nbsp;&mdash;&nbsp;The skin covering the ear frame is firmly bound to the cartilage as the ear lacks a subcutaneous layer and vascularity is dependent on the blood supply from branches of the superficial temporal, occipital, and posterior auricular arteries. Therefore, there is little protection or insulation of the cartilage from injury. Burns distort the delicate cartilage and create scars, deformities, and loss of elasticity. Reconstruction of ear burns is more difficult than other types of ear trauma. In a large retrospective review of reconstruction in 249 patients with traumatized ears, those with burned ears had worse results compared to other mechanisms of injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Burns to the ear are initially managed conservatively. This includes shaving the hair around the ear, assessing the burn depth, daily cleansing, and application of a topical ointment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/5\">",
"     5",
"    </a>",
"    ]. Topical antimicrobial ointments, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/2/36899?source=see_link\">",
"     mafenide",
"    </a>",
"    acetate, are advocated to prevent infection from converting a superficial partial-thickness to a deep partial-thickness burn. Mafenide acetate has a broad spectrum of activity and penetrates eschar. In a retrospective review of 76 patients with ear burns treated with conservative management and mafenide acetate, only two patients (2.6 percent) developed chondritis, a painful and destructive process of the cartilage [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/6\">",
"     6",
"    </a>",
"    ]. External pressure and overzealous debridement of the ear should be avoided to minimize tissue loss.",
"   </p>",
"   <p>",
"    Reconstruction of the burned ear is complex and depends mainly on the depth, not necessarily the extent, of the injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/7\">",
"     7",
"    </a>",
"    ]. Reconstruction should provide skin coverage and cartilage support if it is damaged or exposed. The following procedures are available to reconstruct the burned ear:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Burns restricted to small areas of skin",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cartilage loss are amenable to a primary direct closure, provided the closure will not alter the projection or shape of the ear.",
"     </li>",
"     <li>",
"      Superficial burns to the ear that do not damage or expose the cartilage are treated with topical antimicrobial ointments and dressing changes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29225?source=see_link&amp;anchor=H21593967#H21593967\">",
"       \"Local treatment of burns: Topical antimicrobial agents and dressings\", section on 'Mafenide acetate'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Deeper burns that expose",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      damage the cartilage are debrided to the level of healthy, unburned tissue and protected from desiccation and necrosis by coverage with vascularized tissue (eg, unburned full-thickness skin graft, temporoparietal fascial flap).",
"     </li>",
"     <li>",
"      For total or near total destruction of the ear, reconstruction can be performed as a single procedure or as staged procedures with various local flaps, such as the temporoparietal fascial flap [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/8,9\">",
"       8,9",
"      </a>",
"      ]. When unburned local or regional skin is not available for coverage, distant free flaps can be used [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/10\">",
"       10",
"      </a>",
"      ]. When autologous tissue is limited, a bone-anchored prosthesis is an option [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H553839#H553839\">",
"       \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Regional and distant flaps'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Conchal cartilage may be used for small defects and autologous costal cartilage may be used for defects that involve more than 25 percent of the helical rim or more than two ear planes (helix, antihelix, and scapha) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/12\">",
"       12",
"      </a>",
"      ]. However, in a retrospective review of 25 burned ears reconstructed with a costal cartilage framework, only six ears had an excellent cosmetic result, and seven had a good result [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/4\">",
"       4",
"      </a>",
"      ]. Successful outcome of reconstruction of the burned ear depended on the degree of damage to the surrounding tissues. Coverage of the cartilage framework by unburned mastoid skin was a critical factor for an acceptable outcome in this study.",
"     </li>",
"     <li>",
"      Defects of the helical rims can be covered by local helical advancement techniques (Antia-Buch flap) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/13,14\">",
"       13,14",
"      </a>",
"      ], or by tube pedicle flaps from the retroauricular skin. Local flaps and helical advancement flaps may provide sufficient coverage for defects that involve the upper or middle third of the ear, but autologous conchal or costal cartilage may be necessary to reconstruct the auricle. Skin cover can be provided by tube pedicles, or a combination of temporoparietal fascial flap and skin grafting. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H553839#H553839\">",
"       \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Regional and distant flaps'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111243705\">",
"    <span class=\"h2\">",
"     Ocular",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns to the eyelid, periorbital region, sclera, conjunctiva, and cornea are classified as ocular burns. The eyes must always be evaluated in burns to the face, and an ophthalmologist should be consulted",
"    <strong>",
"    </strong>",
"    and a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29108?source=see_link\">",
"     fluorescein",
"    </a>",
"    test is performed to assess the presence of corneal damage. Thermal and chemical ocular burns may result in exposure keratopathy, infection, loss of central",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    peripheral vision [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Immediate and copious irrigation with sterile saline solution should be performed for chemical burns. A topical ophthalmologic anesthetic can be used in the eyes to facilitate irrigation and a non-steroid containing topical antimicrobial ointment can be applied to the eyes.",
"   </p>",
"   <p>",
"    Burned eyelashes and eschar should be debrided. An eye patch may be needed in the case of a thermal injury or lid retraction from a splash injury.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24211?source=see_link\">",
"     Artificial tears",
"    </a>",
"    are used if the lacrimal ducts are burned. For pain relief, oral or systemic analgesics are effective and cool saline compresses can be applied to the eyelids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111243712\">",
"    <span class=\"h3\">",
"     Eyelid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eyelid burns occur in approximately 10 percent of all thermal injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/17\">",
"     17",
"    </a>",
"    ]. The eyelid is composed of an anterior and a posterior lamella. The anterior lamella consists of skin, subcutaneous tissues, and the striated orbicularis muscle. The posterior lamella includes the tarsal plate, a layer of smooth muscle (M&uuml;ller's palpebral muscle), and the bulbar conjunctiva.",
"    <strong>",
"    </strong>",
"    Reconstruction of the eyelid multilamellar structures present formidable challenges, due to the lack of pliable tissue for cover, mucosal tissue for lining, and support tissue for mechanical integrity, and delayed scar maturation. There is no consensus on the best reconstructive procedures for eyelid burns.",
"   </p>",
"   <p>",
"    Because of the complexity of the anatomy and the inflammatory response to the burn, reconstruction should be delayed for at least nine months following the injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/17\">",
"     17",
"    </a>",
"    ]. Prior to reconstruction, the eye is protected from trauma using topical antibiotics. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/38/19048?source=see_link&amp;anchor=H26#H26\">",
"     \"Blepharitis\", section on 'Topical antibiotics'",
"    </a>",
"    .) Reconstruction of the anterior lamella with tarsal involvement may be performed with split or full-thickness graft; however, multiple procedures to release recurrent contractures may be required. Reconstruction of anterior lamellar defects without tarsal involvement includes direct closure of small burns, full-thickness or partial-thickness skin grafts, and local flaps.",
"   </p>",
"   <p>",
"    Reconstruction of full-thickness defects involving both lamellae depend on the size of the defect. Defects involving one-third to one-half of the upper lids can be reconstructed with direct closure or myocutaneous flaps. For more extensive defects, the options include bridging techniques (occlusive or eyelid-sharing) or non-bridging techniques with lamellar flaps and posterior lamellar graft (hard palate, nasal or buccal mucosa) or bi-lamellar grafts with orbicularis mobilization [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Free tissue transfer (eg, radial forearm flap, anterolateral thigh flap) is an option to reconstruct upper and lower eyelids [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reconstruction of the eyelid depends on the depth of the burn and the amount of unburned pliable tissue available. Any eyelid burn, with the exception of a very superficial burn, will create eyelid retraction and cicatricial ectropion. The following illustrates our algorithm for reconstructing eyelid burns:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For",
"      <strong>",
"       superficial",
"      </strong>",
"      burns of the anterior lamellar structures, the reconstruction involves simple release of the contracture and full-thickness skin grafting. Hooding of the medial canthus is usually addressed with a 5-flap plasty or a V-M plasty, which combines the principles of the V-Y plasty and the Z-plasty [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/21\">",
"       21",
"      </a>",
"      ] .",
"     </li>",
"     <li>",
"      For",
"      <strong>",
"       deeper",
"      </strong>",
"      , more extensive defects of the anterior lamellar structures, we use tissue from the lower lid, with or without skin grafts to provide support if the tarsal plate is missing, if it is available and unburned.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The main concern to take into account is to provide cover for the cornea to avoid exposure keratopathy and desiccation.",
"     </li>",
"     <li>",
"      The main problem faced is to replicate the delicate thin, mobile structure represented by the eyelid lamellae.",
"     </li>",
"     <li>",
"      If no local tissue is available, distant reconstruction with regional flaps (eg, temporoparietal flap, forehead flap) or free flap (eg, posterior auricular chondrocutaneous, anterior lateral thigh, radial forearm flap) may be necessary.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111243719\">",
"    <span class=\"h3\">",
"     Eyebrow",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns to the eyebrow destroy the hair bearing potential of this skin. The eyebrow can be reconstructed with use of superficial temporal artery island flap, composite graft from scalp, or mini or micrografts from scalp [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/22\">",
"     22",
"    </a>",
"    ]. In our practice, we use mainly strip grafts with occasional use of micrografts as these offer minimal morbidity with good outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16666805\">",
"    <span class=\"h3\">",
"     Eyelashes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hair follicular unit transplantation offers the most delicate and cosmetically pleasing outcomes for reconstruction of burned eyelashes [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. The techniques that we use are similar to the hair-bearing options discussed in eyebrow reconstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111243726\">",
"    <span class=\"h2\">",
"     Lip",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reconstruction of the burned lip is performed to improve functional and esthetic outcomes. Microstomia is a complication of the burn and causes limitations of speech, jaw movement, tongue movement, oral intake, oral continence, and oral hygiene, as well as facial distortion. Injury to the commissures is particularly debilitating. No ideal method of reconstruction has been identified [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast to reconstruction for burns to the eyelid after scar maturation, early surgical intervention before scar maturation may be necessary to reestablish oral competence. In a retrospective review of 18 patients suffering with microstomia from facial burns, reconstruction of the oral commissures performed by scar excision and local mucosal flap advancement, wound closure with full-thickness or partial-thickness skin grafts, or rhomboid mucosal flaps, resulted in acceptable esthetics and good functional recovery in all patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/26\">",
"     26",
"    </a>",
"    ]. Mucosal advancement flaps provided better esthetic and functional results than skin grafts. The use of a trapeze-flap plasty has been reported to achieve a normal size oral opening [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other innovative options include the use of cervical tubed flaps [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/28\">",
"     28",
"    </a>",
"    ], pre-expanded scalp tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/29\">",
"     29",
"    </a>",
"    ], or procedures based on oncologic techniques. All local advancement procedures are limited by availability of perioral unburned skin. Free flap reconstruction can be used when no unburned skin or oral mucosa is available. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H8044867#H8044867\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Burn reconstruction procedures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111243733\">",
"    <span class=\"h2\">",
"     Nose",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nose is a central, prominent, and frequently deformed structure in the burned face. Cosmetic and functional embarrassment for the patient is considerable. The secondary reconstruction starts only when scars are mature, usually after two years. The nose is a tridimensional tissue pyramid consisting of three tissue layers: inner lining, framework support, and soft tissue cover. Depending on the depth of the burn, all three layers may require reconstruction. There is no consensus on the best reconstructive or esthetic procedure to use to reconstruct the burned nose.",
"   </p>",
"   <p>",
"    Full-thickness or partial-thickness skin grafts or a combination of grafts and a dermal substitute may be used for partial-thickness defects with intact framework and lining. Local flaps (eg, bilateral nasolabial) or regional flaps can be used for larger defects. Regional flaps include forehead flap [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/30\">",
"     30",
"    </a>",
"    ], deltopectoral flaps [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/31\">",
"     31",
"    </a>",
"    ], cervical tube pedicle flap [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/28\">",
"     28",
"    </a>",
"    ], flaps based in the temporal artery territory [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/32\">",
"     32",
"    </a>",
"    ], or complex options such as a pre-expanded scalp skin [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Framework reconstruction is mandatory for deep burn defects with loss of the tridimensional projection. Full reconstruction is needed to support, augment, or enhance the nasal projection. Reconstructive options include costal cartilage, bone grafts from the radius or ulna, and split calvarial bone graft [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/34\">",
"     34",
"    </a>",
"    ]. Alloplastic materials can be used to increase the nasal projection; however, extrusion, infection,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    prosthesis displacement are complications of this technique.",
"   </p>",
"   <p>",
"    The classic esthetic rhinoplasty procedures are applicable to burns involving the nose [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/35\">",
"     35",
"    </a>",
"    ]. In a retrospective review of 13 patients with complete or subtotal nasal burns and severely burned or grafted skin, there was no necrosis of the tissues following esthetic procedures. The use of free flaps (eg, prelaminated osteocutaneous radial forearm flap) combines tissue for lining, support, and coverage of the burn defect [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/36\">",
"     36",
"    </a>",
"    ]. Scar contractures occluding the nostrils are usually managed with a combination of release, local flaps, and full-thickness skin grafts [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111243740\">",
"    <span class=\"h2\">",
"     Cheek",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns to the cheek are treated conservatively with local topical agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29225?source=see_link\">",
"     \"Local treatment of burns: Topical antimicrobial agents and dressings\"",
"    </a>",
"    .) If conservative management will result in early scarring or distortion of surrounding sphincter structures (eg, nose, eye canthi) because the burn is deep, or if the burn is not healed in three weeks, primary reconstruction can be performed with skin grafts from the scalp [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Burn scars mature between 12 and 24 months following the injury. Secondary reconstruction is planned following full scar management therapy to obtain as much supple tissue quantity as possible. The full-thickness scalp graft provides the best match in terms of texture and color for the cheek. The size of the graft from the donor site is limited due to excessive scarring and alopecia. Donor full-thickness skin from the supraclavicular area, post auricular area, the medial skin of the upper arm, and the lateral thoracic skin as are suitable source of matching reconstructive grafts for the face [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Small local flaps based on the Z-plasty transposition principle relocate scars and redirect contractures. These procedures are particularly important for treating contractural deformities affecting the eyes, mouth, or nose. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/11/11446?source=see_link\">",
"     \"Z-plasty\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While esthetic results of using dermal regeneration templates for facial burns are variable, they provide an acceptable alternative to autografts [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. However, dermal regeneration templates cannot be used without subsequent autografting. Early reconstruction with Integra&reg; does not offer results superior to grafting. In a retrospective review of 12 patients with deep facial burns, the dermal regeneration procedures resulted in excellent color, minimal visible skin graft junctures, and good texture, but less pliability when compared to thick autografts [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/41\">",
"     41",
"    </a>",
"    ]. In another study, Integra&reg; provided an acceptable esthetic and functional when used to resurface areas of contractures [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/40\">",
"     40",
"    </a>",
"    ]. Matriderm&reg;, a second generation dermal substitute, provided an acceptable result in reconstructing an extensive chemical burn of the face [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/39\">",
"     39",
"    </a>",
"    ]. No randomized trials have been performed to determine the role of dermal regeneration templates in reconstruction of burns to the face. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29225?source=see_link&amp;anchor=H21594043#H21594043\">",
"     \"Local treatment of burns: Topical antimicrobial agents and dressings\", section on 'Biosynthetic dressings'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H8044936#H8044936\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Dermal regeneration templates'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Regional pedicled flaps (eg, chest, deltopectoral) from unburned skin can match the color and texture of the recipient site, and provide pliability with the presence of healthy dermis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/29,31,32,35,42-45\">",
"     29,31,32,35,42-45",
"    </a>",
"    ]. Flaps can be used with or without tissue expansion. The expanded cervicofacial flap reconstructive technique provides staged coverage of the burned face [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/43\">",
"     43",
"    </a>",
"    ]. The first stage involves placing a single rectangular tissue into a subcutaneous pocket created in the anterior neck and the port in the infraclavicular area. The expander is inflated intraoperatively. The second stage involves inflating the expander. Once maximum insertion is achieved, the expander is removed, the burn defect is excised, and the tissue flap is advanced to cover the defect. Expanders can be inserted endoscopically, with the potential advantages of lower risk of dehiscence, less disruption of normal tissue, smaller and remote incisions for insertion of the expander, and lower risk of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H1453206#H1453206\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Tissue expansion'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Free flap surgery (eg, radial forearm or anterolateral thigh fasciocutaneous flaps) is the most complicated reconstructive option and is reserved for situations when there is no other option of pliable skin or when deep structures (eg, frontal sinuses) must be covered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1941172\">",
"    <span class=\"h1\">",
"     BURNS TO THE SCALP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns to the scalp should be carefully cleansed and debrided to remove loose, devitalized, and necrotic tissue. Topical antimicrobial agents and dressings are applied as the burn wound is being prepared for grafting or other type of tissue or biologic substitute coverage. Evidence for reconstruction of the scalp is based upon observational studies and the clinical setting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29225?source=see_link\">",
"     \"Local treatment of burns: Topical antimicrobial agents and dressings\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1941516\">",
"    <span class=\"h2\">",
"     Primary goals",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two primary goals of scalp burn reconstruction are to cover the defect with hair bearing skin and to provide full coverage of the calvarium to prevent dessication, sequestration, and infection. The type of reconstruction is dependent on several factors including [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/47\">",
"     47",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Size, depth and location of the defect in the scalp",
"     </li>",
"     <li>",
"      Presence or absence of periosteum",
"     </li>",
"     <li>",
"      Quality of surrounding scalp tissue",
"     </li>",
"     <li>",
"      Presence or absence of hair",
"     </li>",
"     <li>",
"      Location of the hairline",
"     </li>",
"     <li>",
"      Patient comorbidities",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1941539\">",
"    <span class=\"h2\">",
"     Reconstruction options",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns to the scalp are best covered by skin from the scalp, if at all possible. Other reconstruction options are dependent on tissue availability, extensiveness of the burn, and location [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H553839#H553839\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Regional and distant flaps'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/11/11446?source=see_link\">",
"     \"Z-plasty\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1943249\">",
"    <span class=\"h3\">",
"     Anterior",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principle goal of reconstruction of burns in the anterior portion of the scalp is restoration of hair bearing skin to recreate the anterior hairline. A rotational flap should be designed to avoid distortion of the anterior or temporal hairline.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Small defects  For small defects (&lt;2 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), the best surgical option is a primary closure. Redundant forehead skin is an excellent option. Advancement flaps based on a pedicle are also an option [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Moderate defects  For moderate defects (2 to 25 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), successful coverage of the burn requires adjacent tissue transfer from rotation or advancement flaps, such as V-Y flaps, pedicled flaps, or rotational flaps.",
"     </li>",
"     <li>",
"      Large defects  For large defects (&gt;25 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), a temporoparietal-occipital flap or an orticochea flap are used to recreate the anterior hairline [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/52-54\">",
"       52-54",
"      </a>",
"      ]. Large rotation flaps may restore hair anteriorly, but require grafting of the donor site. If tissue expansion is an option, this is preferable to the orticochea flap for a better cosmetic result.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1943240\">",
"    <span class=\"h3\">",
"     Parietal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns to the parietal scalp are amenable to local tissue rearrangement [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/48\">",
"     48",
"    </a>",
"    ]. The tissue of the parietal scalp is more mobile than other scalp tissue because the temporoparietal fascia, the lateral continuation of the galea aponeurosis, overlies the deep temporal fascia instead of the periosteum.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Small defects  For small defects (&lt;2 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), the burns can be closed primarily or by a V-Y flaps, pedicled flaps or rhomboid flap [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/55\">",
"       55",
"      </a>",
"      ]. The redirected hair follicles of the rhomboid flap serves as an excellent match for the burned hair-bearing pattern.",
"     </li>",
"     <li>",
"      Moderate defects  For moderate defects (2 to 25 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), rotation advancement flaps are the preferred coverage. Bilobed flaps also provide excellent coverage in this area [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Large defects  For large defects (&ge;25 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), skin grafts may be applied if bone is not exposed. Tissue expansion is the only technique that provides satisfactory coverage of a large parietal burn defect. An orticochea flap is not used in this area because tissue advancement from the contralateral parietal scalp is often inadequate for tissue coverage. Large bipedicled fronto-occipital flaps have been used but require skin grafts to the donor site, with unfavorable cosmetic results [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1943232\">",
"    <span class=\"h3\">",
"     Occipital",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns to the occipital scalp are amenable to local tissue transfer because of the moderate skin mobility in this area [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/48\">",
"     48",
"    </a>",
"    ]. Depending on the size of the burn, the occipital hairline may be restored but this area is not as cosmetically sensitive as the anterior scalp.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Small defects  For small defects (&lt;2 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), the best option is a primary closure.",
"     </li>",
"     <li>",
"      Moderate defects  For moderate defects (2 to 25 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), rotation advancement flaps are used. Dissection can be carried over the neck in order to obtain tissue to cover the burn, but care must be taken to preserve the posterior hairline. Islanded pedicled V-Y advancement flaps are based on the ipsilateral occipital artery. The donor site can be closed primarily and the operation performed in a single stage [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/58\">",
"       58",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Large defects  For large defects (&gt;25 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), larger rotation flaps (eg, orticochea flap) are used. Tissue expansion of adjacent skin also provides satisfactory coverage.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1943188\">",
"    <span class=\"h3\">",
"     Vertex",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vertex of the scalp has limited mobility and requires extensive undermining and recruitment of tissue from the more mobile anterior, parietal and occipital areas of the scalp [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/48\">",
"     48",
"    </a>",
"    ]. If at all possible, the whorl pattern of hair at the vertex should be preserved.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Small defects  For small defects (&lt;2 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), subgaleal dissection and primary closure may be possible. An alternative repair to a primary closure is a local flap, such as a rhomboid flap. This is preferred if tension is present on the primary closure.",
"     </li>",
"     <li>",
"      Moderate defects  For moderate defects (2 to 25 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), double opposing rotation flaps are an excellent option for coverage. Another alternative is a rotation flap from the occipital region, with skin grafting to the donor site. Pinwheel and rhomboid flaps are less useful in the moderate sized defects of the vertex.",
"     </li>",
"     <li>",
"      Large defects  For large defects (&gt;25 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), the only alternative for coverage is a very large rotation flap with skin grafts to the donor site. Tissue expansion offers the best result for coverage in this area.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1943257\">",
"    <span class=\"h3\">",
"     Total or nearly total defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best technique to cover a total loss of skin is a free flap [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/48\">",
"     48",
"    </a>",
"    ]. Free tissue transfer allows for complete skin reconstruction and can be performed in one stage. If the superficial temporal vessels are damaged, arterial branches of the external carotid artery and internal jugular vein may be used. The latissimus dorsi musculocutaneous flap has a long pedicle and provides the best coverage. However, muscle flap atrophy can result in delayed exposure of the calvarium. Other options for coverage of the near total defect of the scalp include radial forearm flap, parascapular and anterolateral perforator flaps, and omentum. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H1453430#H1453430\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Free microvascular tissue transfer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1943265\">",
"    <span class=\"h3\">",
"     Exposed calvarium",
"    </span>",
"    &nbsp;&mdash;&nbsp;An exposed calvarium can by covered with either a free flap [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/59,60\">",
"     59,60",
"    </a>",
"    ] or tissue expansion [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/61,62\">",
"     61,62",
"    </a>",
"    ] If the integrity of the calvarium is compromised by damage to the bone tables of the skull leaving exposed meningeal or neural tissue content, neurosurgical consultation is necessary prior to burn reconstruction. If the only the outer table is compromised, the area can be induced to granulate with the use of carefully performed burring of the outer table to the diploe, with or without postoperative topical negative pressure therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26264?source=see_link\">",
"     \"Negative pressure wound therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1944344\">",
"    <span class=\"h3\">",
"     Exposed dura",
"    </span>",
"    &nbsp;&mdash;&nbsp;A full-thickness scalp defect with exposed dura can be reconstructed with dermal regeneration templates [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/63\">",
"     63",
"    </a>",
"    ]. Exposed dura presents an additional risk to patient recovery and a neurosurgical consultation is necessary prior to burn reconstruction. Secondary reconstruction can be performed with tissue expansion and local flaps based in the transposition, advancement or rotation principles [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H8044936#H8044936\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Dermal regeneration templates'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of tissue expansion for secondary scalp reconstruction requires careful planning and patient selection. The availability of sizes, shapes and mechanisms of expansion with this technique is vast. Patient participation is fundamental to ensure success of this procedure as multiple sessions of expansion may be necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H1453206#H1453206\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Tissue expansion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1941188\">",
"    <span class=\"h1\">",
"     BURNS TO THE NECK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns to the neck can result in significant functional and esthetic complications. Secondary reconstruction of the burned neck aims to import pliable tissue to this delicate area. Burns can result in contractures that foreshorten the mentocervical distance, decrease cervical movement, and fix the head and neck in the flexion position. In severe cases, the dense scars can lead to complete fusion of the chin and the chest skin. The inferior pull of the contracture on the chin and adjacent tissues leads to an open-mouth appearance, with redundant lower lip and gum showing. This rigid deformity complicates oral continence, the ability to eat, and an intubation. Evidence for reconstruction of the neck is based upon observational studies and the clinical setting.",
"   </p>",
"   <p>",
"    Scar maturation occurs in approximately 12 to 24 months. Once scars are mature, management of the scar is completed through splintage and occupational therapy intervention, followed by secondary reconstruction of cervical contractures. Choice of reconstruction procedures should be based on tissue availability, degree of restriction of movement, and neck zones involved [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Small linear contracture bands can be released with Z-plasty type procedures in order to realign or release scars. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H111241766#H111241766\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Interdigitating flaps'",
"    </a>",
"    .) Transposition flaps will cover small to moderate neck burn defects satisfactorily providing that the neck fascia and the platysma muscle are incorporated into the design. Postburn neck contractures can be lengthened 100 to 200 percent using the trapeze-flap plasty technique, described as the opposite transposition of trapezoid scar and fascial flaps [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/68\">",
"     68",
"    </a>",
"    ]. Both flaps include scars, adipose tissue, platysma muscle, and deep cervical fascia. This procedure can eliminate the contracture and restore the mentocervical angle and head movement. In one series, functional results were good in 24 of 26 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other options to release burn scar neck contractures include split thickness skin grafts (STSG), full-thickness skin grafts (FTSG), and dermal regeneration templates. STSG are not the ideal option as contractures can recur due to the lack of dermal elements that provide pliability. In patients with extensive burns, the availability of FTSG may be limited. When available, FTSG are an ideal option as they are more pliable and develop fewer contractures in comparison with STSG. Dermal regeneration templates provide improved pliability and better cosmetic results than STSG. In a retrospective multicenter review of 89 burn patients with 127 contracture release procedures, the dermal regeneration templates (Integra) resulted in favorable functional outcomes and a high rate of patient satisfaction, similar to those of full-thickness grafts without the donor-site morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/69\">",
"     69",
"    </a>",
"    ]. Negative pressure dressings provide an excellent option to control graft position and reduce the formation of hematomas. Grafted areas can also be bolstered with tie-over dressings consisting of nanocrystalline silver to provide local infection control. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H8044920#H8044920\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Split thickness skin grafts'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H8044936#H8044936\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Dermal regeneration templates'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26264?source=see_link&amp;anchor=H13#H13\">",
"     \"Negative pressure wound therapy\", section on 'Clinical applications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Regional flaps based on a pedicle or perforator, with or without a tissue expander, can cover the released neck burn defect with vascularized tissue. Reconstruction based on an undamaged superficial cervical artery with tissue expansion and the superficial transverse cervical artery combined with the bilobed flap principle resulted in a significant improvement in neck range of motion [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/67\">",
"     67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H553839#H553839\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Regional and distant flaps'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A complex algorithm was described for reconstruction of cervical burn defects by classifying the neck into different territories and applying a free flap option to each territory [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/67\">",
"     67",
"    </a>",
"    ]. The reconstructive territories were classified as central above, central below, central above and below, and lateral. The functional outcome of improved range of motion was best in the central above territory, while etiology of the burn and time between injury and reconstruction had no impact on the functional outcome.",
"   </p>",
"   <p>",
"    Free flaps (eg, inguinal region, scapula, anterolateral thigh) can be used to resurface wide contractures in the neck [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/67,70\">",
"     67,70",
"    </a>",
"    ]. Optimal neck contouring is difficult to obtain because of the bulkiness and the limitations in the size of the flaps. To improve esthetic and functional results, free flap donor sites in the groin and scapular regions were prepared by controlled tissue expansion prior to transfer to the neck in eight patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29625/abstract/70\">",
"     70",
"    </a>",
"    ]. All eight patients demonstrated full neck extension and a good esthetic result, five required minor secondary flap revisions. The advantages of the pre-expansion of the donor site includes an increase in tissue for reconstruction, and an increase in vascularity, pliability, and elasticity of the donor flap, and minimal donor site scarring. The disadvantages are that this is a two-staged procedure, and the risks associated with tissue expansion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H1453206#H1453206\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Tissue expansion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H82104483\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of reconstructive surgery for the burn patient are first to restore function, then to restore esthetic appearances. Following resuscitation and stabilization, management of the burn wounds becomes the next priority. The later effects of burns, which are related to loss of normal tissue and scarring, include limitation of movement, pain, disfigurement, and social embarrassment. The type of reconstruction procedure selected depends on the location of the burn, the extensiveness of the injury, and the availability of donor skin and tissue. The optimal reconstructive procedure will vary from patient to patient.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Areas of paramount functional importance are reconstructed first, specifically those surrounded by sphincters such as the mouth and lips to avoid microstomia and the eyelids to avoid exposure keratopathy and cicatricial ectropion. (See",
"      <a class=\"local\" href=\"#H39975411\">",
"       'Introduction'",
"      </a>",
"      above.) Reconstruct areas of paramount functional importance first, specifically those surrounded by sphincters such as the mouth and lips to avoid microstomia, and the eyelids to avoid exposure to keratopathy and cicatricial ectropion.",
"     </li>",
"     <li>",
"      For superficial burns to the ears, gentle debridement is performed to preserve normal anatomic structures. The wounds are managed with typically antimicrobial ointments and dressings. (See",
"      <a class=\"local\" href=\"#H111243698\">",
"       'Ear'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For deep burns to the ears that expose or damage the cartilage, cautious debridement to healthy tissue is performed. Reconstruction with coverage from vascularized tissue is preferred. (See",
"      <a class=\"local\" href=\"#H111243698\">",
"       'Ear'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For burns to the eyes, a",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29108?source=see_link\">",
"       fluorescein",
"      </a>",
"      test is performed to evaluate the cornea, a consultation with an ophthalmologist, and the use of topical ophthalmologic anesthetic and non-steroid containing topical antimicrobial ointments. (See",
"      <a class=\"local\" href=\"#H111243705\">",
"       'Ocular'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For burns to the scalp, skin coverage from other areas of the scalp is preferred, if unburned skin is available. If minimal healthy scalp skin is available, tissue expansion with implants is the reconstructive option of choice. Other reconstruction options include full-thickness skin grafts, tissue expansion,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      advancement, rotation, or transposition flaps (See",
"      <a class=\"local\" href=\"#H1941172\">",
"       'Burns to the scalp'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For small linear contractures resulting from burns to the neck, a z-plasty procedure to realign or release the scar can be performed. For more extensive scarring of the neck, full-thickness skin grafts, split-thickness skin grafts with a dermal regeneration template, tissue expansion, advancement flaps, rotational flaps, or free flaps, are reconstructive options depending on tissue availability. (See",
"      <a class=\"local\" href=\"#H1941188\">",
"       'Burns to the neck'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/1\">",
"      Shelley OP, Dziewulski P. Late management of burns. Surgery Oxford 2006; 24:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/2\">",
"      Klein MB, Moore ML, Costa B, Engrav LH. Primer on the management of face burns at the University of Washington. J Burn Care Rehabil 2005; 26:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/3\">",
"      Leon-Villapalos J, Jeschke MG, Herndon DN. Topical management of facial burns. Burns 2008; 34:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/4\">",
"      Gault D. Post traumatic ear reconstruction. J Plast Reconstr Aesthet Surg 2008; 61 Suppl 1:S5.",
"     </a>",
"    </li>",
"    <li>",
"     Kamal A, Kamel, AH, el Oteify, M. Early management of the burned auricle. Annals of burns and fire disasters. 2004; 17: 197. www.medbc.com/annals/review/vol_17/num_4/text/vol17n4p197.asp (Accessed on August 18, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/6\">",
"      Skedros DG, Goldfarb IW, Slater H, Rocco J. Chondritis of the burned ear: a review. Ear Nose Throat J 1992; 71:359.",
"     </a>",
"    </li>",
"    <li>",
"     Mueller, RV. Facial trauma:soft tissue injuries. In Plastic Surgery 2nd Edition. Mathes SJ (ed). Saunders Elsevier. Philadelphia 2006. Vol 3, p 33",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/8\">",
"      El-Khatib HA, Al-Basti HB, Al-Ghoul A, et al. Subtotal reconstruction of the burned auricle. Burns 2005; 31:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/9\">",
"      Yamada A, Imai K, Nomachi T, et al. Total reconstruction of the burned auricle. Burns 2007; 33:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/10\">",
"      Wilkes GH, Wolfaardt JF. Osseointegrated alloplastic versus autogenous ear reconstruction: criteria for treatment selection. Plast Reconstr Surg 1994; 93:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/11\">",
"      Gentile P, Bottini DJ, Colicchia GM, et al. Burns: bone-anchored, extra-oral implantology. J Burn Care Res 2008; 29:627.",
"     </a>",
"    </li>",
"    <li>",
"     Thorne CH. Otoplasty and Ear reconstruction. In Grabb and Smith&rsquo;s Plastic Surgery 6th Edition. Thorne CH (Ed). Lippincott Williams. Philadelphia 2007. p 302",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/13\">",
"      Antia NH, Buch VI. Chondrocutaneous advancement flap for the marginal defect of the ear. Plast Reconstr Surg 1967; 39:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/14\">",
"      Bialostocki A, Tan ST. Modified Antia-Buch repair for full-thickness upper pole auricular defects. Plast Reconstr Surg 1999; 103:1476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/15\">",
"      Smith SB, Coffee T, Yowler C, Steinemann TL. Risk factors for ophthalmic complications in patients with burns. J Burn Care Res 2010; 31:911.",
"     </a>",
"    </li>",
"    <li>",
"     Warden, GD, Warner, PM.. Chapter 62 Functional sequelae and disability assessment. . In: Total burn care,  p.783.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/17\">",
"      Mandrekas AD, Zambacos GJ, Anastasopoulos A. Treatment of bilateral severe eyelid burns with skin grafts: an odyssey. Burns 2002; 28:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/18\">",
"      Malhotra R, Sheikh I, Dheansa B. The management of eyelid burns. Surv Ophthalmol 2009; 54:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/19\">",
"      Morley AM, deSousa JL, Selva D, Malhotra R. Techniques of upper eyelid reconstruction. Surv Ophthalmol 2010; 55:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/20\">",
"      Rubino C, Farace F, Puddu A, et al. Total upper and lower eyelid replacement following thermal burn using an ALT flap--a case report. J Plast Reconstr Aesthet Surg 2008; 61:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/21\">",
"      Lin SD. Correction of the epicanthal fold using the VM-plasty. Br J Plast Surg 2000; 53:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/22\">",
"      Motamed S, Davami B. Eyebrow reconstruction following burn injury. Burns 2005; 31:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/23\">",
"      Omranifard M, Doosti MI. A trial on subcutaneous pedicle island flap for eyebrow reconstruction. Burns 2010; 36:692.",
"     </a>",
"    </li>",
"    <li>",
"     Gandelman M. Eyebrow and eyelash reconstruction. Operative Techniques in Oculoplastic, Orbital and Reconstructive Surgery 2001; 4:94",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/25\">",
"      Ayhan M, Aytug Z, Deren O, et al. An alternative treatment for postburn microstomia treatment: composite auricular lobule graft for oral comissure reconstruction. Burns 2006; 32:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/26\">",
"      Zweifel CJ, Guggenheim M, Jandali AR, et al. Management of microstomia in adult burn patients revisited. J Plast Reconstr Aesthet Surg 2010; 63:e351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/27\">",
"      Grishkevich VM. Post-burn microstomia: anatomy and elimination with trapeze-flap plasty. Burns 2011; 37:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/28\">",
"      Hassanpour SE, Davami B. Reconstruction of nose and lips with tubed cervical flap in electrical injury: a case report. Burns 2005; 31:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/29\">",
"      Sakurai H, Soejima K, Takeuchi M, et al. Reconstruction of perioral burn deformities in male patients by using the expanded frontal scalp. Burns 2007; 33:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/30\">",
"      Menick, FJ. Nasal reconstruction: forehead flap. Plast Reconstr Surg 2004; 113:100E.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/31\">",
"      Bey E, Hautier A, Pradier JP, Duhamel P. Is the deltopectoral flap born again? Role in postburn head and neck reconstruction. Burns 2009; 35:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/32\">",
"      Stan V, Antohi N, Isac F, et al. Post-burn upper, mid-face and nose reconstruction using a unilateral extended superficial temporal artery-based flap. Burns 2007; 33:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/33\">",
"      Hassanpour SE, Shariati SM. Simultaneous reconstruction of upper and lower lip beside chin and nasal lobule: in a case of facial chemical burn. Burns 2007; 33:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/34\">",
"      Chou TD, Lee WT, Chen SL, et al. Split calvarial bone graft for chemical burn-associated nasal augmentation. Burns 2004; 30:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/35\">",
"      Hafezi F, Karimi H, Nouhi A. Aesthetic septorhinoplasty in the burned nose. Burns 2005; 31:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/36\">",
"      Sinha M, Scott JR, Watson SB. Prelaminated free radial forearm flap for a total nasal reconstruction. J Plast Reconstr Aesthet Surg 2008; 61:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/37\">",
"      Tiwari VK, Sarabahi S. Starplasty: an ideal method for correction of occluded external nares following burns. J Plast Reconstr Aesthet Surg 2006; 59:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/38\">",
"      Cole JK, Engrav LH, Heimbach DM, et al. Early excision and grafting of face and neck burns in patients over 20 years. Plast Reconstr Surg 2002; 109:1266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/39\">",
"      Atherton DD, Tang R, Jones I, Jawad M. Early excision and application of matriderm with simultaneous autologous skin grafting in facial burns. Plast Reconstr Surg 2010; 125:60e.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/40\">",
"      Dorsey ER, Voss TS, Shprecher DR, et al. A U.S. survey of patients with Parkinson's disease: satisfaction with medical care and support groups. Mov Disord 2010; 25:2128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/41\">",
"      Klein MB, Engrav LH, Holmes JH, et al. Management of facial burns with a collagen/glycosaminoglycan skin substitute-prospective experience with 12 consecutive patients with large, deep facial burns. Burns 2005; 31:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/42\">",
"      McGregor JC. Face reconstruction after a major burn using tube pedicles: a 46-year follow-up. J Plast Reconstr Aesthet Surg 2007; 60:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/43\">",
"      El Gawad A, Goodenough J, McArthur P, et al. Facial resurfacing using tissue expanded neck skin as rotational advancement flaps: a case series. J Plast Reconstr Aesthet Surg 2010; 63:e648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/44\">",
"      Lu F, Gao JH, Ogawa R, Hykusoku H. Preexpanded distant \"super-thin\" intercostal perforator flaps for facial reconstruction without the need for microsurgery. J Plast Reconstr Aesthet Surg 2006; 59:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/45\">",
"      Gao JH, Ogawa R, Hyakusoku H, et al. Reconstruction of the face and neck scar contractures using staged transfer of expanded \"Super-thin flaps\". Burns 2007; 33:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/46\">",
"      Elshaer WM, Enab AA, Elmanawi HM. Endoscopic tissue expansion placement in face and neck burn scar reconstruction. Burns 2011; 37:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/47\">",
"      Dalay C, Kesiktas E, Yavuz M, et al. Coverage of scalp defects following contact electrical burns to the head: a clinical series. Burns 2006; 32:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/48\">",
"      Leedy JE, Janis JE, Rohrich RJ. Reconstruction of acquired scalp defects: an algorithmic approach. Plast Reconstr Surg 2005; 116:54e.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/49\">",
"      Oishi SN, Luce EA. The difficult scalp and skull wound. Clin Plast Surg 1995; 22:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/50\">",
"      Seitz IA, Gottlieb LJ. Reconstruction of scalp and forehead defects. Clin Plast Surg 2009; 36:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/51\">",
"      Sakai S, Soeda S, Terayama I. Subcutaneous pedicle flaps for scalp defects. Br J Plast Surg 1988; 41:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/52\">",
"      Orticochea M. New three-flap reconstruction technique. Br J Plast Surg 1971; 24:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/53\">",
"      Yang CC, Lin SD, Lai CS, Chou CK. Reconstruction of children's scalp defects with the Orticochea flap. Ann Plast Surg 1992; 28:584.",
"     </a>",
"    </li>",
"    <li>",
"     Juri, J.. Chapter 4 - Temporoparieto-Occipital and Temporoparieto-Occipitoparietal Scalp Flaps. In: Grabb's Encyclopedia of Flaps, 2009..",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/55\">",
"      Davis WH. Sideburn reconstruction with an arterial V-Y hair-bearing scalp flap after the excision of basal cell carcinoma. Plast Reconstr Surg 2000; 106:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/56\">",
"      Iida N, Ohsumi N, Tonegawa M, Tsutsumi Y. Reconstruction of scalp defects using simple designed bilobed flap. Aesthetic Plast Surg 2000; 24:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/57\">",
"      De Haro F, Giraldo F. Bipedicled fronto-occipital flap for reconstruction of postoncologic defects of the lateral scalp. Plast Reconstr Surg 2001; 107:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/58\">",
"      Sharma RK, Tuli P. Occipital artery island V-Y advancement flap for reconstruction of posterior scalp defects. J Plast Reconstr Aesthet Surg 2010; 63:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/59\">",
"      Ioannides C, Fossion E, McGrouther AD. Reconstruction for large defects of the scalp and cranium. J Craniomaxillofac Surg 1999; 27:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/60\">",
"      Beasley NJ, Gilbert RW, Gullane PJ, et al. Scalp and forehead reconstruction using free revascularized tissue transfer. Arch Facial Plast Surg 2004; 6:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/61\">",
"      Motamed S, Niazi F, Atarian S, Motamed A. Post-burn head and neck reconstruction using tissue expanders. Burns 2008; 34:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/62\">",
"      Sharony Z, Rissin Y, Ullmann Y. Postburn scalp reconstruction using a self-filling osmotic tissue expander. J Burn Care Res 2009; 30:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/63\">",
"      Abbas Khan MA, Chipp E, Hardwicke J, et al. The use of Dermal Regeneration Template (Integra&reg;) for reconstruction of a large full-thickness scalp and calvarial defect with exposed dura. J Plast Reconstr Aesthet Surg 2010; 63:2168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/64\">",
"      Frodel JL Jr, Ahlstrom K. Reconstruction of complex scalp defects: the \"Banana Peel\" revisited. Arch Facial Plast Surg 2004; 6:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/65\">",
"      Gil T, Metanes I, Aman B, et al. Six tissue expansion sessions of the scalp for reconstruction of post-burn alopecia. J Burn Care Res 2008; 29:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/66\">",
"      Di Mascio D, Castagnetti F, Mazzeo F, et al. Overexpansion technique in burn scar management. Burns 2006; 32:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/67\">",
"      Tsai FC, Mardini S, Chen DJ, et al. The classification and treatment algorithm for post-burn cervical contractures reconstructed with free flaps. Burns 2006; 32:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/68\">",
"      Grishkevich VM. Trapeze-flap plasty: effective method for postburn neck contracture elimination. Burns 2010; 36:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/69\">",
"      Frame JD, Still J, Lakhel-LeCoadou A, et al. Use of dermal regeneration template in contracture release procedures: a multicenter evaluation. Plast Reconstr Surg 2004; 113:1330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29625/abstract/70\">",
"      Ninkovic M, Moser-Rumer A, Ninkovic M, et al. Anterior neck reconstruction with pre-expanded free groin and scapular flaps. Plast Reconstr Surg 2004; 113:61.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15318 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-60.18.131.125-6AD27EA953-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29625=[""].join("\n");
var outline_f28_59_29625=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H82104483\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39975411\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1941101\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H111243691\">",
"      BURNS TO THE FACE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H111243698\">",
"      Ear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H111243705\">",
"      Ocular",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H111243712\">",
"      - Eyelid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H111243719\">",
"      - Eyebrow",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16666805\">",
"      - Eyelashes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H111243726\">",
"      Lip",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H111243733\">",
"      Nose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H111243740\">",
"      Cheek",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1941172\">",
"      BURNS TO THE SCALP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1941516\">",
"      Primary goals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1941539\">",
"      Reconstruction options",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1943249\">",
"      - Anterior",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1943240\">",
"      - Parietal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1943232\">",
"      - Occipital",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1943188\">",
"      - Vertex",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1943257\">",
"      - Total or nearly total defects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1943265\">",
"      - Exposed calvarium",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1944344\">",
"      - Exposed dura",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1941188\">",
"      BURNS TO THE NECK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H82104483\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/15318\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15318|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/1/2076\" title=\"table 1\">",
"      Burn class depth",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/38/19048?source=related_link\">",
"      Blepharitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/14/4326?source=related_link\">",
"      Classification of burns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/53/17242?source=related_link\">",
"      Emergency care of moderate and severe thermal burns in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44201?source=related_link\">",
"      Emergency care of moderate and severe thermal burns in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29225?source=related_link\">",
"      Local treatment of burns: Topical antimicrobial agents and dressings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26264?source=related_link\">",
"      Negative pressure wound therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=related_link\">",
"      Principles of burn reconstruction: Overview of surgical procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/11/11446?source=related_link\">",
"      Z-plasty",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_59_29626="Concussion and mild traumatic brain injury";
var content_f28_59_29626=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Concussion and mild traumatic brain injury",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/59/29626/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29626/contributors\">",
"     Randolph W Evans, MD, FAAN",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/59/29626/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29626/contributors\">",
"     Michael J Aminoff, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/59/29626/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/59/29626/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/59/29626/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild traumatic brain injury (TBI) is common and, while typically benign, has a risk of serious short and long-term sequelae. As a result, it is one of the most important public health problems.",
"   </p>",
"   <p>",
"    Important considerations in the management of mild TBI include [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Identification of immediate neurologic emergencies",
"     </li>",
"     <li>",
"      Identification of high-risk individuals for second impact syndrome",
"     </li>",
"     <li>",
"      Recognition and management of neurologic sequelae",
"     </li>",
"     <li>",
"      Prevention of cumulative and chronic brain injury",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An overview of the clinical presentation, evaluation, and management of mild TBI in adults is presented here. Traumatic brain injury in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12906?source=see_link\">",
"     \"Minor head trauma in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4250?source=see_link\">",
"     \"Initial approach to severe traumatic brain injury in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild traumatic brain injury (TBI) occurs with head injury due to contact",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <span class=\"nowrap\">",
"     acceleration/deceleration",
"    </span>",
"    forces. It is typically defined as mild by a Glasgow Coma Scale (GCS) score of 13 to 15, measured at approximately 30 minutes after the injury (",
"    <a class=\"graphic graphic_table graphicRef81854 \" href=\"UTD.htm?28/62/29676\">",
"     table 1",
"    </a>",
"    ). Some recommend classifying patients with a GCS score of 13 as moderate head injury (GCS score of 9 to 12) because they seem more similar with regard to prognosis and incidence of intracranial abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/2-5\">",
"     2-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The term concussion is often used in the medical literature as a synonym for mild TBI, but it probably describes a subset of milder brain injury. The Quality Standards Subcommittee of the American Academy of Neurology defines concussion as a trauma-induced alteration in mental status that may or may not involve loss of consciousness [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An international multidisciplinary conference on concussion convened in 2004 and reaffirmed the following definition [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/6\">",
"     6",
"    </a>",
"    ]: \"Concussion is defined as a complex pathophysiological process affecting the brain, induced by traumatic biomechanical forces. Several common features that incorporate clinical, pathological, and biomechanical injury constructs that may be used in defining the nature of a concussive head injury include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Concussion may be caused by a direct blow to the head, face, neck, or elsewhere on the body with an 'impulsive' force transmitted to the head.",
"     </li>",
"     <li>",
"      Concussion typically results in the rapid onset of short-lived impairment of neurologic function that resolves spontaneously.",
"     </li>",
"     <li>",
"      Concussion may result in neuropathological changes, but the acute clinical symptoms largely reflect a functional disturbance rather than structural injury.",
"     </li>",
"     <li>",
"      Concussion results in a graded set of clinical syndromes that may or may not involve loss of consciousness. Resolution of the clinical and cognitive symptoms typically follows a sequential course.",
"     </li>",
"     <li>",
"      Concussion is typically associated with grossly normal structural neuroimaging studies.\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is important to emphasize that the alteration in mental status characteristic of concussion can occur without loss of consciousness. In fact, the majority of concussions in sports occur without loss of consciousness and are often unrecognized [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 1.74 million people sustain a traumatic brain injury (TBI) in the United States every year [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/8\">",
"     8",
"    </a>",
"    ]. Most, 75 to 95 percent, are mild [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The annual incidence of mild head injury per 100,000 population has been estimated to be 131 for San Diego County, California [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/11\">",
"     11",
"    </a>",
"    ], 149 for Olmsted County, Minnesota [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/12\">",
"     12",
"    </a>",
"    ] and 511 for Auckland, New Zealand [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/13\">",
"     13",
"    </a>",
"    ]. However, the incidence of mild head injury may be as high as 640 persons per 100,000 population, as many cases go unreported [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For an industrialized country such as the United States, estimates of the relative causes of TBI are as follows: motor vehicle accidents (45 percent), falls (30 percent), occupational accidents (10 percent), recreational accidents (10 percent), and assaults (5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/15\">",
"     15",
"    </a>",
"    ]. In the elderly, falls are more likely the cause, and motor vehicle accidents are more common in the young.",
"   </p>",
"   <p>",
"    Mild TBI also occurs in contact sports; American football, ice hockey, soccer, boxing, and rugby have a particularly high incidence. The annual incidence of sports-related concussion in the United State in 1.6 to 3.8 million, and the likelihood of an athlete in a contact sport experiencing a concussion is as high as 20 percent per season [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/16\">",
"     16",
"    </a>",
"    ]. In football alone, an estimated 10 percent of US college and 20 percent of US high school players sustain brain injuries each season [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/17-19\">",
"     17-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mild TBI is also a common injury among soldiers who have participated in combat. In a survey of 2525 Army infantry soldiers performed three to four months after their return from a one-year deployment in Iraq, 5 percent reported injuries with loss of consciousness and 10 percent reported injuries with altered consciousness [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/20\">",
"     20",
"    </a>",
"    ]. The mechanisms of injury (in order of frequency) included blasts or explosions, falls, motor vehicle accidents, and fragment, shrapnel, and bullet wounds.",
"   </p>",
"   <p>",
"    Males are more commonly head-injured, with a ratio between 2.0:1 and 2.8:1 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/10\">",
"     10",
"    </a>",
"    ]. About one-half of all patients with mild TBI are between the ages of 15 and 34. Patients at moderate risk include those less than 5 years and those over 60 years [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/10\">",
"     10",
"    </a>",
"    ]. Lower socioeconomic status is also a risk factor for head injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild head injury may result in cortical contusions due to coup and contrecoup injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/21\">",
"     21",
"    </a>",
"    ]. While axonal rupture from shear and tensile forces can occur at the time of severe head injury, milder degrees of axonal damage are postulated to play a role in mild traumatic brain injury (TBI). Disruption of axonal neurofilament organization impairs axonal transport leading to axonal swelling, Wallerian degeneration, and transection [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/22\">",
"     22",
"    </a>",
"    ]. Release of excitatory neurotransmitters acetylcholine, glutamate, and aspartate, and the generation of free radicals may contribute to secondary injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/23\">",
"     23",
"    </a>",
"    ]. One, somewhat controversial, theory regarding blast trauma is that the transfer of kinetic energy through the vascular system to the brain can lead to TBI in the absence of a direct head injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    That these processes occur in mild TBI is supported by findings in animal models of brain injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/22,25\">",
"     22,25",
"    </a>",
"    ]. Evidence of microscopic axonal injury, axon retraction bulbs and microglial clusters, have also been described in the pathological examination of patients with minor head injury who died of other injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Diffusion tensor MRI studies in patients with mild TBI demonstrate increased fractional anisotropy and decreased diffusivity in the corpus callosum and other white matter tracts that is suggestive of cytotoxic edema [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Other neuroimaging studies have shown that patients with mild head injury may have more frequent and more extensive areas of abnormality as measured by SPECT, PET, CT perfusion, and functional MRI than can be seen on a conventional CT scan, supporting a role for diffuse structural",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    physiologic derangement in mild TBI [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/30-36\">",
"     30-36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2195158\">",
"    <span class=\"h2\">",
"     Acute symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hallmarks of concussion are confusion and amnesia, sometimes with, but often without, preceding loss of consciousness [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/1\">",
"     1",
"    </a>",
"    ]. These may be apparent immediately after the head injury or may appear several minutes later [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The amnesia almost always involves loss of memory for the traumatic event but frequently includes loss of recall for events immediately before (retrograde amnesia) and after (anterograde amnesia) the head trauma. An athlete with amnesia may be unable to recall details about recent plays in the game or details of well known current events in the news. Amnesia also may be evidenced by the patient repeatedly asking a question that has already been answered.",
"   </p>",
"   <p>",
"    Details regarding the presence and the duration of loss of consciousness, confusion, and amnesia are considered potentially important to understanding the severity of the injury and the risk of subsequent complications. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Second impact syndrome'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Other signs and symptoms of a concussion may immediately follow the head trauma or evolve gradually over several minutes to hours. Early symptoms of concussion (within minutes to hours) include headache, dizziness (vertigo or imbalance), lack of awareness of surroundings, and nausea and vomiting [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/37\">",
"     37",
"    </a>",
"    ]. Over the next hours and days, patients may also complain of mood and cognitive disturbances, sensitivity to light and noise, and sleep disturbances [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Signs observed in someone with a concussion may include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/37\">",
"     37",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Vacant stare (befuddled facial expression)",
"     </li>",
"     <li>",
"      Delayed verbal expression (slower to answer questions or follow instructions)",
"     </li>",
"     <li>",
"      Inability to focus attention (easily distracted and unable to follow through with normal activities)",
"     </li>",
"     <li>",
"      Disorientation (walking in the wrong direction, unaware of time, date, place)",
"     </li>",
"     <li>",
"      Slurred or incoherent speech (making disjointed or incomprehensible statements)",
"     </li>",
"     <li>",
"      Gross observable incoordination (stumbling, inability to walk",
"      <span class=\"nowrap\">",
"       tandem/straight",
"      </span>",
"      line)",
"     </li>",
"     <li>",
"      Emotionality out of proportion to circumstances (appearing distraught, crying for no apparent reason)",
"     </li>",
"     <li>",
"      Memory deficits (exhibited by patient repeatedly asking the same question that has already been answered or inability to memorize and return three of three words and three of three objects for five minutes)",
"     </li>",
"     <li>",
"      Any period of loss of consciousness (coma, unresponsiveness to stimuli)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Occasionally, associated transient cortical neurologic deficits, such as global amnesia or cortical blindness, can occur. These deficits are thought to be secondary to vascular hyperreactivity and may be trauma-induced, migraine-equivalent phenomena [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/39-41\">",
"     39-41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early post-traumatic seizures are those that occur within the first week after head injury. These seizures are considered to be acute symptomatic events and not epilepsy. Post-traumatic seizures occur in fewer than 5 percent of mild or moderate traumatic brain injury (TBI), and they are more common with more severe TBI, especially if complicated by intracranial hematoma [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/42,43\">",
"     42,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    About half occur within the first 24 hours of the injury; one quarter occur within the first hour [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. The earlier a seizure begins, the more likely it will be generalized in onset; after the first hour more than half are either simple partial (pure motor) seizures or focal with secondary generalization [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Complex partial seizures are rare in this setting.",
"   </p>",
"   <p>",
"    Early seizures increase the risk of post-traumatic epilepsy by fourfold, to more than 25 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/43\">",
"     43",
"    </a>",
"    ]. While anticonvulsants may be used in the treatment of early seizures, they are not helpful in the prevention of post-traumatic epilepsy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4935?source=see_link\">",
"     \"Post-traumatic seizures and epilepsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Complicated concussion",
"    </span>",
"    &nbsp;&mdash;&nbsp;With uncomplicated, mild TBI, limited structural axonal injury may be present but not evident on diagnostic computed tomographic (CT) scanning or magnetic resonance imaging (MRI). However, mild TBI can be complicated by coexistent cortical contusions and the development of intracranial hemorrhage.",
"   </p>",
"   <p>",
"    Brain contusions are areas of bruising with associated localized ischemia, edema, and mass effect [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/45\">",
"     45",
"    </a>",
"    ]. They result from direct external contact forces or from the brain being slapped against intracranial surfaces with",
"    <span class=\"nowrap\">",
"     acceleration/deceleration",
"    </span>",
"    trauma. Signs of cortical contusions vary based on their number, size, and location within the brain but include focal neurologic signs as well as confusion and impaired consciousness. Brain contusions may delay recovery from a concussion.",
"   </p>",
"   <p>",
"    Neurologic deterioration after mild TBI is highly suggestive of an evolving intracranial hematoma, which may be intracerebral or sub- or epidural and usually occurs secondary to a tear in an intracranial artery or vein [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/46\">",
"     46",
"    </a>",
"    ]. Signs include worsening headache, focal neurologic signs, confusion, and lethargy, which may progress to loss of consciousness or even death.",
"   </p>",
"   <p>",
"    Subdural hemorrhage occurs when trauma results in the tearing of bridging veins or dura. The presentation may be acute, subacute, or chronic. Epidural or intracerebral hemorrhage is usually arterial in origin and has an acute, abrupt presentation, which might be delayed by minutes to hours from the original injury. It is estimated that before neurologic deterioration, 20 to 50 percent of persons with epidural hemorrhage have a \"lucid interval\" following a brief loss of consciousness or period of confusion. In the setting of substantive secondary hemorrhage with deterioration in the GCS, the TBI would be reclassified as moderate or severe.",
"   </p>",
"   <p>",
"    In addition to brain concussion, head trauma may result in injuries to other parts of the head or neck, including skull or facial bone fractures, spine or spinal cord injuries, eye injuries, and damage to major blood vessels within the neck. A skull fracture may be accompanied by underlying pathologic findings, including brain contusions, dural tears, and vascular trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ACUTE EVALUATION AND MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have had a concussion or mild traumatic brain injury (TBI) should be medically evaluated. The acute evaluation of an individual includes a neurologic assessment and mental status testing [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/6\">",
"     6",
"    </a>",
"    ]. Prolonged unconsciousness, persistent mental status alterations, or abnormalities on neurologic examination require urgent neuroimaging and neurosurgical consultation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cognitive assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild TBI and concussion may be unrecognized by both the injured and non-medically-trained observers, particularly if there is no loss of consciousness. Simple questions of orientation have inadequate sensitivity to detect mild TBI after head injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/48\">",
"     48",
"    </a>",
"    ]. Some surveys have found that more than 80 percent of individuals with a past concussion did not recognize it as such [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/49,50\">",
"     49,50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Standardized Assessment of Concussion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Standardized Assessment of Concussion (SAC) was developed as a standardized tool for the sideline evaluation of athletes who suffer a head injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/1,48\">",
"     1,48",
"    </a>",
"    ]. The SAC includes measures of orientation, immediate memory, concentration, delayed recall, neurologic screening, and exertional maneuvers (",
"    <a class=\"graphic graphic_table graphicRef77142 \" href=\"UTD.htm?41/26/42413\">",
"     table 2",
"    </a>",
"    ). Although not part of the scored assessment, the SAC also includes a graded symptom checklist, a brief neurologic examination, and records the presence of post-traumatic and retrograde amnesia (",
"    <a class=\"graphic graphic_table graphicRef67396 \" href=\"UTD.htm?26/57/27549\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/48,51\">",
"     48,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with concussion have significantly lower scores than those without [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/48\">",
"     48",
"    </a>",
"    ]. The SAC has been evaluated in two prospective cohorts of football players:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One investigation administered the SAC to 1313 male college and high school athletes prior to the competitive season, then retested 68 noninjured athletes 60 to 120 days later and compared the difference in scores with the difference obtained by retesting 50 injured athletes immediately following concussion [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/52\">",
"       52",
"      </a>",
"      ]. A decline of 1 point on the SAC at retesting classified injured and noninjured athletes with a sensitivity and specificity of 94 and 76 percent, respectively.",
"     </li>",
"     <li>",
"      In a National Collegiate Athletic Association (NCAA) sponsored study, 1631 players were studied over three seasons [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/53\">",
"       53",
"      </a>",
"      ]. The 79 players with concussion had a decline in SAC score of 2.94 points lower than non-head-injured team mates, also examined acutely. In serial examinations, cognitive function as measured by the SAC returned to baseline levels within seven days.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The SAC was also used as an evaluation tool in 165 children (ages 6 to 18 years) who presented to an emergency room with concussion and were compared to a control group with minor extremity injury, rather than to a premorbid baseline score as in the studies above [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/54\">",
"     54",
"    </a>",
"    ]. SAC scores were slightly lower in the concussion group, but this reached statistical significance only in the group age 12 to 14 years. However, when the graded symptoms checklist (",
"    <a class=\"graphic graphic_table graphicRef67396 \" href=\"UTD.htm?26/57/27549\">",
"     table 3",
"    </a>",
"    ) was summed, this score was significantly higher in concussion patients compared to controls; with patients scoring a mean of 8 to 14 points, while controls scored 1 to 2 points.",
"   </p>",
"   <p>",
"    The SAC can be used as a tool for evaluation of patients with suspected concussion, but is probably most appropriately used when there is a baseline measure. It should not be used in isolation to determine the readiness of athletes to return to play. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Return to play'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Other measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other standardized measures used to assess post-traumatic amnesia and other cognitive neurologic deficits associated with mild TBI include the Westmead post-traumatic amnesia scale (WPTAS), Immediate Postconcussion Assessment and Cognitive Testing (ImPACT), the Galveston orientation and amnesia test, the Military Acute Concussion Evaluation (MACE), Balance Error Scoring System (BESS), and the Sport Concussion Assessment Tool 2 (SCAT2), but these have not been well validated [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/55-60\">",
"     55-60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although not well validated, SCAT2 was endorsed by a Consensus Statement on Concussion in sport in 2008 and is increasingly used [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/57\">",
"     57",
"    </a>",
"    ]. SCAT2 provides a detailed clinical assessment that includes a review of subjective symptoms, the Glasgow coma scale, the SAC cognitive assessment, and an evaluation of balance and coordination. Although scored on a point scale of 0 to 100, normative data and a cut-off score have not been defined.",
"   </p>",
"   <p>",
"    Two studies have demonstrated that a revised version of the WPTAS is both simple to perform, taking less than one minute in the emergency department setting, and correlates with the findings in more detailed neuropsychologic testing [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/55,61\">",
"     55,61",
"    </a>",
"    ]. This version of the WPTAS consists of the following",
"    <span class=\"nowrap\">",
"     questions/tasks:",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      What is your name?",
"     </li>",
"     <li>",
"      What is the name of this place?",
"     </li>",
"     <li>",
"      Why are you here?",
"     </li>",
"     <li>",
"      What month are we in?",
"     </li>",
"     <li>",
"      What year are we in?",
"     </li>",
"     <li>",
"      In what",
"      <span class=\"nowrap\">",
"       town/suburb",
"      </span>",
"      are you in?",
"     </li>",
"     <li>",
"      How old are you?",
"     </li>",
"     <li>",
"      What is your date of birth?",
"     </li>",
"     <li>",
"      What time of day is it? (morning, afternoon, evening)",
"     </li>",
"     <li>",
"      Three pictures are presented for subsequent recall",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An incorrect response to any one question is considered a positive test for cognitive impairment after head injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;While neuroimaging is usually normal in patients with a concussion or mild TBI, there is a defined incidence of abnormalities, some of which are clinically important even indicating neurosurgical intervention.",
"   </p>",
"   <p>",
"    A systematic review of the literature estimated a prevalence of CT scan abnormalities of 5 percent among patients presenting to a hospital with a GCS = 15 and 30 percent for those presenting with a GCS = 13 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/62\">",
"     62",
"    </a>",
"    ]. The incidence of abnormalities leading to neurosurgical intervention is about 1 percent.",
"   </p>",
"   <p>",
"    Compared with CT scanning, MRI is more sensitive in showing small areas of contusion or petechial hemorrhage, axonal injury, and small extra-axial hematomas [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/31,63,64\">",
"     31,63,64",
"    </a>",
"    ]. In case series of patients with mild TBI, MRI abnormalities were reported in 30 percent of cases with normal CT findings [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/31,65\">",
"     31,65",
"    </a>",
"    ]. Most of these additional abnormalities were lesions \"consistent with axonal injury.\" These findings are not specific, may be unrelated to TBI, and do not clearly correlate with TBI severity or outcome.",
"   </p>",
"   <p>",
"    Diffusion tensor MRI (DTI) may be more sensitive than conventional MRI for traumatic axonal injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/28,29,66\">",
"     28,29,66",
"    </a>",
"    ]. One study used DTI to examine 63 US military personnel who sustained uncomplicated mild TBI due to blast trauma (plus another blast-related mechanism of injury such as being struck by a blunt object or injured in a fall or motor vehicle accident) and had normal CT scans [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/66\">",
"     66",
"    </a>",
"    ]. As compared with controls, subjects showed marked abnormalities in the middle cerebellar peduncles, in cingulum bundles, and in the right orbitofrontal white matter, regions not affection in civilian injuries, which are usually limited to corpus callosum and other white matter tracts [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. When analyzed individually, 18 subjects had abnormal scans. Follow-up scans 6-12 months later showed evidence of evolving injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/66\">",
"     66",
"    </a>",
"    ]. In one study, abnormalities on DTI appeared to correlate with symptom-severity [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These data indicate that brain CT is the test of choice for emergency department evaluation. While MRI is more sensitive, most clinically important and all neurosurgical abnormalities are visible on CT [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/67\">",
"     67",
"    </a>",
"    ]. MRI may have a more important role in the evaluation of patients with persistent post-traumatic sequelae. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Sequelae'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    There is evidence that patients with mild TBI can be selected for CT scan based on clinical criteria. Two such criteria have been developed and prospectively validated. The Canadian CT head rule requires a head CT for patients with mild TBI and any one of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      GCS &lt;15 two hours after injury",
"     </li>",
"     <li>",
"      Suspected open or depressed skull fracture",
"     </li>",
"     <li>",
"      Any sign of basilar skull fracture: hemotympanum, raccoon eyes (intraorbital bruising), Battle's sign (retroauricular bruising), or cerebrospinal fluid leak, oto- or rhinorrhea",
"     </li>",
"     <li>",
"      Two or more episodes of vomiting",
"     </li>",
"     <li>",
"      65 years of age or older",
"     </li>",
"     <li>",
"      Amnesia before impact of 30 or more minutes",
"     </li>",
"     <li>",
"      Dangerous mechanism (pedestrian struck by motor vehicle, occupant ejected from motor vehicle, fall from &ge;3 feet or &ge;5 stairs)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with neurologic deficit, seizure, presence of bleeding diathesis, or oral anticoagulant use were excluded in the population in which these criteria were originally developed and tested. The presence of any of these is also an indication for head CT in this protocol.",
"   </p>",
"   <p>",
"    The New Orleans criteria apply to patients with a GCS of 15 and require CT scanning if there is headache, vomiting, age &gt;60 years, drug or alcohol intoxication, persistent anterograde amnesia, or visible trauma above the clavicle.",
"   </p>",
"   <p>",
"    Two studies have validated and compared these criteria within the same patient populations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an emergency department-based study of 2707 patients with mild TBI (GCS 13 to 15), both criteria had high sensitivities (100 percent) for detecting neurosurgical and clinically important brain injury abnormalities [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/68\">",
"       68",
"      </a>",
"      ]. The Canadian CT head rule was significantly more specific resulting in lower CT rates (52.1 versus 88.0 percent).",
"     </li>",
"     <li>",
"      Another study in 3181 patients with mild TBI presenting to Dutch university hospitals also demonstrated 100 percent sensitivity for the detection of neurosurgical abnormalities [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/69\">",
"       69",
"      </a>",
"      ]. In this study, the sensitivity for any intracranial abnormality (including findings not considered clinically important in the previous study) was higher with the New Orleans criteria (99.4 versus 87.2 percent), and the specificity was higher using the Canadian CT head rule (39.7 versus 3.0 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other studies have confirmed the lower specificity of the New Orleans criteria compared to the Canadian CT head rule [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/70\">",
"     70",
"    </a>",
"    ]. This is likely in large part due to inclusion of intoxicated patients. The American College of Emergency Physicians has endorsed indications for neuroimaging that are concordant with the New Orleans criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. A conservative approach to selecting individuals for neuroimaging based on these criteria is presented (",
"    <a class=\"graphic graphic_algorithm graphicRef50743 \" href=\"UTD.htm?17/7/17520\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The risk factors outlined by these criteria for predicting clinically important CT scan abnormalities also apply to patients who have suffered a mild head injury without concussion (no loss of consciousness or post-traumatic amnesia) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/73\">",
"     73",
"    </a>",
"    ]. While the odds ratios for individual risk factors are similar, the overall incidence of abnormal CT scans is lower in this group, and the sensitivity and specificity of these neuroimaging criteria in this group of patients have not been prospectively assessed.",
"   </p>",
"   <p>",
"    In addition to diagnostic utility, CT scanning is helpful for prognostic purposes and for determining patient disposition. Neurologically normal patients with a normal CT scan are at low risk for subsequent neurologic deterioration [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/2,74,75\">",
"     2,74,75",
"    </a>",
"    ]. In one study, for example, none of 542 patients admitted to the hospital with a \"mild\" head injury and a normal initial CT scan showed subsequent deterioration, and none required surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Observation and disposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observation is recommended for at least 24 hours after a mild TBI because of the risk of intracranial complications [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/74,76\">",
"     74,76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hospital admission is recommended for patients at risk for immediate complications from head injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/2,47,77\">",
"     2,47,77",
"    </a>",
"    ]. These include patients with:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      GCS &lt;15",
"     </li>",
"     <li>",
"      Abnormal CT scan: intracranial bleeding, cerebral edema",
"     </li>",
"     <li>",
"      Seizures",
"     </li>",
"     <li>",
"      Abnormal bleeding parameters from underlying bleeding diathesis or oral anticoagulation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While available neurosurgical service in the admitting hospital may be preferred, it may not be required particularly if the CT scan is normal. Decisions regarding transfer to a hospital with neurosurgical service should be individualized. Most patients with an abnormal CT scan should have a follow-up study within 24 hours regardless of clinical change [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Admission should also be considered if no responsible person is available at home to monitor the patient for progression of symptoms. In such patients, a normal CT scan may obviate the need for admission and should be considered specifically for this purpose, even if not otherwise indicated according to the criteria discussed above. In one study, 575 patients with GCS = 15 were randomized to immediate CT scan versus in-hospital observation. Similar clinical outcomes were seen in the two groups; CT scan was the more cost-effective strategy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/75,79\">",
"     75,79",
"    </a>",
"    ]. No patient with a normal immediate CT scan later suffered neurologic complications.",
"   </p>",
"   <p>",
"    Outpatient observation may be permitted for the patient whose neurologic condition is very unlikely to deteriorate. There is substantial evidence that patients with a GCS = 15, normal examination and head CT, and no predisposition to bleeding do not suffer subsequent neurologic deterioration [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/71,74,76,80\">",
"     71,74,76,80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The observer should be given explicit and understandable instructions on patient monitoring and how and when to seek medical help [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/76\">",
"     76",
"    </a>",
"    ]. The patient should be awakened from sleep every two hours for the first night and should avoid strenuous activity for at least 24 hours. The following warning signs should prompt the caregiver to seek immediate medical help:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inability to awaken the patient",
"     </li>",
"     <li>",
"      Severe or worsening headaches",
"     </li>",
"     <li>",
"      Somnolence or confusion",
"     </li>",
"     <li>",
"      Restlessness, unsteadiness, or seizures",
"     </li>",
"     <li>",
"      Difficulties with vision",
"     </li>",
"     <li>",
"      Vomiting, fever, or stiff neck",
"     </li>",
"     <li>",
"      Urinary or bowel incontinence",
"     </li>",
"     <li>",
"      Weakness or numbness involving any part of the body",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These signs may indicate that intracranial bleeding or evolving cerebral edema associated with brain contusions is occurring. If the patient's condition deteriorates during observation, a thorough neurologic examination should be performed, and immediate brain CT scanning should be performed once the patient's condition has been stabilized [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/74\">",
"     74",
"    </a>",
"    ]. Consultation with appropriate subspecialists should be obtained if a repeat brain CT scan indicates new intracranial pathologic findings. In the absence of a clinical deterioration, repeat CT scanning is generally not indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/81,82\">",
"     81,82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A conservative approach to the initial approach for the evaluation and disposition of patients with mild TBI is presented (",
"    <a class=\"graphic graphic_algorithm graphicRef50743 \" href=\"UTD.htm?17/7/17520\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/9,62\">",
"     9,62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SEQUELAE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis for complete recovery is good from an appropriately managed concussion [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/83,84\">",
"     83,84",
"    </a>",
"    ]. Nonetheless, there are a variety of short and long-term sequelae that have important implications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Second impact syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse cerebral swelling is a rare but generally fatal complication of mild head injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/85,86\">",
"     85,86",
"    </a>",
"    ]. The cause is hypothesized to be disordered cerebral autoregulation causing cerebrovascular congestion and malignant cerebral edema with increased intracranial pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/37,87,88\">",
"     37,87,88",
"    </a>",
"    ]. The term \"second impact syndrome\" is used when diffuse cerebral swelling occurs after a second concussion, while an athlete is still symptomatic from an earlier concussion [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/89-91\">",
"     89-91",
"    </a>",
"    ]. Some have suggested a similarity with this phenomenon and the shaken baby syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The second impact syndrome is a rare and somewhat controversial complication [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/92,93\">",
"     92,93",
"    </a>",
"    ]. It is unclear why this is not a more frequently reported occurrence in boxers who seem at very high risk for repeated concussions within a short time span. A 1998 review of the 17 published cases to date revealed that in 12 of these cases, there was insufficient documentation of a second impact",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cerebral pathology such that the diagnosis of second impact syndrome seemed questionable [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Return to play",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite this uncertainty, the suggestion that a second impact may be a risk factor for this severe complication, has led to the development of a series of guidelines that address concussion severity and return to play for athletes [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/90\">",
"     90",
"    </a>",
"    ]. The Cantu guidelines were developed based upon Cantu's experience as a neurosurgeon and a literature review to provide basic guidance for the on-field management of concussion (",
"    <a class=\"graphic graphic_table graphicRef68019 \" href=\"UTD.htm?30/21/31067\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/38,94\">",
"     38,94",
"    </a>",
"    ]. The Colorado Guidelines were published by the Colorado Medical Society following the death of a football player (",
"    <a class=\"graphic graphic_table graphicRef73118 \" href=\"UTD.htm?22/31/23035\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/95\">",
"     95",
"    </a>",
"    ]. The Colorado Guidelines were amended by a panel of experts in multiple specialties assembled by the American Academy of Neurology (AAN) (",
"    <a class=\"graphic graphic_table graphicRef50626 \" href=\"UTD.htm?25/28/26059\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/1\">",
"     1",
"    </a>",
"    ]. Each of these guidelines grades the severity of the injury according to measures that include the presence and duration of both loss of consciousness and post-traumatic amnesia.",
"   </p>",
"   <p>",
"    The more recently issued 2008 Consensus Statement on Concussion in Sport was written by a multi-disciplinary, international group and proposes a six-day graduated return to play protocol in which the athlete makes a stepwise increase in functional activity, is evaluated for symptoms, and is allowed to progress to the next stage each successive day if asymptomatic (",
"    <a class=\"graphic graphic_table graphicRef61318 \" href=\"UTD.htm?43/27/44475\">",
"     table 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/57\">",
"     57",
"    </a>",
"    ]. While these guidelines further suggest that a more rapid return to play may be possible for asymptomatic adult athletes, they suggest that a more conservative approach be followed for adolescents and children [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/96\">",
"     96",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12906?source=see_link&amp;anchor=H38#H38\">",
"     \"Minor head trauma in infants and children\", section on 'Return to play'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/13/36058?source=see_link&amp;anchor=H4#H4\">",
"     \"The preparticipation sports examination in children and adolescents\", section on 'Conditions that require a treatment plan before or during exercise'",
"    </a>",
"    .) As with the other published guidelines on return to play, these are based on consensus opinion rather than well-validated studies.",
"   </p>",
"   <p>",
"    All guidelines agree that athletes suspected of having a concussion should be removed from sports participation immediately, that athletes should not return to play while signs or symptoms of concussion are present, and that athletes who have any loss of consciousness, any symptoms of concussion lasting more than 15 minutes, or who have post-traumatic amnesia should not be permitted to resume sports participation until asymptomatic for at least one week. An emergency department evaluation is indicated for any athlete who suffers loss of consciousness [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/1,95\">",
"     1,95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    None of the available guidelines are based on strong scientific data, and none have been prospectively validated. They do not allow for individual variability in symptom presentation, nor for different vulnerabilities to injury at different ages. The guidelines differ regarding the management of a second or third concussion of the same grade in an athlete. As examples, the Cantu guidelines recommend terminating play for the season after a third concussion of any grade, while the AAN allows for return to play after a one to four week interval (depending on the grade of the concussion) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/1,38\">",
"     1,38",
"    </a>",
"    ]. No recommendations are offered on return to play for athletes who have sustained serial concussions of various grades.",
"   </p>",
"   <p>",
"    Other important considerations include the fact that premature return to play by a symptomatic athlete places that athlete at greater risk for subsequent concussion and cumulative brain injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/7,37,97\">",
"     7,37,97",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Cumulative neuropsychological impairment'",
"    </a>",
"    below.) In one prospective cohort study of 2905 college football players, 1 in 15 players with concussion had additional concussions in the same season, most occurring 7 to 10 days after the first concussion [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/98\">",
"     98",
"    </a>",
"    ]. With each concussion, the risk of future concussions increased. Individuals with three concussions had a three times greater risk of future concussion compared with those without concussion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Postconcussion syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postconcussion symptoms may result from brain injury or from trauma involving head and neck structures [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/84\">",
"     84",
"    </a>",
"    ]. These include headache, dizziness (including vertigo and nonspecific dizziness), neuropsychiatric symptoms, and cognitive impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/99\">",
"     99",
"    </a>",
"    ]. These typically develop in the first days after mild traumatic brain injury (TBI) and generally resolve within a few weeks to a few months. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33929?source=see_link\">",
"     \"Postconcussion syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Post-traumatic headaches",
"    </span>",
"    &nbsp;&mdash;&nbsp;Headaches occur in 25 to 78 of patients after mild TBI [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/100-102\">",
"     100-102",
"    </a>",
"    ]. According to the International Headache Society (IHS) criteria, the onset of the post-traumatic headaches should be within seven days after the injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/103\">",
"     103",
"    </a>",
"    ]. The seven-day onset is arbitrary; some suggest that three months seems a more reasonable latency for onset than does seven days [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/104\">",
"     104",
"    </a>",
"    ]. Headaches may represent a specific injury to the head or neck, may be nonspecific in character, and may have a symptom pattern indistinguishable from other nontraumatic headache syndromes such as migraine and tension headache. A number of other explanations for persistent headaches have been advanced including psychogenic, psychosocial, sociocultural, base rate misattribution, chronic pain, compensation and litigation, and malingering [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/105\">",
"     105",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33929?source=see_link&amp;anchor=H8#H8\">",
"     \"Postconcussion syndrome\", section on 'Headaches'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Post-traumatic epilepsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild TBI is associated with a twofold increase in the risk of epilepsy for the first five years after injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/106\">",
"     106",
"    </a>",
"    ]. Seizures occurring within the first week of injury are acute symptomatic events and are not considered epilepsy. Half of the seizures consistent with post-traumatic epilepsy will occur in the first year; 80 percent will occur within two years. Prophylactic treatment with anticonvulsants does not prevent post-traumatic epilepsy and is not recommended. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4935?source=see_link\">",
"     \"Post-traumatic seizures and epilepsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Post-traumatic vertigo",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of post-traumatic vertigo has not been well characterized in prospective studies. Head injury may lead to vertigo by a variety of mechanisms [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/107,108\">",
"     107,108",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Direct injury to the cochlear",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vestibular structures usually occurs in the setting of transverse fractures of the temporal bone. Hemotympanum and sensorineural loss often occur. The symptoms are maximal at onset and progressively improve in most patients over weeks and months due to CNS compensation.",
"     </li>",
"     <li>",
"      Labyrinthine concussion may occur from blunt injury to the membranous labyrinth against the otic capsule. This also produces acute onset of vertigo and ataxia, which are maximal at the time of symptom onset and improve over days to months, usually somewhat quicker then with the more severe injury described above.",
"     </li>",
"     <li>",
"      Benign paroxysmal positional vertigo (BPPV) occurs after head injury causes shearing and displacement of otoconia, which then settle into one of the semi-circular canals, most often the posterior canal in this setting. BPPV produces isolated paroxysms of positionally induced vertigo [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/109\">",
"       109",
"      </a>",
"      ]. There may be a hiatus of weeks and even months between the injury and the onset of BPPV. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/13/19673?source=see_link\">",
"       \"Benign paroxysmal positional vertigo\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Perilymphatic fistula occurs when trauma causes rupture of the oval or round window and presents with sudden unilateral sensorineural hearing loss and acute, persistent, gradually diminishing vertigo and ataxia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/38/17001?source=see_link&amp;anchor=H10#H10\">",
"       \"Pathophysiology, etiology, and differential diagnosis of vertigo\", section on 'Perilymphatic fistula'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other potential causes of post-traumatic vertigo include post-traumatic Meniere syndrome, brainstem ischemia due to vertebral artery dissection, epileptic vertigo, and migraine-related vertigo.",
"     </li>",
"     <li>",
"      The postconcussion syndrome includes dizziness, which is often nonspecific in character but is sometimes described as vertigo. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33929?source=see_link\">",
"       \"Postconcussion syndrome\"",
"      </a>",
"      .) When a patient has profound vertigo, especially when there is accompanying nystagmus, ataxia, hearing symptoms, or evidence of direct vestibular injury, consideration of the specific vestibular pathologies mentioned previously is advised in order to appropriately manage the patient.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Post-traumatic vertigo and dizziness is a substantial contributor to disability after mild TBI [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/110-114\">",
"     110-114",
"    </a>",
"    ]. While the approach to the evaluation and management of vertigo in this setting is similar to patients who have not had head injury, evaluation and management may be complicated by the fact that there may be more than one site and mechanism of vestibular injury in the same patient. Some case series also indicate that the symptoms are somewhat more refractory to treatment than their idiopathic counterparts, perhaps because of multiple contributing pathologic injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/107,110,115\">",
"     107,110,115",
"    </a>",
"    ]. The evaluation and treatment of these and other cause of vertigo are discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32057?source=see_link\">",
"     \"Approach to the patient with vertigo\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13559?source=see_link\">",
"     \"Treatment of vertigo\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/13/19673?source=see_link\">",
"     \"Benign paroxysmal positional vertigo\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Other cranial nerve injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of injury to other cranial nerves increases with the severity of brain injury, but these can also occur in mild TBI with an incidence of 0.3 percent according to one case series [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/116\">",
"     116",
"    </a>",
"    ]. The distribution is similar to that for moderate or severe head injuries:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anosmia and hyposmia, which are often reported by the patient as impaired taste as well as smell, occur following injury to olfactory filaments as they enter the brain through the cribiform plate. While recovery occurs in about one-third of patients, loss of smell is likely permanent if present one year after the injury [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/117\">",
"       117",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13801?source=see_link\">",
"       \"Anatomy and etiology of taste and smell disorders\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Diplopia may result from injury to cranial nerves III, IV, and VI. In the setting of mild TBI, injury to cranial nerve IV is most common, followed by VI. Cranial nerve III is less commonly affected by mild TBI. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25320?source=see_link\">",
"       \"Overview of diplopia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Facial pain and occipital neuralgia may occur in association with mild TBI. The former usually occurs in the setting of blunt force injury to the trigeminal nerve in the face, while occipital nerve injury may be indirect from a contiguous musculoskeletal injury in the neck. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/10/11431?source=see_link\">",
"       \"Overview of craniofacial pain\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Cumulative neuropsychological impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is some evidence that repeated concussions can cause cumulative neuropsychological deficits (ie, increasing severity and duration of mental status abnormalities after each separate incident) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/97,118\">",
"     97,118",
"    </a>",
"    ]. In addition to cognitive impairment and neuropsychological symptoms (behavior, personality changes, depression, and suicidality), parkinsonism and other speech and gait abnormalities are described [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/16,119\">",
"     16,119",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cumulative effects of repeated concussions have been implicated in cognitive impairments among college football players [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/7\">",
"     7",
"    </a>",
"    ] and poorer neuropsychological functioning in amateur and professional soccer players [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/120,121\">",
"     120,121",
"    </a>",
"    ]. However, failure to control for potential biases, such as alcohol intake and other factors that may influence sports participation and risk of head injury, limits the conclusions that can be drawn from these studies. A study of 19 former athletes (mean age 61 years) with a history of concussion and 21 former athletes without a concussion history found that a concussion history was associated with lower performance on neuropsychological tests of episodic memory [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/122\">",
"     122",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chronic TBI has long been recognized as a sequelae of boxing, and it is often called dementia pugilistica in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/123\">",
"     123",
"    </a>",
"    ]. The incidence is approximately 20 percent in professional boxers, and is much lower, perhaps negligible, in amateur boxers [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/124,125\">",
"     124,125",
"    </a>",
"    ]. The number of professional bouts (typically greater than 20) appears to be more important than the number of \"knockouts\" [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/126\">",
"     126",
"    </a>",
"    ]. The total number and type of head blows, particularly if the angle of impact or failure to stabilize the head results in rotational head movements, may be important as well, but it is difficult to quantify.",
"   </p>",
"   <p>",
"    Increasing reports of dementia among American National Football League players with a history of multiple concussions have focused attention on this entity, which has been labeled chronic traumatic encephalopathy in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/119,127\">",
"     119,127",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neuropathologic studies in football players and boxers with this syndrome have demonstrated cerebral atrophy and a fenestrated cavum septum pellucidum, with extensive tau-immunoreactive degenerative changes that are distinct from other tauopathies in their distribution with preferential involvement of the superficial cortical layers [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A possible relationship between Alzheimer disease (AD) and chronic cognitive sequelae of TBI has been suggested by some clinical investigations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neuropathological study of boxers with chronic TBI demonstrates some features of AD including beta-amyloid protein&ndash;containing diffuse plaques and neurofibrillary tangles [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/128\">",
"       128",
"      </a>",
"      ]. Unlike AD, the neurofibrillary tangles of dementia pugilistica are located in superficial rather than deep layers of the neocortex and occur without neuritic plaques.",
"     </li>",
"     <li>",
"      In one study, the molecular profile of tau pathologies in two patients with dementia pugilistica were similar to the abnormally phosphorylated brain tau isoforms in AD brains [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/129\">",
"       129",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      APOE genotype is a risk factor for AD. In one series of 30 boxers, APOE genotype was associated with severity of neurologic deficits among high, but not low, exposure boxers [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/130\">",
"       130",
"      </a>",
"      ]. In a similar study of 53 professional football players, older patients with APOE genotype were more likely to have cognitive impairment than those without the APOE genotype [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/131\">",
"       131",
"      </a>",
"      ]. However, other studies suggest that APOE epsilon 4 is not associated with increased burden of neuropsychological deficits after TBI [",
"      <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/132,133\">",
"       132,133",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It has been suggested that recurrent brain injury may activate pathologic mechanisms similar to those that cause brain degeneration in AD. However, these studies may reflect a co-incidence of the two conditions rather than a causal relationship or shared pathogenesis; further investigation is required [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/131\">",
"     131",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5379452\">",
"    <span class=\"h3\">",
"     Motor neuron disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a neuropathological autopsy study of 12 former athletes with chronic traumatic encephalopathy (confirmed pathologically), three also had motor neuron disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/134\">",
"     134",
"    </a>",
"    ]. These three, along with seven others, were found to have abundant TDP-43&ndash;positive inclusions and neurites in the spinal cord as well. Although there has long been suspicion of head trauma including trauma sustained in sports such as American football and soccer as a risk factor for motor neuron disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/135\">",
"     135",
"    </a>",
"    ], this is the first pathological evidence that supports this concern. Further pathological confirmation of these findings will be of great interest.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1243455\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least one cohort study that included patients with mild TBI found that patients had increased mortality rates compared with controls for at least 13 years after mild TBI (27.9 versus 13.2 per 1000 per year) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/136\">",
"     136",
"    </a>",
"    ]. All patients were hospitalized after head injury, perhaps selecting for a more severely injured population. While comorbid lifestyle factors (physical disability, living alone, alcohol abuse) further increased mortality in this group, the causes of death were similar among head injured patients and controls.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;These combined acute and chronic morbidity associated with mild TBI suggest placing a premium on reducing the number of concussions in athletes. Use of sport-specific helmets has been found to reduce head injuries in sports such as baseball, ice hockey, and alpine skiing and snowboarding [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/137-139\">",
"     137-139",
"    </a>",
"    ]. However, these case control studies leave open the possibility that the observed effects associated with voluntary use of a helmet are the result of general risk avoidant behavior rather than the helmet itself. In contrast, helmets have not been found to reduce the rate of head injury in soccer players [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/140\">",
"     140",
"    </a>",
"    ]. Furthermore, in some cases, use of protective equipment may adversely affect playing behavior, encouraging risky behavior, so that the risk of injury actually increases [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/141,142\">",
"     141,142",
"    </a>",
"    ]. While American football helmets are widely used, there is no standard for helmet construction to prevent concussions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/59/29626/abstract/143\">",
"     143",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bicycle and motorcycle helmets reduce the severity of accident-related head injuries. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13225?source=see_link\">",
"     \"Prevention of bicycle injuries in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The NFL has been making rules changes emphasizing player safety. As an example, in 2009, the return to play from concussion guideline was amended and blows to the head of a defenseless receiver were prohibited. During the 2010 NFL season, there was increased discipline (increased enforcement, large fines, and possible suspensions) for helmet to helmet contact in violation of players&rsquo; safety rules and a change where the ball is immediately blown dead if a ball-carrier&rsquo;s helmet comes off during a play.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/12/22722?source=see_link\">",
"       \"Patient information: Concussion (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/24/34178?source=see_link\">",
"       \"Patient information: Skull and facial fractures (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/47/8947?source=see_link\">",
"       \"Patient information: Closed head injury (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/44/14020?source=see_link\">",
"       \"Patient information: Head injury in children and adolescents (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/31/41460?source=see_link\">",
"       \"Patient information: Dizziness and vertigo (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild traumatic brain injury (TBI) is common; most individuals have an excellent prognosis. However, some patients will have acute, life-threatening sequelae that require emergent evaluation and management. Others will suffer chronic sequelae that are associated with mild to moderate disability. While the risks of repeated concussions are not well defined, there is sufficient evidence to support measures that limit repeated injuries.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A mild TBI is an injury to the brain that may result after blunt force or",
"      <span class=\"nowrap\">",
"       acceleration/deceleration",
"      </span>",
"      head injury. Its occurrence is most obvious when the individual has experienced brief loss of consciousness or demonstrates overt confusion or amnesia. Subtler degrees of neurologic impairment may be unrecognized by the individual and observer. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An athlete with known or suspected head injury should be evaluated by a trained observer for potential concussion. Simple orientation questions are inadequate to detect concussion. One suggested tool for nonmedically trained personnel is the Standardized Assessment of Concussion (SAC) (",
"      <a class=\"graphic graphic_table graphicRef77142 \" href=\"UTD.htm?41/26/42413\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Standardized Assessment of Concussion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with mild TBI should be medically evaluated. Patients who have suffered loss of consciousness or have persistent symptoms should be referred to an emergency department. A conservative approach to the initial evaluation and disposition with mild TBI is presented (",
"      <a class=\"graphic graphic_algorithm graphicRef50743 \" href=\"UTD.htm?17/7/17520\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Acute evaluation and management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Repeated TBI soon after an initial injury may lead to acute life-threatening cerebral edema. Recurrent TBI may also lead to chronic neuropsychological impairments. A number of guidelines regarding return to play for athletes in contact sports have been developed, but none appears to be superior to another (",
"      <a class=\"graphic graphic_table graphicRef68019 \" href=\"UTD.htm?30/21/31067\">",
"       table 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef73118 \" href=\"UTD.htm?22/31/23035\">",
"       table 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef50626 \" href=\"UTD.htm?25/28/26059\">",
"       table 6",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Return to play'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that athletes with a single concussion who have suffered loss of consciousness or who have symptoms of concussion lasting more than 15 minutes NOT return to play until asymptomatic for at least one week (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). We suggest that athletes who have suffered repeated concussions that are associated with either loss of consciousness or symptoms for more than 15 minutes NOT return to play that season (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Other potential long-term sequelae of mild TBI include postconcussion syndrome, epilepsy, and vertigo. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Sequelae'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/1\">",
"      Practice parameter: the management of concussion in sports (summary statement). Report of the Quality Standards Subcommittee. Neurology 1997; 48:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/2\">",
"      Stein SC, Ross SE. The value of computed tomographic scans in patients with low-risk head injuries. Neurosurgery 1990; 26:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/3\">",
"      Servadei F, Teasdale G, Merry G, Neurotraumatology Committee of the World Federation of Neurosurgical Societies. Defining acute mild head injury in adults: a proposal based on prognostic factors, diagnosis, and management. J Neurotrauma 2001; 18:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/4\">",
"      Uchino Y, Okimura Y, Tanaka M, et al. Computed tomography and magnetic resonance imaging of mild head injury--is it appropriate to classify patients with Glasgow Coma Scale score of 13 to 15 as \"mild injury\"? Acta Neurochir (Wien) 2001; 143:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/5\">",
"      Culotta VP, Sementilli ME, Gerold K, Watts CC. Clinicopathological heterogeneity in the classification of mild head injury. Neurosurgery 1996; 38:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/6\">",
"      McCrory P. Do not go gentle into that good night... Br J Sports Med 2005; 39:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/7\">",
"      Collins MW, Grindel SH, Lovell MR, et al. Relationship between concussion and neuropsychological performance in college football players. JAMA 1999; 282:964.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Injury Prevention &amp; Control: Traumatic Brain Injury. Traumatic Brain Injury. Available at: file://www.cdc.gov/TraumaticBrainInjury/index.html (Accessed on March 25, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/9\">",
"      Vos PE, Battistin L, Birbamer G, et al. EFNS guideline on mild traumatic brain injury: report of an EFNS task force. Eur J Neurol 2002; 9:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/10\">",
"      Kraus JF, McArthur DL. Epidemiologic aspects of brain injury. Neurol Clin 1996; 14:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/11\">",
"      Kraus JF, Nourjah P. The epidemiology of mild, uncomplicated brain injury. J Trauma 1988; 28:1637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/12\">",
"      Annegers JF, Grabow JD, Kurland LT, Laws ER Jr. The incidence, causes, and secular trends of head trauma in Olmsted County, Minnesota, 1935-1974. Neurology 1980; 30:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/13\">",
"      Wrightson P, Gronwall D. Time off work and symptoms after minor head injury. Injury 1981; 12:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/14\">",
"      Bernstein DM. Recovery from mild head injury. Brain Inj 1999; 13:151.",
"     </a>",
"    </li>",
"    <li>",
"     Jennett B, Frankovyski RF. The epidemiology of head injury. In: Handbook of Clinical Neurology, Braakman R (Ed), Elsevier, New York 1990. Vol 13, p.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/16\">",
"      McKee AC, Cantu RC, Nowinski CJ, et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 2009; 68:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/17\">",
"      Kelly JP, Rosenberg JH. The development of guidelines for the management of concussion in sports. J Head Trauma Rehabil 1998; 13:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/18\">",
"      Powell JW, Barber-Foss KD. Traumatic brain injury in high school athletes. JAMA 1999; 282:958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/19\">",
"      Marar M, McIlvain NM, Fields SK, Comstock RD. Epidemiology of concussions among United States high school athletes in 20 sports. Am J Sports Med 2012; 40:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/20\">",
"      Hoge CW, McGurk D, Thomas JL, et al. Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N Engl J Med 2008; 358:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/21\">",
"      Goodman JC. Pathologic changes in mild head injury. Semin Neurol 1994; 14:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/22\">",
"      Povlishock JT, Katz DI. Update of neuropathology and neurological recovery after traumatic brain injury. J Head Trauma Rehabil 2005; 20:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/23\">",
"      Hayes RL, Dixon CE. Neurochemical changes in mild head injury. Semin Neurol 1994; 14:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/24\">",
"      Bhattacharjee Y. Neuroscience. Shell shock revisited: solving the puzzle of blast trauma. Science 2008; 319:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/25\">",
"      Ommaya AK, Gennarelli TA. Cerebral concussion and traumatic unconsciousness. Correlation of experimental and clinical observations of blunt head injuries. Brain 1974; 97:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/26\">",
"      Oppenheimer DR. Microscopic lesions in the brain following head injury. J Neurol Neurosurg Psychiatry 1968; 31:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/27\">",
"      Blumbergs PC, Scott G, Manavis J, et al. Staining of amyloid precursor protein to study axonal damage in mild head injury. Lancet 1994; 344:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/28\">",
"      Wilde EA, McCauley SR, Hunter JV, et al. Diffusion tensor imaging of acute mild traumatic brain injury in adolescents. Neurology 2008; 70:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/29\">",
"      Mayer AR, Ling J, Mannell MV, et al. A prospective diffusion tensor imaging study in mild traumatic brain injury. Neurology 2010; 74:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/30\">",
"      McAllister TW, Sparling MB, Flashman LA, Saykin AJ. Neuroimaging findings in mild traumatic brain injury. J Clin Exp Neuropsychol 2001; 23:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/31\">",
"      Hughes DG, Jackson A, Mason DL, et al. Abnormalities on magnetic resonance imaging seen acutely following mild traumatic brain injury: correlation with neuropsychological tests and delayed recovery. Neuroradiology 2004; 46:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/32\">",
"      Kant R, Smith-Seemiller L, Isaac G, Duffy J. Tc-HMPAO SPECT in persistent post-concussion syndrome after mild head injury: comparison with MRI/CT. Brain Inj 1997; 11:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/33\">",
"      Korn A, Golan H, Melamed I, et al. Focal cortical dysfunction and blood-brain barrier disruption in patients with Postconcussion syndrome. J Clin Neurophysiol 2005; 22:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/34\">",
"      Umile EM, Sandel ME, Alavi A, et al. Dynamic imaging in mild traumatic brain injury: support for the theory of medial temporal vulnerability. Arch Phys Med Rehabil 2002; 83:1506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/35\">",
"      Chen SH, Kareken DA, Fastenau PS, et al. A study of persistent post-concussion symptoms in mild head trauma using positron emission tomography. J Neurol Neurosurg Psychiatry 2003; 74:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/36\">",
"      Metting Z, R&ouml;diger LA, Stewart RE, et al. Perfusion computed tomography in the acute phase of mild head injury: regional dysfunction and prognostic value. Ann Neurol 2009; 66:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/37\">",
"      Kelly JP, Rosenberg JH. Diagnosis and management of concussion in sports. Neurology 1997; 48:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/38\">",
"      Cantu RC. Posttraumatic Retrograde and Anterograde Amnesia: Pathophysiology and Implications in Grading and Safe Return to Play. J Athl Train 2001; 36:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/39\">",
"      Yamamoto LG, Bart RD Jr. Transient blindness following mild head trauma. Criteria for a benign outcome. Clin Pediatr (Phila) 1988; 27:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/40\">",
"      Haas DC, Ross GS. Transient global amnesia triggered by mild head trauma. Brain 1986; 109 ( Pt 2):251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/41\">",
"      Harrison DW, Walls RM. Blindness following minor head trauma in children: a report of two cases with a review of the literature. J Emerg Med 1990; 8:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/42\">",
"      Lee ST, Lui TN. Early seizures after mild closed head injury. J Neurosurg 1992; 76:435.",
"     </a>",
"    </li>",
"    <li>",
"     Barry E. Posttraumatic epilepsy, In: The treatment of epilepsy: Principles and practice, 3rd ed, Wyllie E (Ed), Lippincott Williams, Philadelphia 2001. p.609.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/44\">",
"      Pagni CA. Posttraumatic epilepsy. Incidence and prophylaxis. Acta Neurochir Suppl (Wien) 1990; 50:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/45\">",
"      Williams DH, Levin HS, Eisenberg HM. Mild head injury classification. Neurosurgery 1990; 27:422.",
"     </a>",
"    </li>",
"    <li>",
"     Liau LM, Bergsneider M, Becker DP. Pathology and pathophysiology of head injury. In: Neurological surgery: A comprehensive reference guide to the diagnosis and management of neurosurgical problems, 4th ed, Youmans JR, Becker DP, et al (Eds), Saunders, Philadelphia 1996. p.1549.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/47\">",
"      Dacey RG Jr, Alves WM, Rimel RW, et al. Neurosurgical complications after apparently minor head injury. Assessment of risk in a series of 610 patients. J Neurosurg 1986; 65:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/48\">",
"      McCrea M, Kelly JP, Kluge J, et al. Standardized assessment of concussion in football players. Neurology 1997; 48:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/49\">",
"      Delaney JS, Abuzeyad F, Correa JA, Foxford R. Recognition and characteristics of concussions in the emergency department population. J Emerg Med 2005; 29:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/50\">",
"      Delaney SJ, Lacroix VJ, Leclerc S, et al. Concussions during the 1997 Canadian football league season. Clin J Sports Med 2000; 54:1488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/51\">",
"      McCrea M, Kelly JP, Randolph C, et al. Standardized assessment of concussion (SAC): on-site mental status evaluation of the athlete. J Head Trauma Rehabil 1998; 13:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/52\">",
"      Barr WB, McCrea M. Sensitivity and specificity of standardized neurocognitive testing immediately following sports concussion. J Int Neuropsychol Soc 2001; 7:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/53\">",
"      McCrea M, Guskiewicz KM, Marshall SW, et al. Acute effects and recovery time following concussion in collegiate football players: the NCAA Concussion Study. JAMA 2003; 290:2556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/54\">",
"      Grubenhoff JA, Kirkwood M, Gao D, et al. Evaluation of the standardized assessment of concussion in a pediatric emergency department. Pediatrics 2010; 126:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/55\">",
"      Shores EA, Lamm&eacute;l A, Hullick C, et al. The diagnostic accuracy of the Revised Westmead PTA Scale as an adjunct to the Glasgow Coma Scale in the early identification of cognitive impairment in patients with mild traumatic brain injury. J Neurol Neurosurg Psychiatry 2008; 79:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/56\">",
"      Levin HS, O'Donnell VM, Grossman RG. The Galveston Orientation and Amnesia Test. A practical scale to assess cognition after head injury. J Nerv Ment Dis 1979; 167:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/57\">",
"      McCrory P, Meeuwisse W, Johnston K, et al. Consensus statement on Concussion in Sport 3rd International Conference on Concussion in Sport held in Zurich, November 2008. Clin J Sport Med 2009; 19:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/58\">",
"      Mayers LB, Redick TS. Clinical utility of ImPACT assessment for postconcussion return-to-play counseling: psychometric issues. J Clin Exp Neuropsychol 2012; 34:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/59\">",
"      Elbin RJ, Schatz P, Covassin T. One-year test-retest reliability of the online version of ImPACT in high school athletes. Am J Sports Med 2011; 39:2319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/60\">",
"      Valovich McLeod TC, Bay RC, Lam KC, Chhabra A. Representative baseline values on the Sport Concussion Assessment Tool 2 (SCAT2) in adolescent athletes vary by gender, grade, and concussion history. Am J Sports Med 2012; 40:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/61\">",
"      Ponsford J, Willmott C, Rothwell A, et al. Use of the Westmead PTA scale to monitor recovery of memory after mild head injury. Brain Inj 2004; 18:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/62\">",
"      Borg J, Holm L, Cassidy JD, et al. Diagnostic procedures in mild traumatic brain injury: results of the WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury. J Rehabil Med 2004; :61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/63\">",
"      Hesselink JR, Dowd CF, Healy ME, et al. MR imaging of brain contusions: a comparative study with CT. AJR Am J Roentgenol 1988; 150:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/64\">",
"      Wilberger JE Jr, Rothfus WE, Tabas J, et al. Acute tissue tear hemorrhages of the brain: computed tomography and clinicopathological correlations. Neurosurgery 1990; 27:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/65\">",
"      Mittl RL, Grossman RI, Hiehle JF, et al. Prevalence of MR evidence of diffuse axonal injury in patients with mild head injury and normal head CT findings. AJNR Am J Neuroradiol 1994; 15:1583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/66\">",
"      Mac Donald CL, Johnson AM, Cooper D, et al. Detection of blast-related traumatic brain injury in U.S. military personnel. N Engl J Med 2011; 364:2091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/67\">",
"      Manolakaki D, Velmahos GC, Spaniolas K, et al. Early magnetic resonance imaging is unnecessary in patients with traumatic brain injury. J Trauma 2009; 66:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/68\">",
"      Stiell IG, Clement CM, Rowe BH, et al. Comparison of the Canadian CT Head Rule and the New Orleans Criteria in patients with minor head injury. JAMA 2005; 294:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/69\">",
"      Smits M, Dippel DW, de Haan GG, et al. External validation of the Canadian CT Head Rule and the New Orleans Criteria for CT scanning in patients with minor head injury. JAMA 2005; 294:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/70\">",
"      Papa L, Stiell IG, Clement CM, et al. Performance of the Canadian CT Head Rule and the New Orleans Criteria for predicting any traumatic intracranial injury on computed tomography in a United States Level I trauma center. Acad Emerg Med 2012; 19:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/71\">",
"      Jagoda AS, Bazarian JJ, Bruns JJ Jr, et al. Clinical policy: neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Ann Emerg Med 2008; 52:714.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Injury Prevention &amp; Control: Traumatic Brain Injury. Heads Up to Clinicians: Updated Mild Traumatic Brain Injury Guideline for Adults. file://www.cdc.gov/concussion/HeadsUp/clinicians_guide.html (Accessed on October 23, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/73\">",
"      Smits M, Hunink MG, Nederkoorn PJ, et al. A history of loss of consciousness or post-traumatic amnesia in minor head injury: \"conditio sine qua non\" or one of the risk factors? J Neurol Neurosurg Psychiatry 2007; 78:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/74\">",
"      The management of minor closed head injury in children. Committee on Quality Improvement, American Academy of Pediatrics. Commission on Clinical Policies and Research, American Academy of Family Physicians. Pediatrics 1999; 104:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/75\">",
"      af Geijerstam JL, Oredsson S, Britton M, OCTOPUS Study Investigators. Medical outcome after immediate computed tomography or admission for observation in patients with mild head injury: randomised controlled trial. BMJ 2006; 333:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/76\">",
"      Lawler KA, Terregino CA. Guidelines for evaluation and education of adult patients with mild traumatic brain injuries in an acute care hospital setting. J Head Trauma Rehabil 1996; 11:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/77\">",
"      Atzema C, Mower WR, Hoffman JR, et al. Defining \"therapeutically inconsequential\" head computed tomographic findings in patients with blunt head trauma. Ann Emerg Med 2004; 44:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/78\">",
"      Bee TK, Magnotti LJ, Croce MA, et al. Necessity of repeat head CT and ICU monitoring in patients with minimal brain injury. J Trauma 2009; 66:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/79\">",
"      Norlund A, Mark&eacute; LA, af Geijerstam JL, et al. Immediate computed tomography or admission for observation after mild head injury: cost comparison in randomised controlled trial. BMJ 2006; 333:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/80\">",
"      Jagoda AS, Cantrill SV, Wears RL, et al. Clinical policy: neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Ann Emerg Med 2002; 40:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/81\">",
"      Peck KA, Sise CB, Shackford SR, et al. Delayed intracranial hemorrhage after blunt trauma: are patients on preinjury anticoagulants and prescription antiplatelet agents at risk? J Trauma 2011; 71:1600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/82\">",
"      Sifri ZC, Nayak N, Nyak N, et al. Utility of repeat head computed tomography in patients with an abnormal neurologic examination after minimal head injury. J Trauma 2011; 71:1605.",
"     </a>",
"    </li>",
"    <li>",
"     Evans, RW. The postconcussion syndrome and the sequelae of mild head injury. In: Neurology and Trauma, 2nd ed, Evans, RW (Ed), Oxford, New York 2006. p.95.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/84\">",
"      Kushner D. Mild traumatic brain injury: toward understanding manifestations and treatment. Arch Intern Med 1998; 158:1617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/85\">",
"      Bruce DA. Delayed deterioration of consciousness after trivial head injury in childhood. Br Med J (Clin Res Ed) 1984; 289:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/86\">",
"      Kors EE, Terwindt GM, Vermeulen FL, et al. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol 2001; 49:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/87\">",
"      McQuillen JB, McQuillen EN, Morrow P. Trauma, sport, and malignant cerebral edema. Am J Forensic Med Pathol 1988; 9:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/88\">",
"      Cantu RC, Gean AD. Second-impact syndrome and a small subdural hematoma: an uncommon catastrophic result of repetitive head injury with a characteristic imaging appearance. J Neurotrauma 2010; 27:1557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/89\">",
"      Saunders RL, Harbaugh RE. The second impact in catastrophic contact-sports head trauma. JAMA 1984; 252:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/90\">",
"      Collins MW, Lovell MR, Mckeag DB. Current issues in managing sports-related concussion. JAMA 1999; 282:2283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/91\">",
"      Cantu, RC, Voy, R. Second impact syndrome: a risk in any sport. Physician Sports Med 1995; 23:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/92\">",
"      McCrory PR, Berkovic SF. Second impact syndrome. Neurology 1998; 50:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/93\">",
"      McCrory P. Does second impact syndrome exist? Clin J Sport Med 2001; 11:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/94\">",
"      Cantu, RC. Guidelines for return to contact sports after a cerebral concussion. Physician Sports Med 1986; 14:75.",
"     </a>",
"    </li>",
"    <li>",
"     Guidelines for the management of concussion in sports. Rev May 1991. Colorado Medical Society, Denver 1991.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/96\">",
"      Halstead ME, Walter KD, Council on Sports Medicine and Fitness. American Academy of Pediatrics. Clinical report--sport-related concussion in children and adolescents. Pediatrics 2010; 126:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/97\">",
"      Gronwall D, Wrightson P. Cumulative effect of concussion. Lancet 1975; 2:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/98\">",
"      Guskiewicz KM, McCrea M, Marshall SW, et al. Cumulative effects associated with recurrent concussion in collegiate football players: the NCAA Concussion Study. JAMA 2003; 290:2549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/99\">",
"      Dikmen SS, Corrigan JD, Levin HS, et al. Cognitive outcome following traumatic brain injury. J Head Trauma Rehabil 2009; 24:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/100\">",
"      Paniak C, Reynolds S, Phillips K, et al. Patient complaints within 1 month of mild traumatic brain injury: a controlled study. Arch Clin Neuropsychol 2002; 17:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/101\">",
"      Baandrup L, Jensen R. Chronic post-traumatic headache--a clinical analysis in relation to the International Headache Classification 2nd Edition. Cephalalgia 2005; 25:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/102\">",
"      Nampiaparampil DE. Prevalence of chronic pain after traumatic brain injury: a systematic review. JAMA 2008; 300:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/103\">",
"      Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004; 24 Suppl 1:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/104\">",
"      Haas DC. Chronic post-traumatic headaches classified and compared with natural headaches. Cephalalgia 1996; 16:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/105\">",
"      Evans RW. Persistent post-traumatic headache, postconcussion syndrome, and whiplash injuries: the evidence for a non-traumatic basis with an historical review. Headache 2010; 50:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/106\">",
"      Annegers JF, Grabow JD, Groover RV, et al. Seizures after head trauma: a population study. Neurology 1980; 30:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/107\">",
"      Friedman JM. Post-traumatic vertigo. Med Health R I 2004; 87:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/108\">",
"      Hoffer ME, Gottshall KR, Moore R, et al. Characterizing and treating dizziness after mild head trauma. Otol Neurotol 2004; 25:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/109\">",
"      Ahn SK, Jeon SY, Kim JP, et al. Clinical characteristics and treatment of benign paroxysmal positional vertigo after traumatic brain injury. J Trauma 2011; 70:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/110\">",
"      Marzo SJ, Leonetti JP, Raffin MJ, Letarte P. Diagnosis and management of post-traumatic vertigo. Laryngoscope 2004; 114:1720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/111\">",
"      Chamelian L, Feinstein A. Outcome after mild to moderate traumatic brain injury: the role of dizziness. Arch Phys Med Rehabil 2004; 85:1662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/112\">",
"      Yang CC, Tu YK, Hua MS, Huang SJ. The association between the postconcussion symptoms and clinical outcomes for patients with mild traumatic brain injury. J Trauma 2007; 62:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/113\">",
"      De Kruijk JR, Leffers P, Menheere PP, et al. Prediction of post-traumatic complaints after mild traumatic brain injury: early symptoms and biochemical markers. J Neurol Neurosurg Psychiatry 2002; 73:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/114\">",
"      Lau BC, Kontos AP, Collins MW, et al. Which on-field signs/symptoms predict protracted recovery from sport-related concussion among high school football players? Am J Sports Med 2011; 39:2311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/115\">",
"      Gordon CR, Levite R, Joffe V, Gadoth N. Is posttraumatic benign paroxysmal positional vertigo different from the idiopathic form? Arch Neurol 2004; 61:1590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/116\">",
"      Coello AF, Canals AG, Gonzalez JM, Mart&iacute;n JJ. Cranial nerve injury after minor head trauma. J Neurosurg 2010; 113:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/117\">",
"      Yousem DM, Geckle RJ, Bilker WB, et al. Posttraumatic olfactory dysfunction: MR and clinical evaluation. AJNR Am J Neuroradiol 1996; 17:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/118\">",
"      Covassin T, Elbin R, Kontos A, Larson E. Investigating baseline neurocognitive performance between male and female athletes with a history of multiple concussion. J Neurol Neurosurg Psychiatry 2010; 81:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/119\">",
"      Omalu BI, DeKosky ST, Hamilton RL, et al. Chronic traumatic encephalopathy in a national football league player: part II. Neurosurgery 2006; 59:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/120\">",
"      Matser EJ, Kessels AG, Lezak MD, et al. Neuropsychological impairment in amateur soccer players. JAMA 1999; 282:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/121\">",
"      Matser JT, Kessels AG, Jordan BD, et al. Chronic traumatic brain injury in professional soccer players. Neurology 1998; 51:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/122\">",
"      De Beaumont L, Th&eacute;oret H, Mongeon D, et al. Brain function decline in healthy retired athletes who sustained their last sports concussion in early adulthood. Brain 2009; 132:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/123\">",
"      Martland, HS. Punch-drunk. JAMA 1928; 19:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/124\">",
"      Jordan BD. Chronic traumatic brain injury associated with boxing. Semin Neurol 2000; 20:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/125\">",
"      Loosemore M, Knowles CH, Whyte GP. Amateur boxing and risk of chronic traumatic brain injury: systematic review of observational studies. BMJ 2007; 335:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/126\">",
"      Ryan AJ. Intracranial injuries resulting from boxing. Clin Sports Med 1998; 17:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/127\">",
"      Cantu RC. Chronic traumatic encephalopathy in the National Football League. Neurosurgery 2007; 61:223.",
"     </a>",
"    </li>",
"    <li>",
"     Ardila, A. Mendez, MF. Dementia pugilistica. In: MedLink Neurology, Gilman, S (Ed), MedLink Corporation, San Diego 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/129\">",
"      Schmidt ML, Zhukareva V, Newell KL, et al. Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease. Acta Neuropathol 2001; 101:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/130\">",
"      Jordan BD, Relkin NR, Ravdin LD, et al. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. JAMA 1997; 278:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/131\">",
"      Kutner KC, Erlanger DM, Tsai J, et al. Lower cognitive performance of older football players possessing apolipoprotein E epsilon4. Neurosurgery 2000; 47:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/132\">",
"      Han SD, Drake AI, Cessante LM, et al. Apolipoprotein E and traumatic brain injury in a military population: evidence of a neuropsychological compensatory mechanism? J Neurol Neurosurg Psychiatry 2007; 78:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/133\">",
"      Chamelian L, Reis M, Feinstein A. Six-month recovery from mild to moderate Traumatic Brain Injury: the role of APOE-epsilon4 allele. Brain 2004; 127:2621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/134\">",
"      McKee AC, Gavett BE, Stern RA, et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010; 69:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/135\">",
"      Al-Chalabi A, Leigh PN. Trouble on the pitch: are professional football players at increased risk of developing amyotrophic lateral sclerosis? Brain 2005; 128:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/136\">",
"      McMillan TM, Teasdale GM, Weir CJ, Stewart E. Death after head injury: the 13 year outcome of a case control study. J Neurol Neurosurg Psychiatry 2011; 82:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/137\">",
"      Johnston KM, McCrory P, Mohtadi NG, Meeuwisse W. Evidence-Based review of sport-related concussion: clinical science. Clin J Sport Med 2001; 11:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/138\">",
"      Sulheim S, Holme I, Ekeland A, Bahr R. Helmet use and risk of head injuries in alpine skiers and snowboarders. JAMA 2006; 295:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/139\">",
"      Russell K, Christie J, Hagel BE. The effect of helmets on the risk of head and neck injuries among skiers and snowboarders: a meta-analysis. CMAJ 2010; 182:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/140\">",
"      McIntosh AS, McCrory P. Impact energy attenuation performance of football headgear. Br J Sports Med 2000; 34:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/141\">",
"      Finch CF, McIntosh AS, McCrory P. What do under 15 year old schoolboy rugby union players think about protective headgear? Br J Sports Med 2001; 35:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/59/29626/abstract/142\">",
"      Hagel B, Meeuwisse W. Risk compensation: a \"side effect\" of sport injury prevention? Clin J Sport Med 2004; 14:193.",
"     </a>",
"    </li>",
"    <li>",
"     Schwarz A. As Injuries Rise, Scant Oversight of Helmet Safety. New York Times. 10/20/10.  file://www.nytimes.com/2010/10/21/sports/football/21helmets.html?pagewanted=1&amp;_r=1&amp;sq=sports%20and%20concussion&amp;st=cse&amp;scp=27 (Accessed on October 23, 2010).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4828 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.111.122.2-E64CDCC3B7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29626=[""].join("\n");
var outline_f28_59_29626=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2195158\">",
"      Acute symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Complicated concussion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ACUTE EVALUATION AND MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cognitive assessment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Standardized Assessment of Concussion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Other measures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Observation and disposition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SEQUELAE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Second impact syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Return to play",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Postconcussion syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Post-traumatic headaches",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Post-traumatic epilepsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Post-traumatic vertigo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Other cranial nerve injuries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Cumulative neuropsychological impairment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5379452\">",
"      - Motor neuron disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1243455\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/4828\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/4828|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?17/7/17520\" title=\"algorithm 1\">",
"      Evaluation of patients with mild TBI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/4828|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/62/29676\" title=\"table 1\">",
"      Glasgow coma scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/26/42413\" title=\"table 2\">",
"      Standard assessment of concussion SAC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/57/27549\" title=\"table 3\">",
"      SAC unscored portion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/21/31067\" title=\"table 4\">",
"      Cantu guideline for concussion management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/31/23035\" title=\"table 5\">",
"      Colorado guidelines for concussion management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/28/26059\" title=\"table 6\">",
"      AAN parameter for concussion management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/27/44475\" title=\"table 7\">",
"      Return to play protocol",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13801?source=related_link\">",
"      Anatomy and etiology of taste and smell disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32057?source=related_link\">",
"      Approach to the patient with vertigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/13/19673?source=related_link\">",
"      Benign paroxysmal positional vertigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4250?source=related_link\">",
"      Initial approach to severe traumatic brain injury in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12906?source=related_link\">",
"      Minor head trauma in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/10/11431?source=related_link\">",
"      Overview of craniofacial pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25320?source=related_link\">",
"      Overview of diplopia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/38/17001?source=related_link\">",
"      Pathophysiology, etiology, and differential diagnosis of vertigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/47/8947?source=related_link\">",
"      Patient information: Closed head injury (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/12/22722?source=related_link\">",
"      Patient information: Concussion (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/31/41460?source=related_link\">",
"      Patient information: Dizziness and vertigo (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/44/14020?source=related_link\">",
"      Patient information: Head injury in children and adolescents (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/24/34178?source=related_link\">",
"      Patient information: Skull and facial fractures (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4935?source=related_link\">",
"      Post-traumatic seizures and epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33929?source=related_link\">",
"      Postconcussion syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13225?source=related_link\">",
"      Prevention of bicycle injuries in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/13/36058?source=related_link\">",
"      The preparticipation sports examination in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13559?source=related_link\">",
"      Treatment of vertigo",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_59_29627="Valvular disease vs age";
var content_f28_59_29627=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77504&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77504&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Prevalence of significant valvular heart disease found in population-based studies and stratified by age",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        &lt;49 yrs, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        50-59 yrs, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        60-69 yrs, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        &gt;70 yrs, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AS*",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MR&bull;",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        1.3",
"       </td>",
"       <td>",
"        2.3",
"       </td>",
"       <td>",
"        5.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AR&bull;",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        3.7",
"       </td>",
"       <td>",
"        2.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        TR&bull;",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        0.9",
"       </td>",
"       <td>",
"        3.6",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AS: aortic stenosis; MR: mitral regurgitation; AR: aortic regurgitation; TR: tricuspid regurgitation.",
"     <br>",
"      * Lindroos, M, Kupari, M, Heikkila, J, et al. J Am Coll Cardiol 1993; 21:1220.",
"      <br>",
"       &bull; Singh, JP, Evans, JC, Levy, D, et al. Am J Cardiol 1999; 83:897.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29627=[""].join("\n");
var outline_f28_59_29627=null;
var title_f28_59_29628="Dox combos desmoids";
var content_f28_59_29628=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F71589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F71589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Doxorubicin-based combination chemotherapy for desmoid tumors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Regimen",
"      </td>",
"      <td class=\"subtitle1\">",
"       No of patients",
"      </td>",
"      <td class=\"subtitle1\">",
"       Duration of therapy (cycles)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Response",
"      </td>",
"      <td class=\"subtitle1\">",
"       Duration of response",
"      </td>",
"      <td class=\"subtitle1\">",
"       Author, year",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       DOXO+DTIC",
"      </td>",
"      <td>",
"       11*",
"      </td>",
"      <td>",
"       2-10 cycles (median 5)",
"      </td>",
"      <td>",
"       <p>",
"        2 CR",
"       </p>",
"       <p>",
"        4 PR",
"       </p>",
"       <p>",
"        1 MR",
"       </p>",
"       <p>",
"        2 SD",
"       </p>",
"      </td>",
"      <td>",
"       29-235 months",
"      </td>",
"      <td>",
"       Patel, S; 1993",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       DOXO+DTIC",
"      </td>",
"      <td>",
"       5",
"      </td>",
"      <td>",
"       4-6 cycles (median 5) preoperatively",
"      </td>",
"      <td>",
"       <p>",
"        2 pCR",
"       </p>",
"       <p>",
"        3 PR",
"       </p>",
"      </td>",
"      <td>",
"       21-72 months&bull;",
"      </td>",
"      <td>",
"       Goepfert, H; 1982",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       DOXO+DTIC+Meloxicam",
"      </td>",
"      <td>",
"       7",
"      </td>",
"      <td>",
"       4-5 (median 5) cycles",
"      </td>",
"      <td>",
"       <p>",
"        3 CR",
"       </p>",
"       <p>",
"        4 PR",
"       </p>",
"      </td>",
"      <td>",
"       32.5-107.5 (median 74)",
"      </td>",
"      <td>",
"       Gega, M; 2006",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       DOXO+DTIC (7cycles) followed by CARBO+DTIC",
"      </td>",
"      <td>",
"       5",
"      </td>",
"      <td>",
"       6-19 cycles",
"      </td>",
"      <td>",
"       <p>",
"        1 CR",
"       </p>",
"       <p>",
"        3 PR",
"       </p>",
"       <p>",
"        1 SD&Delta;",
"       </p>",
"      </td>",
"      <td>",
"       10-30 months",
"      </td>",
"      <td>",
"       Schnitzler, M; 1997",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       DOXO+Cy or IF+VP-16 or IF+VP-16+MITO+DOXO+P",
"      </td>",
"      <td>",
"       7",
"      </td>",
"      <td>",
"       2-8 cycles (median 6)",
"      </td>",
"      <td>",
"       3 OR&loz;",
"      </td>",
"      <td>",
"       3-180 months",
"      </td>",
"      <td>",
"       Okuno, S; 2003",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     DOXO: doxorubicin; DTIC: dacarbazine; CARBO: carboplatin; Cy: cyclophosphamide; IF: ifosfamide; VP-16: etoposide; MITO: mitomycin; pCR: pathological CR; CR: complete response; PR: partial response; SD: stable disease; OR: objective response; MR: minor response.",
"     <br>",
"      * 9 out of 11 patients were evaluable, 2 patients were treated in 1970s could not be evaluated objectively but reported to have responses that enabled the resection of axillary and pelvic disease.",
"      <br>",
"       &bull; All patients received chemotherapy preoperatively, only 1 patient recurred after surgery at 21 months. All others remain NED.",
"       <br>",
"        &Delta; Patient progressed rapidly after cessation of chemotherapy.",
"        <br>",
"         &loz; All patients on chemotherapy showed some form of clinical benefit such as objective response or stable disease or symptomatic improvement.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29628=[""].join("\n");
var outline_f28_59_29628=null;
var title_f28_59_29629="Pulm drug complication I";
var content_f28_59_29629=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F54967%7EPULM%2F69778&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=15\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F54967%7EPULM%2F69778&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=15\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pulmonary complications of cardiovascular drugs",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Agent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Syndrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency",
"       </td>",
"       <td class=\"subtitle1\">",
"        Potential mechanism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Procainamide",
"       </td>",
"       <td>",
"        SLE-like syndrome",
"       </td>",
"       <td>",
"        50 to 90 percent of patients have positive ANA test; 10",
"to 20 percent become symptomatic; pleuritis, pleural effusion, and",
"parenchymal infiltrates are common",
"       </td>",
"       <td>",
"        Autoantibodies against histone H2A-H2B complex,",
"potentially induced by interaction of drug",
"metabolites with DNA, or drug-induced alteration in T-cell DNA",
"methylation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Quinidine",
"       </td>",
"       <td>",
"        SLE-like syndrome",
"       </td>",
"       <td>",
"        Rare; pleuritis and pleural effusions are most common",
"pulmonary signs; parenchymal infiltrates uncommon",
"       </td>",
"       <td>",
"        Autoantibodies against histone H2A-H2B complex,",
"potentially induced by interaction of drug",
"metabolites with DNA, or drug-induced alteration in T-cell DNA",
"methylation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tocainide",
"       </td>",
"       <td>",
"        Pneumonitis/fibrosis",
"       </td>",
"       <td>",
"        Incidence is about 0.3 percent",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Flecainide",
"       </td>",
"       <td>",
"        Pneumonitis/fibrosis",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mexiletine",
"       </td>",
"       <td>",
"        Pneumonitis/fibrosis",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Unknown; interferes with theophylline metabolism and",
"can cause toxic elevations",
"in theophylline levels in serum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        ACE inhibitors",
"       </td>",
"       <td>",
"        Cough",
"       </td>",
"       <td>",
"        Incidence is 5 to 15 percent; occurs with all ACE",
"inhibitors; whether these agents precipitate bronchospasm in patients",
"with asthma is controversial",
"       </td>",
"       <td>",
"        Decreased degradation of irritant and",
"bronchoconstrictive mediators (bradykinin and",
"substance P); direct increase in sensitivity to irritant-induced",
"cough; genetic predisposition (based on differences in ACE gene).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Angioneurotic edema",
"       </td>",
"       <td>",
"        Rare; can lead to respiratory failure",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sotalol",
"       </td>",
"       <td>",
"        Bronchospasm",
"       </td>",
"       <td>",
"        Occurs in 2 percent of patients",
"       </td>",
"       <td>",
"        Direct blockage of &beta;2-receptors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adenosine",
"       </td>",
"       <td>",
"        Bronchospasm",
"       </td>",
"       <td>",
"        Occurs with rapid infusion in 5 to 10 percent of",
"patients; may trigger acute bronchospasm in patients with asthma or",
"COPD. Reversible with aminophylline",
"       </td>",
"       <td>",
"        Induction of mast cell mediator release",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Zitnik, RJ, J Respir Dis 1996; 17:254; and Zitnik, RJ, J Respir Dis 1996; 17:293.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pulmonary complications of cardiovascular drugs",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Agent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Syndrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency",
"       </td>",
"       <td class=\"subtitle1\">",
"        Potential mechanism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Beta blockers",
"       </td>",
"       <td>",
"        Cough or bronchospasm",
"       </td>",
"       <td>",
"        Common; usually occurs in patients with asthma or COPD;&nbsp;&beta;1-selective agents, labetalol, esmolol, and pindolol are",
"better tolerated than nonselective agents",
"       </td>",
"       <td>",
"        Direct antagonism of &beta;2 receptor-mediated",
"bronchodilation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary fibrosis",
"       </td>",
"       <td>",
"        Rare&nbsp;",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lupus-like syndrome",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydralazine",
"       </td>",
"       <td>",
"        Lupus-like syndrome",
"       </td>",
"       <td>",
"        Renal disease more common than in other drug-induced",
"lupus-like syndromes",
"       </td>",
"       <td>",
"        Unknown; slow acetylation may be a risk factor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dipyridamole (IV form only)",
"       </td>",
"       <td>",
"        Bronchospasm",
"       </td>",
"       <td>",
"        Occurs in about 0.15 percent of patients during",
"infusion for stress testing",
"       </td>",
"       <td>",
"        Induction of mast cell mediator release",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Protamine",
"       </td>",
"       <td>",
"        Anaphylaxis, uritcaria, angioedema, bronchospasm",
"       </td>",
"       <td>",
"        Occurs in 0.2 percent of patients",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary hypertension",
"       </td>",
"       <td>",
"        Mild pulmonary hypertension and systemic hypotension in",
"up to 5 percent of patients; severe reaction rare",
"       </td>",
"       <td>",
"        Antiprotamine antibodies; activated neutrophils;",
"thromboxane A2 generation",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Zitnik, RJ, J Respir Dis 1996; 17:254; and Zitnik, RJ, J Respir Dis 1996; 17:293.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29629=[""].join("\n");
var outline_f28_59_29629=null;
var title_f28_59_29630="Dobutamine echo mortality-II";
var content_f28_59_29630=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 497px\">",
"   <div class=\"ttl\">",
"    Dobutamine echocardiography predicts cardiac mortality",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 477px; height: 437px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In a study of 3156 patients, those with an abnormal dobutamine echocardiogram (ischemic, scar, or mixed) have a higher cardiac mortality compared to those with a normal echocardiogram. The highest mortality is in those with both scar and ischemia (mixed). Kaplan-Meier survival curves for the prediction of cardiac mortality based on results of dobutamine echocardiography.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Marwick, TH, Case, C, Sawada, S, J Am Coll Cardiol 2001; 37:754.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29630=[""].join("\n");
var outline_f28_59_29630=null;
var title_f28_59_29631="Traumatic ulcer 1";
var content_f28_59_29631=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F61973&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F61973&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Traumatic gingival ulcer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gingival ulceration resulting from a nervous habit of gingival scratching in an 8-year-old child.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Delaney JE, Keels MA. Pediatric oral pathology. Soft tissue and periodontal conditions. Pediatr Clin North Am 2000; 47:1125. Copyright &copy; 2000 W.B. Saunders.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_59_29631=[""].join("\n");
var outline_f28_59_29631=null;
